data_1v4r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1v4r _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.757 0.789 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.669 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 23.3 ttpt -94.67 118.71 32.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.489 -170.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.44 142.67 50.47 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.005 -173.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.65 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 72.1 Cg_endo -79.33 112.18 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.757 2.305 . . . . 0.0 111.713 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -70.34 -56.21 7.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.414 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.88 34.98 0.62 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.92 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HD2' ' CB ' ' A' ' 13' ' ' ASP . 51.2 pttt -123.34 148.88 45.56 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.813 -0.227 . . . . 0.0 110.906 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.9 -140.52 10.08 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.614 ' HA ' HG11 ' A' ' 14' ' ' VAL . 4.2 p90 -80.29 10.83 4.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.849 0.459 . . . . 0.0 112.209 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.87 -38.82 19.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.48 ' CB ' ' HD2' ' A' ' 9' ' ' LYS . 24.4 t70 -70.57 -35.46 73.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.338 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.703 ' HB ' ' HD2' ' A' ' 43' ' ' PHE . 2.5 p -71.58 -42.81 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.499 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.82 -37.53 76.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.237 0.541 . . . . 0.0 109.859 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.3 m -67.83 -46.08 72.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.122 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -78.22 -20.8 51.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.513 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -69.74 -29.2 66.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.841 0.353 . . . . 0.0 110.397 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -61.68 -23.4 66.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.492 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m -80.49 -44.29 19.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 21' ' ' LEU . 1.5 mm? -53.53 -40.76 65.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.29 0.567 . . . . 0.0 111.295 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.651 HD13 HG13 ' A' ' 73' ' ' VAL . 19.3 mm -72.82 -14.3 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.477 -176.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -75.88 -75.93 0.17 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 26' ' ' GLU . 5.5 t -119.39 -31.87 4.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.951 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 26' ' ' GLU . . . 10.31 -41.01 0.0 OUTLIER Glycine 0 C--N 1.354 1.576 0 C-N-CA 129.745 3.545 . . . . 0.0 119.558 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 24' ' ' SER . 2.0 pt-20 111.79 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.834 2.054 . . . . 0.0 107.949 -162.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 32.4 tp -112.79 58.5 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.467 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.54 166.34 14.89 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.758 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 7.6 Cg_exo -74.01 121.25 6.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 120.948 1.098 . . . . 0.0 110.428 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.3 -6.48 12.93 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.673 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -108.65 158.7 17.35 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.811 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 6.3 m -94.35 148.47 22.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.734 0.302 . . . . 0.0 111.287 -172.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.793 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.3 mp -54.79 135.72 65.15 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.712 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.38 171.3 17.12 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.222 2.614 . . . . 0.0 112.051 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -72.31 156.94 38.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.3 m -54.98 -21.58 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 122.707 0.403 . . . . 0.0 112.066 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.15 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.8 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.38 -51.09 67.3 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 109.798 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.793 HG22 ' HB ' ' A' ' 50' ' ' VAL . 4.8 mp -56.96 -50.17 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.269 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.889 ' HA ' ' HE1' ' A' ' 43' ' ' PHE . 63.0 ttt180 -44.71 -33.57 1.91 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.38 -33.89 13.68 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.926 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -75.14 -44.94 44.14 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.806 0.812 . . . . 0.0 109.052 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.889 ' HE1' ' HA ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -89.45 119.72 30.14 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 172.322 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' A' ' 4' ' ' LYS . . . -73.51 53.62 1.96 Allowed Glycine 0 C--N 1.302 -1.321 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.713 ' HB ' ' CD2' ' A' ' 43' ' ' PHE . 1.8 t -136.38 170.58 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -161.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' O ' ' CZ ' ' A' ' 43' ' ' PHE . . . -78.49 152.16 32.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.29 40.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.144 0.497 . . . . 0.0 110.9 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 5.4 tmmm? -92.61 -24.22 18.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.789 171.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.493 HG21 ' HA ' ' A' ' 11' ' ' TYR . 4.1 m -69.34 -27.9 65.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.793 ' HB ' HG22 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -61.59 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 54' ' ' LEU . 32.3 t -63.5 -14.37 50.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.252 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' THR . 5.6 mmp_? -81.03 -58.17 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.683 0.278 . . . . 0.0 110.258 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.659 ' HB1' HG13 ' A' ' 14' ' ' VAL . . . -63.75 -25.41 68.18 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 41.4 mt -49.08 -38.91 25.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -18.93 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.988 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.06 -28.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.544 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.902 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -72.58 -1.93 17.94 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.988 -173.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 57.7 pttt -66.69 -42.35 86.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 78' ' ' ILE . 2.8 m -94.77 -36.17 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.003 0.906 . . . . 0.0 109.24 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 11.1 tp10 -83.95 -66.07 0.94 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.032 -169.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.902 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -83.29 1.18 89.12 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.635 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.84 HD23 HG13 ' A' ' 78' ' ' ILE . 20.7 mt 73.2 37.27 0.76 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 172.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 8.4 p -113.15 150.16 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.739 -0.6 . . . . 0.0 111.332 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.819 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 31.8 t -148.32 145.28 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.385 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -67.9 106.8 2.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 7.0 ttm180 -114.3 97.38 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.996 -176.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.69 50.51 2.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.311 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.23 -63.89 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' HB2' HG23 ' A' ' 72' ' ' VAL . 71.0 mt -91.2 -14.36 31.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.543 176.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 114.11 -160.98 12.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.896 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.793 HG23 ' HB2' ' A' ' 33' ' ' LEU . 6.4 t -78.78 81.81 5.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.427 1.108 . . . . 0.0 109.611 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.811 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 38.5 t -92.94 141.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.671 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.651 HG13 HD13 ' A' ' 22' ' ' ILE . 4.5 t -88.22 75.67 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.815 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -146.56 80.31 1.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.737 158.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.819 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 88.2 tttt -98.85 -85.59 0.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.196 0.998 . . . . 0.0 111.745 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 5.9 t-20 -130.23 95.13 28.51 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.88 -165.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.41 122.63 4.84 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.021 1.814 . . . . 0.0 111.059 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.84 HG13 HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -56.3 136.15 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -175.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 C--N 1.32 -0.687 0 O-C-N 124.395 1.059 . . . . 0.0 111.697 179.221 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.5 p90 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 44' ' ' GLY . 58.0 tttp -104.92 145.26 30.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.757 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 163.24 20.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.596 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.507 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 10.1 Cg_exo -76.08 96.24 1.06 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.121 1.88 . . . . 0.0 112.18 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.568 ' N ' ' HE3' ' A' ' 9' ' ' LYS . 1.8 mp0 -63.89 -65.38 0.69 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.18 54.1 0.31 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.039 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.772 ' HG3' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -123.42 164.98 17.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.918 0.389 . . . . 0.0 110.716 -176.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.39 -143.54 10.56 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.661 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 3.0 p90 -70.87 2.34 4.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.409 . . . . 0.0 111.524 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.26 54.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.569 . . . . 0.0 110.207 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.772 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 2.5 t70 -73.99 -47.99 33.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.743 HG11 HG12 ' A' ' 45' ' ' VAL . 33.0 m -70.22 -31.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.407 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.604 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.64 -45.15 89.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.253 0.549 . . . . 0.0 109.656 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -68.43 -34.43 75.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.704 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.669 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 45.0 t-80 -52.87 -54.38 35.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.954 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.408 ' CG ' HD13 ' A' ' 57' ' ' LEU . 5.7 m-85 -68.03 -40.17 82.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.811 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -60.88 -27.43 68.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.841 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.432 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 37.9 m -80.06 -36.01 36.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 0.0 109.95 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.867 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 68.8 mt -70.86 -44.81 65.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.223 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 61' ' ' GLY . 49.2 mm -68.69 -21.8 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.457 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 22.6 ttmm -56.78 -63.73 1.11 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.798 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -114.29 -33.16 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.8 -29.67 0.03 OUTLIER Glycine 0 CA--C 1.511 -0.177 0 C-N-CA 118.666 -1.731 . . . . 0.0 114.538 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.2 -57.57 12.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -164.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.867 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 tp -98.44 89.19 4.35 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.42 153.79 65.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.479 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 63.4 Cg_endo -77.31 137.63 17.04 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.102 1.868 . . . . 0.0 112.092 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.91 -24.99 9.14 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.007 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.41 161.85 14.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -79.03 161.23 26.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.731 0.3 . . . . 0.0 111.355 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.4 145.64 98.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.332 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.11 171.49 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.826 2.351 . . . . 0.0 112.507 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.8 p -79.27 159.59 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.06 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.439 ' HA ' HD12 ' A' ' 39' ' ' ILE . 25.2 m -54.01 -26.25 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.9 82.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.131 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.33 -29.66 66.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 110.297 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.669 ' HA ' ' CE1' ' A' ' 17' ' ' HIS . 3.7 mp -75.48 -49.94 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.244 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 22.0 ttm180 -66.93 -46.95 73.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.12 75.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 0.0 110.955 -170.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -84.39 -65.96 0.95 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.175 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.443 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 18.8 m-85 -93.48 102.12 14.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.269 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.611 ' H ' ' HD3' ' A' ' 4' ' ' LYS . . . -57.37 99.56 0.1 Allowed Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.624 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.743 HG12 HG11 ' A' ' 14' ' ' VAL . 19.4 m -140.73 179.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.115 0.483 . . . . 0.0 111.384 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -97.89 176.35 5.82 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.44 52.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.79 0.329 . . . . 0.0 110.748 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -79.16 -29.72 43.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 109.955 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.543 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.8 m -63.69 -43.58 96.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.539 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.661 ' HA ' HG13 ' A' ' 14' ' ' VAL . 96.4 t -55.81 -58.86 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.782 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.677 ' HA ' HD13 ' A' ' 54' ' ' LEU . 26.0 t -68.37 -6.41 24.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.871 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 4.6 tpm_? -77.74 -50.67 11.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.542 0.211 . . . . 0.0 110.678 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.734 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -90.74 -9.89 45.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 51' ' ' SER . 95.5 mt -51.6 -31.06 23.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.825 0.284 . . . . 0.0 111.486 174.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.845 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 44.2 t -80.73 -30.39 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.742 0.782 . . . . 0.0 109.514 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.604 HD21 ' HA ' ' A' ' 15' ' ' ALA . 86.9 mt -76.06 1.27 15.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.632 -173.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -66.04 -56.45 11.5 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.4 p -93.57 -34.43 13.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.481 0.657 . . . . 0.0 110.356 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.4 tp10 -77.07 -52.14 9.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.722 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.563 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -90.52 -7.4 67.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.977 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp 63.04 66.7 0.72 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.812 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 57' ' ' LEU . 31.1 m -136.14 162.49 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.681 175.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.8 m -144.59 128.5 17.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.139 0.495 . . . . 0.0 111.372 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -78.53 92.76 4.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 9.9 tpt180 -85.45 101.87 12.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.92 50.66 2.28 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.647 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.87 -60.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.05 -16.23 44.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.434 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 109.53 178.42 21.21 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.666 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.66 99.26 3.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 19.5 m -117.61 159.94 17.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 111.417 -170.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 22.3 t -85.68 93.82 3.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.789 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.585 ' HG3' HG23 ' A' ' 72' ' ' VAL . 31.2 mt-10 -102.64 151.3 22.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.675 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 57.6 mtpt -68.51 88.55 0.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -94.75 96.04 1.76 Allowed Pre-proline 0 CA--C 1.503 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.675 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 50.8 Cg_exo -56.39 151.34 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.216 1.944 . . . . 0.0 112.405 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.412 ' H ' HG13 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -55.7 105.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.052 -178.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 t . . . . . 0 C--N 1.32 -0.703 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.642 -179.589 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 121.026 0.441 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -85.05 134.88 34.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.958 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.35 150.05 36.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.451 0.167 . . . . 0.0 111.182 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.59 118.45 4.21 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.067 2.512 . . . . 0.0 111.681 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -99.66 -74.41 0.6 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.707 -175.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.96 29.52 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.405 -176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -116.61 156.66 26.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.09 -107.7 2.66 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.921 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -95.85 -12.25 25.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 174.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.51 9.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.501 0.667 . . . . 0.0 111.141 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD1' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -91.14 -52.8 4.65 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.388 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.685 HG13 HH22 ' A' ' 52' ' ' ARG . 2.0 m -68.74 -34.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.642 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.554 ' HA ' HD13 ' A' ' 57' ' ' LEU . . . -55.73 -44.71 77.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.64 170.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -64.57 -39.11 93.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.527 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 22.9 t60 -57.62 -48.01 80.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.471 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.37 -40.31 85.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.192 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -56.66 -27.57 58.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.588 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 m -85.33 -54.02 4.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.802 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.792 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . 3.3 pp -75.64 -12.04 60.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.554 -172.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.02 -41.48 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 110.452 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -92.9 -13.34 29.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.218 0.533 . . . . 0.0 110.513 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.739 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 23.0 t -86.54 26.79 1.03 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.317 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.15 25.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.792 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.2 mt-10 -69.79 -34.98 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' HG ' HD13 ' A' ' 21' ' ' LEU . 61.0 mt -122.9 92.1 3.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.526 166.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.05 54.63 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 5.8 Cg_exo -75.19 123.47 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.669 1.579 . . . . 0.0 110.691 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.35 27.89 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.43 163.5 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.877 ' HB ' HG21 ' A' ' 71' ' ' THR . 6.7 t -107.88 161.9 14.5 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -172.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.789 HD12 ' HB ' ' A' ' 63' ' ' VAL . 4.2 mp -57.52 109.69 1.95 Allowed Pre-proline 0 N--CA 1.432 -1.357 0 CA-C-N 111.196 -2.729 . . . . 0.0 108.435 167.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.95 175.41 10.87 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 123.359 2.706 . . . . 0.0 113.225 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -64.69 158.12 25.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.49 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.31 -19.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.02 -52.99 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.21 -53.42 58.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.375 0.607 . . . . 0.0 111.08 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.695 HD11 ' H ' ' A' ' 39' ' ' ILE . 4.2 mp -56.05 -53.66 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.652 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 43.8 ttp180 -65.6 -40.03 92.22 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.79 -46.23 25.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -75.84 -56.45 4.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.938 0.399 . . . . 0.0 110.673 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 45' ' ' VAL . 5.2 m-85 -91.81 103.99 16.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.795 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.79 86.31 0.01 OUTLIER Glycine 0 CA--C 1.516 0.111 0 O-C-N 124.642 1.214 . . . . 0.0 114.459 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 43' ' ' PHE . 33.6 m -137.77 177.38 5.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -97.17 178.89 5.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.57 -33.11 58.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.096 0.474 . . . . 0.0 109.973 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.941 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -68.49 -36.79 79.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 175.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.725 HG23 ' HE ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -65.18 -53.3 46.88 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 46' ' ' ALA . 92.0 t -41.25 -52.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.596 -0.69 . . . . 0.0 111.189 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.639 ' HA ' HD13 ' A' ' 54' ' ' LEU . 47.9 t -60.75 -34.07 73.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.063 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.921 ' CZ ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -72.25 -31.31 65.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.548 -169.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.655 ' N ' ' HD2' ' A' ' 52' ' ' ARG . . . -91.12 -5.37 55.18 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.671 -0.643 . . . . 0.0 111.807 173.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.639 HD13 ' HA ' ' A' ' 51' ' ' SER . 44.5 mt -57.88 -35.05 70.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.708 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.16 -18.16 64.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.009 176.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 60' ' ' GLU . 34.3 t -90.46 -29.22 4.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.622 ' O ' HG21 ' A' ' 63' ' ' VAL . 1.2 mp -73.85 2.89 7.48 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.251 -174.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.97 -41.8 20.29 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.403 ' HG ' ' HB ' ' A' ' 78' ' ' ILE . 15.7 m -94.04 -41.68 9.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.773 0.797 . . . . 0.0 109.887 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.488 ' HB3' HG11 ' A' ' 56' ' ' VAL . 39.0 tp10 -89.6 -34.49 16.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.809 -175.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -90.72 -10.3 63.35 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.561 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 11.2 mp 79.36 12.78 1.19 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.789 ' HB ' HD12 ' A' ' 33' ' ' LEU . 9.3 m -100.91 154.62 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.647 -0.658 . . . . 0.0 109.5 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -128.28 179.01 5.86 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.611 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -52.47 122.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.829 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.777 ' HA ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -64.94 163.93 13.57 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.374 -168.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.79 -67.45 1.43 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.683 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.71 -16.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.711 0.767 . . . . 0.0 109.504 168.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -93.64 -39.21 10.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.404 -170.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.704 ' N ' ' HG3' ' A' ' 66' ' ' ARG . . . 143.33 -5.04 1.83 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.706 -166.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.877 HG21 ' HB ' ' A' ' 32' ' ' THR . 89.0 m -97.52 92.86 6.13 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.777 HG21 ' HA ' ' A' ' 66' ' ' ARG . 90.8 t -151.52 96.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 123.852 0.72 . . . . 0.0 112.095 156.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 60.5 t -89.07 130.38 38.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 159.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 29' ' ' PRO . 40.1 mt-10 -133.39 165.14 25.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -84.87 49.01 1.64 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 166.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -118.95 91.9 44.02 Favored Pre-proline 0 CA--C 1.515 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.477 -170.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.25 115.9 4.04 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.821 1.681 . . . . 0.0 109.473 171.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.403 ' HB ' ' HG ' ' A' ' 59' ' ' SER . 19.1 mt -70.74 100.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.984 -176.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.47 0.553 0 O-C-N 124.728 1.268 . . . . 0.0 111.335 177.836 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.3 t80 . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.81 117.88 24.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.851 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.1 167.44 21.61 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.427 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.48 92.09 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.339 2.026 . . . . 0.0 110.804 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.497 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 9.3 pt-20 -71.39 73.31 0.71 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.905 -176.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.83 16.55 68.31 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.67 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.497 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 60.1 pttt -124.25 147.63 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.541 0.21 . . . . 0.0 110.456 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.1 -137.69 7.18 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.13 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.401 ' HA ' HG21 ' A' ' 49' ' ' THR . 11.1 p90 -68.48 -9.55 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.789 0.328 . . . . 0.0 111.81 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.47 -17.44 56.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.849 0.357 . . . . 0.0 110.516 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.476 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 15.5 t70 -74.36 -51.56 14.74 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.909 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.64 HG22 ' HB2' ' A' ' 53' ' ' ALA . 2.2 m -68.86 -33.7 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.72 63.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.966 0.413 . . . . 0.0 110.578 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -74.16 -37.04 64.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.21 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -68.13 -36.41 79.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.493 ' CG ' HD22 ' A' ' 57' ' ' LEU . 5.2 m-85 -65.05 -44.28 89.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 0.0 110.14 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.595 ' HG2' ' HA2' ' A' ' 61' ' ' GLY . 73.8 mtp180 -53.11 -26.38 16.29 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.281 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.616 HG21 ' HB2' ' A' ' 24' ' ' SER . 13.1 m -88.53 -54.78 4.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.668 HD21 HD13 ' A' ' 27' ' ' LEU . 1.1 tp -52.55 -26.63 13.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.608 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 18' ' ' PHE . 1.3 mp -50.03 -58.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.688 0.28 . . . . 0.0 110.421 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.424 ' N ' HG22 ' A' ' 22' ' ' ILE . 16.5 ptpt -94.46 -29.54 14.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.616 ' HB2' HG21 ' A' ' 20' ' ' THR . 38.9 m -102.47 28.66 5.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.285 -171.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.66 ' HA3' HD12 ' A' ' 21' ' ' LEU . . . -165.1 20.57 0.12 Allowed Glycine 0 CA--C 1.505 -0.544 0 C-N-CA 119.37 -1.395 . . . . 0.0 112.239 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 64.92 10.35 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.56 -0.82 . . . . 0.0 112.852 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.668 HD13 HD21 ' A' ' 21' ' ' LEU . 23.2 mt -84.2 59.15 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 160.46 28.42 Favored Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 6.5 Cg_exo -75.09 136.77 20.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.944 1.763 . . . . 0.0 112.322 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.95 -17.75 11.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.717 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -95.55 159.89 14.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.606 HG23 HG11 ' A' ' 72' ' ' VAL . 36.8 p -78.66 165.06 24.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.636 0.255 . . . . 0.0 111.137 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.86 141.6 98.39 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 171.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HG2' HD11 ' A' ' 39' ' ' ILE . 57.0 Cg_endo -77.71 163.86 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.379 2.052 . . . . 0.0 111.669 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 m -65.81 140.31 58.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.456 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HA ' HD12 ' A' ' 39' ' ' ILE . 31.0 m -52.07 -27.19 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.81 86.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -66.67 -48.8 68.2 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.283 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.608 ' H ' HD13 ' A' ' 39' ' ' ILE . 4.2 mp -55.02 -50.76 60.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.257 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 19.9 ptt180 -81.17 -9.75 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -173.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.01 -38.66 17.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.721 0.296 . . . . 0.0 110.282 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.647 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.1 OUTLIER -87.99 -59.13 2.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.637 0.732 . . . . 0.0 110.09 177.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.554 ' O ' HG21 ' A' ' 45' ' ' VAL . 21.0 m-85 -90.23 81.85 6.07 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.416 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.56 92.67 0.01 OUTLIER Glycine 0 CA--C 1.523 0.564 0 O-C-N 124.613 1.196 . . . . 0.0 115.274 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.674 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 14.7 m -139.01 178.71 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.19 -175.02 5.15 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.8 51.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.372 . . . . 0.0 111.246 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -90.24 -22.32 21.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.521 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.674 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.5 m -64.16 -35.34 80.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.539 -174.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.548 HG11 HG23 ' A' ' 39' ' ' ILE . 65.1 t -56.17 -59.1 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.331 0.586 . . . . 0.0 110.571 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.601 ' HA ' HD12 ' A' ' 54' ' ' LEU . 42.1 t -66.14 -14.26 61.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.815 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -77.17 -40.53 45.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 109.847 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.64 ' HB2' HG22 ' A' ' 14' ' ' VAL . . . -74.17 -30.67 62.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.562 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.601 HD12 ' HA ' ' A' ' 51' ' ' SER . 83.9 mt -51.92 -30.39 24.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . . . -68.59 -24.43 64.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.962 0.41 . . . . 0.0 111.096 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.93 -23.8 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.734 0.778 . . . . 0.0 109.448 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.674 ' HG ' ' HA3' ' A' ' 61' ' ' GLY . 4.5 mp -68.67 -19.49 64.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.019 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HE3' ' HA ' ' A' ' 55' ' ' ALA . 73.8 mttt -54.42 -59.23 4.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.166 0.508 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -93.02 -41.24 10.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.95 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HG2' ' HD2' ' A' ' 19' ' ' ARG . 23.4 tt0 -93.2 -55.79 3.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.966 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.674 ' HA3' ' HG ' ' A' ' 57' ' ' LEU . . . -75.31 -10.23 84.38 Favored Glycine 0 N--CA 1.461 0.302 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.814 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.927 HD23 HG13 ' A' ' 78' ' ' ILE . 7.7 mt 69.74 80.33 0.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.686 0.755 . . . . 0.0 111.966 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.425 HG13 ' C ' ' A' ' 57' ' ' LEU . 9.0 p -140.32 161.29 25.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.2 m -141.77 102.23 4.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.215 0.531 . . . . 0.0 111.171 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 9.4 m -72.37 86.53 1.13 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 34.2 mmt180 -68.93 125.25 26.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.692 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.97 -9.0 87.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.925 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.54 -45.37 4.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.863 0.363 . . . . 0.0 110.999 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.34 -18.04 29.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.389 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 102.38 172.87 27.18 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 2.7 m -72.06 103.86 3.4 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.606 HG11 HG23 ' A' ' 32' ' ' THR . 23.1 m -121.96 169.5 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.238 -172.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 31.5 t -93.23 114.15 29.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.222 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.547 ' HG2' HG22 ' A' ' 72' ' ' VAL . 6.0 mm-40 -126.31 146.79 49.88 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -72.93 77.87 1.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 173.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.432 ' O ' HD22 ' A' ' 62' ' ' LEU . 59.9 t30 -64.65 132.69 95.49 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.05 113.97 1.71 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.076 1.184 . . . . 0.0 110.35 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.927 HG13 HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -64.09 127.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 172.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.322 -0.606 0 O-C-N 124.056 0.847 . . . . 0.0 110.638 178.256 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.539 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 6.3 p90 . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -93.36 137.99 32.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -78.63 146.65 69.78 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.132 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 2.7 Cg_exo -77.68 117.42 4.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.746 2.297 . . . . 0.0 112.622 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -86.95 -157.61 0.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.04 175.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.428 ' H ' ' CD ' ' A' ' 7' ' ' GLU . . . -74.58 60.46 2.45 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.545 ' HD2' ' O ' ' A' ' 44' ' ' GLY . 19.5 ptpt -122.53 178.37 5.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 0.0 110.249 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.27 -148.47 5.44 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.271 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.561 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -71.15 -10.68 60.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.65 -17.98 57.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 110.397 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.476 ' CG ' ' HZ2' ' A' ' 9' ' ' LYS . 26.9 t70 -71.08 -45.97 62.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.388 175.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.643 HG23 HG13 ' A' ' 45' ' ' VAL . 72.0 t -59.9 -40.25 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.065 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.58 ' HA ' HD13 ' A' ' 57' ' ' LEU . . . -57.2 -43.57 82.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -61.33 -34.77 75.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.708 ' CD2' ' HA ' ' A' ' 39' ' ' ILE . 5.2 t60 -67.53 -44.93 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.102 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.584 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-85 -69.21 -46.47 67.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.984 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -61.01 -19.43 61.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -85.66 -51.15 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.967 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.635 HD13 HD13 ' A' ' 27' ' ' LEU . 3.9 pp -71.84 -21.83 61.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 18' ' ' PHE . 26.5 mm -61.12 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 110.739 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -85.11 1.19 48.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.231 0.538 . . . . 0.0 110.525 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 26' ' ' GLU . 27.5 t -96.88 24.93 5.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.603 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 22.34 26.12 0.0 OUTLIER Glycine 0 N--CA 1.475 1.268 0 N-CA-C 117.374 1.71 . . . . 0.0 117.374 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 24' ' ' SER . 7.9 pt-20 -85.78 -34.66 21.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.671 HD21 ' HG3' ' A' ' 34' ' ' PRO . 9.9 mp -109.16 72.77 0.82 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 166.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.55 153.31 83.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.483 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.45 123.21 7.47 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.113 1.875 . . . . 0.0 111.284 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.55 -10.03 10.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.033 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.2 161.31 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.587 HG23 HG12 ' A' ' 72' ' ' VAL . 17.1 p -81.53 167.77 18.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.883 0.373 . . . . 0.0 111.478 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.77 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.4 mm? -65.12 140.08 97.87 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.336 175.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.671 ' HG3' HD21 ' A' ' 27' ' ' LEU . 57.3 Cg_endo -76.95 165.56 28.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.598 2.199 . . . . 0.0 111.565 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -74.08 156.09 37.81 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.405 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 28.0 m -52.48 -22.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.76 -52.57 64.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -58.16 -30.24 66.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.043 0.449 . . . . 0.0 110.974 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.708 ' HA ' ' CD2' ' A' ' 17' ' ' HIS . 4.3 mp -80.02 -59.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.519 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 33.5 ptt180 -79.03 -19.88 50.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -166.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . . . -76.69 -39.76 51.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.396 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -78.71 -62.07 1.81 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.708 . . . . 0.0 109.206 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 9.7 m-85 -92.17 105.1 17.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.956 176.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' A' ' 9' ' ' LYS . . . -60.41 91.56 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.157 0 CA-C-N 115.225 -0.898 . . . . 0.0 114.0 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.646 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 17.6 m -134.82 178.31 5.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.408 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -94.98 -170.55 2.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.09 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -76.21 -22.71 54.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.646 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -65.68 -42.05 91.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 110.158 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.461 ' HA ' HG22 ' A' ' 14' ' ' VAL . 99.1 t -59.48 -55.84 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.715 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 t -66.9 -12.11 58.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.675 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -82.4 -36.13 27.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.038 0.446 . . . . 0.0 110.223 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.492 ' O ' HD11 ' A' ' 57' ' ' LEU . . . -74.3 -29.85 61.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.277 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 83.7 mt -49.28 -32.26 10.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.62 -28.63 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.076 0.465 . . . . 0.0 111.355 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.27 -25.16 5.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.877 0.846 . . . . 0.0 109.76 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.63 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -76.48 -5.04 45.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.46 -175.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -66.02 -40.11 90.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 p -93.14 -53.8 3.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.573 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -81.35 -38.32 26.87 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -172.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.63 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -90.49 -3.56 71.65 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.489 -174.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.665 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 10.1 mp 57.85 57.08 4.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.084 0.469 . . . . 0.0 111.808 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 57' ' ' LEU . 33.7 m -124.57 161.39 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.1 t -130.56 143.56 50.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.064 0.459 . . . . 0.0 111.337 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 p -82.78 103.04 11.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.551 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 12.1 tpp180 -118.43 48.43 1.43 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.3 4.12 2.07 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.978 -169.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.0 -47.02 21.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.05 -62.1 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 175.1 171.31 39.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.146 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.77 HG23 ' HB2' ' A' ' 33' ' ' LEU . 4.9 t -70.0 134.71 48.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 -174.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 32' ' ' THR . 34.3 m -131.47 162.51 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.311 -171.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -99.15 113.58 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -123.58 144.34 49.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -69.18 78.67 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.438 0.461 . . . . 0.0 110.858 -174.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.665 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 18.2 m-80 -73.6 116.54 52.54 Favored Pre-proline 0 CA--C 1.517 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.365 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.56 116.92 4.34 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.785 2.323 . . . . 0.0 111.264 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.633 HD12 HD13 ' A' ' 62' ' ' LEU . 1.2 mp -79.89 103.35 6.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.241 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.64 0.733 . . . . 0.0 110.374 179.609 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.233 0.222 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.47 115.28 12.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.305 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.6 99.43 52.8 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -99.29 172.08 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.669 2.913 . . . . 0.0 111.731 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 157.52 46.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.23 -10.09 43.02 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -108.84 167.27 10.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -146.13 6.69 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.297 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.579 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 4.6 p90 -71.92 -4.53 28.85 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.038 0.446 . . . . 0.0 110.373 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.29 -12.83 60.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.864 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.71 -60.99 1.96 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.738 HG13 HG11 ' A' ' 45' ' ' VAL . 35.6 m -67.05 -29.32 45.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.486 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.72 -39.63 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.226 0.536 . . . . 0.0 110.455 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 m -83.41 -39.23 20.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.432 ' HB3' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-70 -70.43 -20.41 62.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.761 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.45 ' HA ' HD13 ' A' ' 21' ' ' LEU . 1.4 m-85 -77.02 -25.66 52.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 111.239 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -70.96 -20.06 62.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.652 0.263 . . . . 0.0 111.377 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -13.59 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.502 . . . . 0.0 110.453 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.693 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 82.7 mt -85.5 -47.16 10.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.918 175.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 18' ' ' PHE . 17.5 mm -75.65 2.23 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.743 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HD2' ' HB2' ' A' ' 24' ' ' SER . 4.8 tmmt? -61.09 -81.04 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.526 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 23' ' ' LYS . 11.1 t -119.67 -31.7 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 118.732 -1.187 . . . . 0.0 113.809 -171.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.22 -20.9 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.065 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.693 ' HB2' ' HA ' ' A' ' 21' ' ' LEU . 33.2 mp0 -45.32 -45.44 12.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.729 0.812 . . . . 0.0 110.927 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.675 ' HG ' HG21 ' A' ' 73' ' ' VAL . 23.0 tp -133.87 91.03 2.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.4 152.29 89.92 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.185 -169.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 5.2 Cg_exo -76.81 129.39 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.005 2.47 . . . . 0.0 111.213 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.3 -15.43 17.99 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -95.7 162.08 13.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.575 HG22 HG11 ' A' ' 72' ' ' VAL . 25.2 p -81.95 160.83 23.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.432 0.158 . . . . 0.0 110.705 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.523 ' CD1' ' HG1' ' A' ' 71' ' ' THR . 10.9 mt -66.36 139.05 96.08 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.32 157.56 33.21 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.223 1.948 . . . . 0.0 111.834 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.8 t -69.31 155.36 40.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.532 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.6 m -54.85 -15.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.13 81.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.582 0.229 . . . . 0.0 111.404 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.96 -39.42 87.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 -176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.557 HD11 ' H ' ' A' ' 39' ' ' ILE . 4.5 mp -66.3 -57.04 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.91 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 8.6 ttp180 -62.71 -31.27 72.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -170.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.65 -41.68 17.51 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.967 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -81.57 -50.47 9.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.401 0.62 . . . . 0.0 109.56 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.582 ' O ' HG23 ' A' ' 45' ' ' VAL . 5.4 m-85 -92.07 101.9 14.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.355 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.413 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . -52.67 92.42 0.01 OUTLIER Glycine 0 CA--C 1.518 0.27 0 O-C-N 123.587 0.554 . . . . 0.0 113.865 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.738 HG11 HG13 ' A' ' 14' ' ' VAL . 17.6 m -146.85 178.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 123.042 0.537 . . . . 0.0 109.725 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.53 -174.99 3.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 -36.31 57.05 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.689 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -84.06 -15.11 48.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.94 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.683 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.9 m -68.5 -39.46 81.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.52 HG11 HG23 ' A' ' 39' ' ' ILE . 52.3 t -57.5 -58.29 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.314 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.561 ' HA ' ' CD1' ' A' ' 54' ' ' LEU . 24.8 t -59.38 -17.45 30.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.237 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.579 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 74.7 ttt180 -79.8 -44.6 20.3 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.377 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.628 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -79.68 -15.64 57.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 51' ' ' SER . 69.6 mt -48.64 -33.79 10.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.728 0.299 . . . . 0.0 111.407 174.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.482 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.17 -38.2 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.965 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.07 -28.56 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.45 0.643 . . . . 0.0 109.994 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.518 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . 69.6 mt -73.28 -15.64 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.283 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 55' ' ' ALA . 49.2 mtmt -66.51 -48.13 70.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.338 0.59 . . . . 0.0 110.007 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -90.61 -54.88 3.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.649 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.34 -31.64 15.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.0 -169.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 57' ' ' LEU . . . -78.43 -29.48 52.77 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.128 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 77' ' ' PRO . 22.6 mt 75.16 80.05 0.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.159 0.984 . . . . 0.0 111.39 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 57' ' ' LEU . 36.0 m -145.92 172.85 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.174 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.0 m -146.6 116.21 7.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.39 0.614 . . . . 0.0 110.943 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.71 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 38.0 t -84.33 105.41 15.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.875 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.536 ' HD3' ' OE2' ' A' ' 74' ' ' GLU . 15.1 mmm-85 -83.79 119.14 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.39 34.7 1.34 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.127 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 66' ' ' ARG . . . -149.25 -68.3 0.21 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -69.92 -31.53 69.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.347 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.81 172.1 13.22 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.71 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 9.0 t -78.55 120.58 23.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.315 0.579 . . . . 0.0 109.441 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.575 HG11 HG22 ' A' ' 32' ' ' THR . 33.6 m -126.05 170.72 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.277 0.56 . . . . 0.0 111.387 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.675 HG21 ' HG ' ' A' ' 27' ' ' LEU . 29.4 t -93.87 120.42 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.131 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.536 ' OE2' ' HD3' ' A' ' 66' ' ' ARG . 48.6 mt-10 -131.57 158.87 39.84 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.061 0.457 . . . . 0.0 110.95 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -79.22 38.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 74' ' ' GLU . 66.8 m-20 -123.95 84.23 54.83 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.561 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HB3' HD21 ' A' ' 62' ' ' LEU . 10.0 Cg_endo -52.2 116.07 2.58 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.003 2.468 . . . . 0.0 110.472 166.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.0 mm -64.61 127.79 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-O 121.561 0.696 . . . . 0.0 109.807 177.018 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 96.0 m-85 . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -88.23 142.2 27.94 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.58 134.4 34.2 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 64.7 Cg_endo -78.14 111.48 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.339 2.026 . . . . 0.0 111.656 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -69.33 -77.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.039 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.11 -6.41 4.88 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.91 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.54 154.25 42.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.821 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.88 -135.27 3.68 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.81 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.547 ' HA ' HG11 ' A' ' 14' ' ' VAL . 3.0 p90 -74.24 -1.6 21.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.127 0.489 . . . . 0.0 111.011 -175.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.34 22.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.256 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.05 -36.65 13.91 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.64 0.733 . . . . 0.0 109.105 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.715 ' HB ' HG13 ' A' ' 45' ' ' VAL . 7.3 p -75.1 -32.6 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.856 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.67 -46.22 84.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.934 0.397 . . . . 0.0 110.681 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -71.46 -27.89 63.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.875 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -74.34 -20.84 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.834 0.35 . . . . 0.0 110.883 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.0 -24.07 65.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.886 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.1 m -75.27 -28.11 59.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.316 0.579 . . . . 0.0 110.038 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 1.017 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 67.5 mt -78.96 -28.84 43.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.87 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 tp -90.29 -7.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.364 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.06 -79.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 26' ' ' GLU . 8.5 t -119.71 -34.62 3.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 159.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.017 ' HA3' ' HA ' ' A' ' 21' ' ' LEU . . . 18.12 22.46 0.0 OUTLIER Glycine 0 C--N 1.354 1.561 0 C-N-CA 127.949 2.69 . . . . 0.0 118.652 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' SER . 33.0 mt-10 59.53 9.79 1.66 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 117.413 0.606 . . . . 0.0 111.225 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.668 HD13 HD21 ' A' ' 21' ' ' LEU . 8.3 mp -129.64 34.2 4.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.07 166.28 2.15 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.137 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 10.7 Cg_exo -73.53 123.81 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.744 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.03 5.5 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.929 -172.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -104.37 164.07 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.662 HG21 HG11 ' A' ' 72' ' ' VAL . 2.7 p -97.38 153.23 18.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.65 0.262 . . . . 0.0 110.953 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 10.5 mp -72.42 120.0 78.08 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 111.881 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.51 6.69 5.48 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 123.284 2.656 . . . . 0.0 111.871 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 1.104 ' HA ' HD11 ' A' ' 39' ' ' ILE . 5.7 p -79.04 59.15 2.61 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -160.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.87 -58.05 4.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.614 1.197 . . . . 0.0 110.008 142.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.32 -58.98 2.34 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.924 -166.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.65 -30.49 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.401 -174.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 1.104 HD11 ' HA ' ' A' ' 35' ' ' SER . 1.8 mp -86.1 -56.07 5.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.03 -173.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 4.2 ptm180 -66.01 -18.62 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.826 -172.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . . . -67.99 -57.53 6.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.513 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -81.16 -51.86 7.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.846 0.831 . . . . 0.0 110.065 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.688 ' HD2' HG23 ' A' ' 39' ' ' ILE . 4.8 m-85 -89.8 83.11 6.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.867 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.46 88.17 0.01 OUTLIER Glycine 0 N--CA 1.462 0.419 0 O-C-N 125.002 1.439 . . . . 0.0 115.182 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.715 HG13 ' HB ' ' A' ' 14' ' ' VAL . 17.4 m -142.02 178.11 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB3' ' OG1' ' A' ' 49' ' ' THR . . . -89.08 -175.12 4.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.83 -35.17 51.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.277 0.56 . . . . 0.0 110.645 -174.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.893 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 10.5 mmpt? -85.12 -13.05 51.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.678 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.69 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 m -71.95 -40.07 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.678 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.458 HG12 HG22 ' A' ' 39' ' ' ILE . 48.7 t -55.16 -57.01 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.396 0.617 . . . . 0.0 110.375 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.706 ' HA ' HD12 ' A' ' 54' ' ' LEU . 36.0 t -64.16 -14.06 52.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.639 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 16.2 tpp180 -78.28 -44.14 26.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.68 ' HB3' HG13 ' A' ' 14' ' ' VAL . . . -66.58 -33.4 75.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.881 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.706 HD12 ' HA ' ' A' ' 51' ' ' SER . 69.1 mt -53.56 -31.33 46.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.628 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.527 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.6 -26.34 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.078 0.466 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.55 -29.98 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.647 0.737 . . . . 0.0 109.669 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -74.03 -13.8 60.91 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.624 -173.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 62.2 pttt -64.53 -36.69 85.04 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.602 173.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.701 ' HA ' HG13 ' A' ' 78' ' ' ILE . 6.1 m -93.09 -53.48 4.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.284 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -88.37 -31.02 19.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.005 -170.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.43 -12.52 59.64 Favored Glycine 0 C--O 1.229 -0.216 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.922 -176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp 63.49 52.43 2.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.874 0.368 . . . . 0.0 111.707 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.82 164.2 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.663 ' HB3' HG21 ' A' ' 72' ' ' VAL . 22.6 t -117.17 105.2 11.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.184 0.516 . . . . 0.0 110.608 -174.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.2 m -81.39 71.38 8.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 20.9 tpp180 -75.77 96.46 3.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.313 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.15 49.47 3.54 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.001 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.23 -47.26 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.96 -44.66 10.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.093 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 138.06 -177.6 19.87 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.692 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 33' ' ' LEU . 17.7 p -75.01 106.66 6.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.968 0.413 . . . . 0.0 110.466 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 64' ' ' SER . 18.2 m -123.05 150.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.101 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 27' ' ' LEU . 17.5 t -92.57 105.18 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -126.45 135.54 51.5 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 20.8 pttm -66.63 92.73 0.22 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.498 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 19.8 m-80 -90.35 110.86 43.78 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.056 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 76' ' ' ASN . 28.0 Cg_endo -62.64 115.38 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.021 1.814 . . . . 0.0 109.703 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.701 HG13 ' HA ' ' A' ' 59' ' ' SER . 13.1 mm -95.68 117.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.078 0.466 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 113.682 -1.599 . . . . 0.0 111.658 -177.151 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.612 0.244 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -88.67 93.14 9.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.184 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.8 117.33 66.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.503 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 68.2 Cg_endo -91.77 178.79 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.414 2.742 . . . . 0.0 112.544 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -93.23 -89.45 0.21 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.76 101.27 0.61 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.5 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -123.48 150.97 43.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.969 0.414 . . . . 0.0 110.875 -174.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.34 -145.29 14.94 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 170.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.6 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 2.0 p90 -80.17 23.47 0.47 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.769 0.318 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.57 -46.46 8.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.857 0.361 . . . . 0.0 111.567 -172.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -77.45 -26.58 51.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.45 0.643 . . . . 0.0 110.157 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.981 ' HB ' HG11 ' A' ' 45' ' ' VAL . 12.8 p -75.1 -26.09 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.257 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 19' ' ' ARG . . . -63.16 -34.79 78.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.485 ' HB ' ' CE2' ' A' ' 43' ' ' PHE . 10.3 m -60.02 -26.59 66.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.11 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.507 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 53.9 t-80 -56.12 -48.47 76.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.65 ' HE2' HD22 ' A' ' 33' ' ' LEU . 74.7 m-85 -83.21 -35.71 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.523 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 72.4 mtp180 -57.08 -32.63 66.47 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 110.635 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.6 m -79.13 -55.55 5.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.827 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.554 HD12 HD23 ' A' ' 27' ' ' LEU . 31.1 mt -48.88 -46.91 43.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 61' ' ' GLY . 1.8 mp -68.97 -43.25 82.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -86.26 -7.07 58.79 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.454 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.2 p -105.23 17.53 23.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.54 27.49 0.0 OUTLIER Glycine 0 N--CA 1.469 0.88 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -169.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.07 -32.3 71.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.554 HD23 HD12 ' A' ' 21' ' ' LEU . 22.7 tp -102.95 95.58 6.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.52 153.92 95.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.518 -170.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.24 126.68 8.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.654 2.236 . . . . 0.0 110.914 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.45 -6.24 33.76 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -95.99 149.97 20.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.805 HG21 HG12 ' A' ' 72' ' ' VAL . 19.2 p -78.37 156.8 29.33 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.724 HD23 HG22 ' A' ' 63' ' ' VAL . 14.0 mt -60.63 139.39 92.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.814 172.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.06 168.13 25.53 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.336 2.024 . . . . 0.0 111.913 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.7 p -66.09 148.94 51.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 39' ' ' ILE . 20.0 m -49.72 -28.11 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.306 0.378 . . . . 0.0 111.681 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.96 91.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.561 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.51 -23.67 63.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 36' ' ' VAL . 3.8 mp -79.35 -55.67 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 7.1 ptm180 -77.64 -20.64 53.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.46 68.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.673 . . . . 0.0 110.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -83.16 -60.61 2.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.018 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 48.6 m-85 -92.54 99.06 11.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.777 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 6' ' ' PRO . . . -56.33 100.13 0.1 OUTLIER Glycine 0 CA--C 1.515 0.078 0 CA-C-N 115.299 -0.864 . . . . 0.0 114.044 -172.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.981 HG11 ' HB ' ' A' ' 14' ' ' VAL . 6.1 m -146.38 178.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 122.575 0.35 . . . . 0.0 110.141 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.92 175.15 7.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.8 -19.3 55.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.467 0.651 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.648 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 71.8 mmtt -74.36 -46.48 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.963 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.739 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.5 m -56.38 -43.06 78.84 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.833 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.763 ' HA ' HG22 ' A' ' 14' ' ' VAL . 93.5 t -52.83 -53.66 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.327 0.584 . . . . 0.0 110.95 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.546 ' HA ' HD13 ' A' ' 54' ' ' LEU . 23.2 t -70.48 -6.68 37.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.624 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.648 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 5.2 mmp_? -83.61 -47.05 11.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.122 -0.362 . . . . 0.0 110.293 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 14' ' ' VAL . . . -70.77 -20.11 62.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.791 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.546 HD13 ' HA ' ' A' ' 51' ' ' SER . 65.5 mt -53.22 -29.81 34.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.234 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.51 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -63.03 -30.87 71.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.146 0.498 . . . . 0.0 110.643 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.68 -31.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.369 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.628 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -75.36 -17.71 60.16 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -171.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.65 ' HZ3' ' HB3' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -66.41 -34.76 78.67 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.347 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 m -93.57 -51.74 4.81 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.31 0.576 . . . . 0.0 110.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -84.32 -53.5 5.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.008 -172.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.628 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -77.06 -7.02 86.62 Favored Glycine 0 C--O 1.225 -0.423 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.801 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 16.7 mt 63.29 78.28 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.375 0.67 . . . . 0.0 111.972 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.724 HG22 HD23 ' A' ' 33' ' ' LEU . 1.4 p -160.57 135.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.681 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 8.4 t 147.9 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.843 1.339 . . . . 0.0 111.687 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.589 ' CB ' HG23 ' A' ' 72' ' ' VAL . 3.8 t -94.82 -59.87 1.82 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.283 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 0.3 OUTLIER -118.72 135.28 54.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.214 0.53 . . . . 0.0 112.217 -169.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.74 -30.79 9.25 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 168.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.22 -61.35 2.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.88 -62.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 169.28 160.63 17.91 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.904 176.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 121.1 24.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.678 0.752 . . . . 0.0 109.829 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.805 HG12 HG21 ' A' ' 32' ' ' THR . 2.6 m -121.92 163.96 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.229 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.486 HG22 ' HG ' ' A' ' 27' ' ' LEU . 16.7 t -84.97 123.41 39.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.185 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -132.28 159.49 38.95 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -76.09 66.09 2.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.834 0.826 . . . . 0.0 110.128 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.453 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 7.5 m-20 -55.17 142.24 58.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.491 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.11 117.92 5.41 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.141 1.894 . . . . 0.0 111.51 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.444 HG23 HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -79.73 111.64 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.418 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.444 HG22 HG23 ' A' ' 78' ' ' ILE . 34.3 m . . . . . 0 N--CA 1.468 0.433 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.255 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.965 0.412 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -93.67 128.63 39.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.705 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.45 118.27 60.75 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.604 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -88.31 160.55 6.88 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.938 2.425 . . . . 0.0 112.65 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.6 95.44 3.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.03 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.99 38.64 55.64 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.484 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.562 ' HD2' ' HB2' ' A' ' 13' ' ' ASP . 3.3 tppp? -104.44 108.66 20.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -157.86 33.39 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.868 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.507 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -71.92 0.51 9.07 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.622 0.369 . . . . 0.0 111.308 -177.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.5 50.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.687 0.28 . . . . 0.0 111.338 -169.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.562 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 40.3 t0 -76.1 -38.65 56.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.375 0.607 . . . . 0.0 109.511 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.659 HG21 ' HB1' ' A' ' 53' ' ' ALA . 3.8 m -85.19 -23.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.56 61.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.264 0.554 . . . . 0.0 109.873 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.654 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 5.1 m -104.13 -27.31 12.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.993 174.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.485 ' HD2' HG22 ' A' ' 39' ' ' ILE . 4.0 t60 -60.54 -21.22 62.28 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.693 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 24.8 p90 -58.21 -33.43 69.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.365 0.602 . . . . 0.0 110.453 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 16' ' ' THR . 2.6 ptm180 -68.25 -25.88 65.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.767 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.444 ' HB ' HD21 ' A' ' 21' ' ' LEU . 2.4 m -65.13 -35.63 81.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.219 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 1.137 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.1 mm? -91.93 -48.12 6.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.298 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 27' ' ' LEU . 36.4 mm -67.52 -12.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.861 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 2.7 tmmt? -48.0 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.325 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 p -118.31 -32.08 4.77 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.73 -20.7 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.198 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.666 ' HG2' ' HA ' ' A' ' 21' ' ' LEU . 2.1 pm0 -63.37 -21.39 66.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -168.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 1.137 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.7 tp -121.59 83.4 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.24 141.34 80.66 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.508 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.64 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 3.0 Cg_exo -77.09 123.7 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 110.903 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.14 46.43 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -174.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -118.26 156.63 28.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 24.1 p -82.69 138.77 34.0 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.256 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 151.09 86.2 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.63 168.32 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.696 2.264 . . . . 0.0 112.694 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -76.73 -179.23 5.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.192 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.17 -19.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.924 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.63 75.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.53 -55.06 19.86 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.861 0.362 . . . . 0.0 111.058 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.64 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.4 mp -58.11 -39.83 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.047 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 5.2 tmm_? -79.76 -28.25 40.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.347 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.6 -31.73 28.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.48 -65.36 0.9 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.446 ' O ' HG21 ' A' ' 45' ' ' VAL . 3.1 m-85 -91.92 111.27 22.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.19 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.95 92.33 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 O-C-N 124.016 0.822 . . . . 0.0 113.363 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.489 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 18.8 m -138.81 -179.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.51 174.61 7.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.913 0.387 . . . . 0.0 110.535 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -14.62 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 44.0 m -73.15 -42.11 63.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 81.5 t -54.52 -61.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.484 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.598 ' HA ' HD12 ' A' ' 54' ' ' LEU . 13.0 t -57.48 -25.43 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.522 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 77.1 ttt180 -72.93 -48.29 38.19 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.099 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.659 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -63.58 -31.04 72.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.037 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.625 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 86.8 mt -58.18 -29.52 65.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.161 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.43 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -67.77 -28.84 67.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.354 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 26.3 t -84.84 -32.15 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 175.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.664 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.8 mp -77.51 4.46 11.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.828 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 41.4 mtmt -65.62 -56.63 11.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -93.85 -40.5 10.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.893 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 9.7 tp10 -73.62 -51.07 18.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.772 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.693 ' HA2' ' CD2' ' A' ' 18' ' ' PHE . . . -88.64 -13.23 63.3 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.877 -176.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.541 HD22 ' O ' ' A' ' 76' ' ' ASN . 63.9 mt 66.2 66.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.979 0.458 . . . . 0.0 111.826 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 57' ' ' LEU . 32.8 m -136.87 156.45 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.46 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -116.61 95.63 5.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.359 0.6 . . . . 0.0 109.842 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -84.86 109.17 17.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.92 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.41 108.6 20.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.141 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.15 47.24 2.58 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.164 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.76 -55.87 0.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.293 0.568 . . . . 0.0 109.613 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -85.81 -36.53 20.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.253 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.0 175.41 13.88 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.56 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.4 p -87.83 104.9 17.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 15.5 t -114.54 139.84 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.388 . . . . 0.0 110.267 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.643 HG23 ' HG ' ' A' ' 27' ' ' LEU . 21.4 t -90.84 91.0 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -94.51 138.81 31.97 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -71.31 84.73 0.78 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.541 ' O ' HD22 ' A' ' 62' ' ' LEU . 83.1 m-20 -67.97 140.13 93.5 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.615 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 76' ' ' ASN . 6.3 Cg_exo -77.67 118.2 4.46 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.705 2.27 . . . . 0.0 110.055 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.492 HG12 HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -58.88 115.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.743 -174.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.471 0.611 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.245 179.048 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 66.5 t80 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.176 0.512 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.93 114.12 26.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.401 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -81.89 122.28 79.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.731 0.301 . . . . 0.0 110.531 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.456 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 84.6 Cg_endo -95.53 134.08 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.199 2.6 . . . . 0.0 113.182 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -99.87 -73.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.11 92.08 1.71 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.663 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -75.92 178.55 6.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.196 0.998 . . . . 0.0 112.919 -172.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 168.57 151.13 6.98 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.122 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.446 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 9.3 p90 -70.66 8.03 0.96 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.419 0.609 . . . . 0.0 110.584 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . -79.78 -28.1 40.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.17 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 12.4 t70 -67.56 -50.08 60.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.026 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.531 HG12 HG12 ' A' ' 45' ' ' VAL . 2.3 m -71.02 -36.89 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.415 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -55.37 -48.76 73.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.036 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -80.05 -22.41 42.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.479 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 1.7 m170 -85.97 -30.3 22.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -73.27 -18.44 61.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.983 0.421 . . . . 0.0 110.625 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -63.18 -17.53 62.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.504 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.801 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 6.8 m -81.94 -26.48 33.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.137 0.494 . . . . 0.0 110.769 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.946 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.6 mm? -81.88 -51.81 7.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.474 HG23 ' HA2' ' A' ' 61' ' ' GLY . 11.2 tp -79.69 14.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.072 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.801 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 24.4 ttmm -67.64 -77.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 m -117.36 -29.79 5.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.6 -25.84 0.02 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 118.84 -1.648 . . . . 0.0 114.957 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -53.95 -42.74 69.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.025 0.412 . . . . 0.0 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.946 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -113.31 78.31 1.13 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.92 95.27 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.447 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.586 ' HA ' HG13 ' A' ' 73' ' ' VAL . 37.5 Cg_endo -70.93 136.84 30.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.032 2.488 . . . . 0.0 111.767 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.4 56.59 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.481 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.473 ' O ' HG11 ' A' ' 73' ' ' VAL . 4.8 t0 -122.77 164.19 18.81 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 22.1 p -78.87 152.81 31.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.969 0.414 . . . . 0.0 111.11 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.592 HD21 ' HB ' ' A' ' 73' ' ' VAL . 8.7 mt -85.94 152.12 55.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.287 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.49 168.09 24.41 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.594 2.196 . . . . 0.0 111.017 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 t -73.21 155.82 39.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.621 ' HA ' HD11 ' A' ' 39' ' ' ILE . 28.8 m -53.86 -21.21 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 O-C-N 123.28 0.363 . . . . 0.0 111.914 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.83 92.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.59 -51.88 63.38 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.393 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.645 HG22 HG12 ' A' ' 50' ' ' VAL . 4.4 mp -57.88 -54.51 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.218 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -73.26 -17.89 61.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -171.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 3' ' ' TYR . . . -82.57 -44.81 15.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.595 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.885 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -75.99 -52.24 10.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.534 ' HD2' HG23 ' A' ' 39' ' ' ILE . 2.9 m-85 -93.11 105.78 17.83 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.631 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 85.43 0.01 OUTLIER Glycine 0 CA--C 1.516 0.115 0 O-C-N 123.638 0.586 . . . . 0.0 113.926 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.784 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 27.8 m -142.03 179.12 2.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.61 -169.93 2.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.22 -40.36 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.987 0.422 . . . . 0.0 110.349 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -75.05 -31.07 61.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.604 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.784 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 5.4 m -58.06 -34.49 70.18 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.141 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.645 HG12 HG22 ' A' ' 39' ' ' ILE . 60.8 t -57.32 -59.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.376 0.608 . . . . 0.0 109.974 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.572 ' HA ' HD11 ' A' ' 54' ' ' LEU . 23.1 t -65.25 -11.9 46.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.612 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 49' ' ' THR . 32.2 tpt180 -76.74 -42.68 40.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.524 ' CB ' HG23 ' A' ' 14' ' ' VAL . . . -80.56 -19.66 45.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.437 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 63' ' ' VAL . 44.8 mt -57.31 -25.52 59.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -72.65 -20.71 61.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.078 0.466 . . . . 0.0 110.71 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.06 -39.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.648 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 4.8 mp -71.27 6.68 1.59 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.922 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.84 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 22.0 pttp -76.37 -42.37 44.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -92.7 -45.05 8.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.161 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -75.97 -46.42 29.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.088 0.47 . . . . 0.0 111.243 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.648 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.21 -13.52 58.65 Favored Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.605 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.759 HD23 HG12 ' A' ' 78' ' ' ILE . 22.2 mt 67.69 28.33 7.33 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.785 0.434 . . . . 0.0 111.742 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.787 HG13 HG22 ' A' ' 73' ' ' VAL . 8.6 m -108.81 143.38 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.903 0.383 . . . . 0.0 111.342 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 41.0 t -144.95 149.24 34.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 p -90.32 90.1 7.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 4.3 tpp180 -71.48 105.19 3.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.054 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.97 59.07 3.53 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.239 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.95 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.48 -28.1 37.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.753 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 128.51 -159.21 21.95 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.591 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.91 112.57 16.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 60.9 t -132.24 135.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -169.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.787 HG22 HG13 ' A' ' 63' ' ' VAL . 11.6 p -82.56 75.7 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 122.335 1.064 . . . . 0.0 110.856 -173.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -144.96 83.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.11 162.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.84 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 55.6 tptt -95.82 -81.1 0.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.764 0.792 . . . . 0.0 111.374 175.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.443 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 3.1 t-20 -130.7 91.96 35.89 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.839 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -40.06 122.41 1.14 Allowed 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.983 2.455 . . . . 0.0 111.23 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.759 HG12 HD23 ' A' ' 62' ' ' LEU . 4.0 mm -55.41 118.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t . . . . . 0 C--O 1.235 0.331 0 O-C-N 124.567 1.167 . . . . 0.0 111.384 -177.184 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.804 0.335 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -91.98 116.24 0.4 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.095 2.53 . . . . 0.0 111.246 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -69.56 102.57 1.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.757 0.789 . . . . 0.0 110.155 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.669 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 23.3 ttpt -94.67 118.71 32.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.489 -170.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.44 142.67 50.47 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.005 -173.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.65 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 72.1 Cg_endo -79.33 112.18 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.757 2.305 . . . . 0.0 111.713 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -70.34 -56.21 7.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.414 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.88 34.98 0.62 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.92 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HD2' ' CB ' ' A' ' 13' ' ' ASP . 51.2 pttt -123.34 148.88 45.56 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.813 -0.227 . . . . 0.0 110.906 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.9 -140.52 10.08 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.614 ' HA ' HG11 ' A' ' 14' ' ' VAL . 4.2 p90 -80.29 10.83 4.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.849 0.459 . . . . 0.0 112.209 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.87 -38.82 19.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.48 ' CB ' ' HD2' ' A' ' 9' ' ' LYS . 24.4 t70 -70.57 -35.46 73.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.338 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.703 ' HB ' ' HD2' ' A' ' 43' ' ' PHE . 2.5 p -71.58 -42.81 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.499 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.82 -37.53 76.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.237 0.541 . . . . 0.0 109.859 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.3 m -67.83 -46.08 72.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.122 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -78.22 -20.8 51.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.513 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -69.74 -29.2 66.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.841 0.353 . . . . 0.0 110.397 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -61.68 -23.4 66.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.492 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m -80.49 -44.29 19.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 21' ' ' LEU . 1.5 mm? -53.53 -40.76 65.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.29 0.567 . . . . 0.0 111.295 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.651 HD13 HG13 ' A' ' 73' ' ' VAL . 19.3 mm -72.82 -14.3 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.477 -176.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -75.88 -75.93 0.17 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 26' ' ' GLU . 5.5 t -119.39 -31.87 4.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.951 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' HG2' ' A' ' 26' ' ' GLU . . . 10.31 -41.01 0.0 OUTLIER Glycine 0 C--N 1.354 1.576 0 C-N-CA 129.745 3.545 . . . . 0.0 119.558 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 24' ' ' SER . 2.0 pt-20 111.79 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.834 2.054 . . . . 0.0 107.949 -162.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 32.4 tp -112.79 58.5 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.467 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.54 166.34 14.89 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.758 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 7.6 Cg_exo -74.01 121.25 6.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 120.948 1.098 . . . . 0.0 110.428 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.3 -6.48 12.93 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.673 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -108.65 158.7 17.35 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.811 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 6.3 m -94.35 148.47 22.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.734 0.302 . . . . 0.0 111.287 -172.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.793 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.3 mp -54.79 135.72 65.15 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.712 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.38 171.3 17.12 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.222 2.614 . . . . 0.0 112.051 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -72.31 156.94 38.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.3 m -54.98 -21.58 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 122.707 0.403 . . . . 0.0 112.066 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.15 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.8 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.38 -51.09 67.3 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 109.798 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.793 HG22 ' HB ' ' A' ' 50' ' ' VAL . 4.8 mp -56.96 -50.17 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.269 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.889 ' HA ' ' HE1' ' A' ' 43' ' ' PHE . 63.0 ttt180 -44.71 -33.57 1.91 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.38 -33.89 13.68 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.926 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -75.14 -44.94 44.14 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.806 0.812 . . . . 0.0 109.052 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.889 ' HE1' ' HA ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -89.45 119.72 30.14 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 172.322 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.669 ' HA2' ' HB3' ' A' ' 4' ' ' LYS . . . -73.51 53.62 1.96 Allowed Glycine 0 C--N 1.302 -1.321 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.713 ' HB ' ' CD2' ' A' ' 43' ' ' PHE . 1.8 t -136.38 170.58 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -161.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' O ' ' CZ ' ' A' ' 43' ' ' PHE . . . -78.49 152.16 32.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.29 40.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.144 0.497 . . . . 0.0 110.9 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 5.4 tmmm? -92.61 -24.22 18.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.789 171.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.493 HG21 ' HA ' ' A' ' 11' ' ' TYR . 4.1 m -69.34 -27.9 65.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.793 ' HB ' HG22 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -61.59 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 54' ' ' LEU . 32.3 t -63.5 -14.37 50.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.252 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' THR . 5.6 mmp_? -81.03 -58.17 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.683 0.278 . . . . 0.0 110.258 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.659 ' HB1' HG13 ' A' ' 14' ' ' VAL . . . -63.75 -25.41 68.18 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 41.4 mt -49.08 -38.91 25.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -18.93 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.988 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.06 -28.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.544 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.902 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -72.58 -1.93 17.94 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.988 -173.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 57.7 pttt -66.69 -42.35 86.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 78' ' ' ILE . 2.8 m -94.77 -36.17 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.003 0.906 . . . . 0.0 109.24 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 11.1 tp10 -83.95 -66.07 0.94 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.032 -169.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.902 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -83.29 1.18 89.12 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.635 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.84 HD23 HG13 ' A' ' 78' ' ' ILE . 20.7 mt 73.2 37.27 0.76 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 172.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 8.4 p -113.15 150.16 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.739 -0.6 . . . . 0.0 111.332 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.819 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 31.8 t -148.32 145.28 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.385 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -67.9 106.8 2.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 7.0 ttm180 -114.3 97.38 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.996 -176.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.69 50.51 2.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.311 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.23 -63.89 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' HB2' HG23 ' A' ' 72' ' ' VAL . 71.0 mt -91.2 -14.36 31.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.543 176.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 114.11 -160.98 12.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.896 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.793 HG23 ' HB2' ' A' ' 33' ' ' LEU . 6.4 t -78.78 81.81 5.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.427 1.108 . . . . 0.0 109.611 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.811 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 38.5 t -92.94 141.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.671 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.651 HG13 HD13 ' A' ' 22' ' ' ILE . 4.5 t -88.22 75.67 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.815 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -146.56 80.31 1.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.737 158.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.819 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 88.2 tttt -98.85 -85.59 0.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.196 0.998 . . . . 0.0 111.745 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 5.9 t-20 -130.23 95.13 28.51 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.88 -165.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.41 122.63 4.84 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.021 1.814 . . . . 0.0 111.059 175.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.84 HG13 HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -56.3 136.15 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -175.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.7 t -55.3 79.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 124.395 1.059 . . . . 0.0 111.697 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.563 HD13 ' HB2' ' A' ' 85' ' ' ARG . 41.1 mm -113.43 106.77 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.948 175.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.1 t -120.04 -0.76 10.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.725 0.774 . . . . 0.0 109.034 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.17 171.28 36.41 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.073 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.06 -0.54 36.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.176 0.512 . . . . 0.0 111.205 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.98 -35.12 57.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.768 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 80' ' ' ILE . 22.4 mmm180 -73.52 -32.53 64.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.976 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.4 tp -100.36 -40.71 7.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.029 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -94.11 -30.41 14.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.044 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 66.53 111.23 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.907 0.754 . . . . 0.0 111.08 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -0.8 13.48 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -75.99 -39.58 55.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.39 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -100.88 167.1 10.49 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.879 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.11 138.58 55.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.719 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.96 67.82 2.61 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.955 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 73.4 mtm -86.4 171.31 11.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.324 -0.251 . . . . 0.0 110.324 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -59.03 129.96 44.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.242 0.544 . . . . 0.0 112.444 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -112.99 166.41 11.43 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.86 106.46 0.88 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.742 0.306 . . . . 0.0 110.68 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.5 -4.07 4.23 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.028 2.485 . . . . 0.0 113.095 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.81 43.12 0.51 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.194 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 C--O 1.25 1.12 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.126 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 23.6 ptm . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 5.1 Cg_exo -78.73 98.19 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.786 2.324 . . . . 0.0 111.161 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -72.31 141.8 48.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 44' ' ' GLY . 58.0 tttp -104.92 145.26 30.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.757 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 163.24 20.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.596 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.507 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 10.1 Cg_exo -76.08 96.24 1.06 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.121 1.88 . . . . 0.0 112.18 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.568 ' N ' ' HE3' ' A' ' 9' ' ' LYS . 1.8 mp0 -63.89 -65.38 0.69 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.18 54.1 0.31 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.039 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.772 ' HG3' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -123.42 164.98 17.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.918 0.389 . . . . 0.0 110.716 -176.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.39 -143.54 10.56 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.661 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 3.0 p90 -70.87 2.34 4.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.409 . . . . 0.0 111.524 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.26 54.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.569 . . . . 0.0 110.207 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.772 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 2.5 t70 -73.99 -47.99 33.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.743 HG11 HG12 ' A' ' 45' ' ' VAL . 33.0 m -70.22 -31.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.407 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.604 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.64 -45.15 89.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.253 0.549 . . . . 0.0 109.656 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -68.43 -34.43 75.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.704 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.669 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 45.0 t-80 -52.87 -54.38 35.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.954 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.408 ' CG ' HD13 ' A' ' 57' ' ' LEU . 5.7 m-85 -68.03 -40.17 82.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.811 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -60.88 -27.43 68.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.841 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.432 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 37.9 m -80.06 -36.01 36.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 0.0 109.95 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.867 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 68.8 mt -70.86 -44.81 65.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.223 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 61' ' ' GLY . 49.2 mm -68.69 -21.8 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.457 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 22.6 ttmm -56.78 -63.73 1.11 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.798 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -114.29 -33.16 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.8 -29.67 0.03 OUTLIER Glycine 0 CA--C 1.511 -0.177 0 C-N-CA 118.666 -1.731 . . . . 0.0 114.538 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.2 -57.57 12.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -164.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.867 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 tp -98.44 89.19 4.35 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.42 153.79 65.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.479 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 63.4 Cg_endo -77.31 137.63 17.04 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.102 1.868 . . . . 0.0 112.092 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.91 -24.99 9.14 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.007 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.41 161.85 14.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -79.03 161.23 26.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.731 0.3 . . . . 0.0 111.355 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.4 145.64 98.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.332 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.11 171.49 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.826 2.351 . . . . 0.0 112.507 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.8 p -79.27 159.59 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.06 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.439 ' HA ' HD12 ' A' ' 39' ' ' ILE . 25.2 m -54.01 -26.25 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.9 82.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.131 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.33 -29.66 66.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 110.297 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.669 ' HA ' ' CE1' ' A' ' 17' ' ' HIS . 3.7 mp -75.48 -49.94 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.244 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.578 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 22.0 ttm180 -66.93 -46.95 73.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.12 75.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 0.0 110.955 -170.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -84.39 -65.96 0.95 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.175 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.443 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 18.8 m-85 -93.48 102.12 14.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.269 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.611 ' H ' ' HD3' ' A' ' 4' ' ' LYS . . . -57.37 99.56 0.1 Allowed Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.624 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.743 HG12 HG11 ' A' ' 14' ' ' VAL . 19.4 m -140.73 179.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.115 0.483 . . . . 0.0 111.384 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -97.89 176.35 5.82 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.44 52.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.79 0.329 . . . . 0.0 110.748 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -79.16 -29.72 43.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 109.955 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.543 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.8 m -63.69 -43.58 96.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.539 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.661 ' HA ' HG13 ' A' ' 14' ' ' VAL . 96.4 t -55.81 -58.86 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.782 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.677 ' HA ' HD13 ' A' ' 54' ' ' LEU . 26.0 t -68.37 -6.41 24.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.871 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 4.6 tpm_? -77.74 -50.67 11.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.542 0.211 . . . . 0.0 110.678 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.734 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -90.74 -9.89 45.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 51' ' ' SER . 95.5 mt -51.6 -31.06 23.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.825 0.284 . . . . 0.0 111.486 174.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.845 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 44.2 t -80.73 -30.39 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.742 0.782 . . . . 0.0 109.514 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.604 HD21 ' HA ' ' A' ' 15' ' ' ALA . 86.9 mt -76.06 1.27 15.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.632 -173.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -66.04 -56.45 11.5 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.4 p -93.57 -34.43 13.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.481 0.657 . . . . 0.0 110.356 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.4 tp10 -77.07 -52.14 9.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.722 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.563 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -90.52 -7.4 67.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.977 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp 63.04 66.7 0.72 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.812 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 57' ' ' LEU . 31.1 m -136.14 162.49 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.681 175.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.8 m -144.59 128.5 17.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.139 0.495 . . . . 0.0 111.372 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -78.53 92.76 4.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 9.9 tpt180 -85.45 101.87 12.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.92 50.66 2.28 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.647 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.87 -60.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.05 -16.23 44.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.434 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 109.53 178.42 21.21 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.666 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.66 99.26 3.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 19.5 m -117.61 159.94 17.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 111.417 -170.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 22.3 t -85.68 93.82 3.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.789 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.585 ' HG3' HG23 ' A' ' 72' ' ' VAL . 31.2 mt-10 -102.64 151.3 22.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.675 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 57.6 mtpt -68.51 88.55 0.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -94.75 96.04 1.76 Allowed Pre-proline 0 CA--C 1.503 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.675 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 50.8 Cg_exo -56.39 151.34 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.216 1.944 . . . . 0.0 112.405 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.412 ' H ' HG13 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -55.7 105.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.052 -178.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 t 65.85 72.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.642 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.673 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.9 mm -115.61 128.68 72.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.752 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.2 t -91.79 152.57 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.15 120.96 5.41 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.866 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.42 -55.14 3.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -101.75 -14.32 17.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.244 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -82.51 -6.54 59.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.522 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.1 tp -101.58 116.39 32.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.905 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -84.93 130.16 34.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.712 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -82.15 -173.48 4.55 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 62.0 mtm -97.0 -51.99 4.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.192 0.52 . . . . 0.0 110.314 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 1.1 pm0 -72.66 -35.72 67.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.386 -175.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -108.89 102.6 11.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.964 0.411 . . . . 0.0 111.138 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -105.15 98.66 8.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.995 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.0 -26.19 22.56 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.516 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.8 ttm -105.24 171.78 7.14 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -69.79 160.05 32.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.265 0.555 . . . . 0.0 111.609 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -131.77 166.74 20.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.379 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . . . -82.06 110.87 22.87 Favored Pre-proline 0 C--N 1.321 -0.659 0 O-C-N 123.325 0.391 . . . . 0.0 110.327 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -87.74 27.08 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.091 2.528 . . . . 0.0 112.072 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.76 -47.23 0.43 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.615 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.491 0.186 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.93 142.66 76.32 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.776 2.317 . . . . 0.0 111.991 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -73.12 155.89 39.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.492 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -85.05 134.88 34.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.958 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.35 150.05 36.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.451 0.167 . . . . 0.0 111.182 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.59 118.45 4.21 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.067 2.512 . . . . 0.0 111.681 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -99.66 -74.41 0.6 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.707 -175.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.96 29.52 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.405 -176.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -116.61 156.66 26.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.09 -107.7 2.66 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.921 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -95.85 -12.25 25.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 174.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.51 9.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.501 0.667 . . . . 0.0 111.141 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' OD1' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -91.14 -52.8 4.65 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.388 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.685 HG13 HH22 ' A' ' 52' ' ' ARG . 2.0 m -68.74 -34.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.642 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.554 ' HA ' HD13 ' A' ' 57' ' ' LEU . . . -55.73 -44.71 77.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.64 170.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -64.57 -39.11 93.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.527 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 22.9 t60 -57.62 -48.01 80.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.471 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.37 -40.31 85.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.192 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -56.66 -27.57 58.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.588 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 m -85.33 -54.02 4.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.802 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.792 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . 3.3 pp -75.64 -12.04 60.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.554 -172.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.02 -41.48 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 110.452 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -92.9 -13.34 29.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.218 0.533 . . . . 0.0 110.513 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.739 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 23.0 t -86.54 26.79 1.03 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.317 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.15 25.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.792 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.2 mt-10 -69.79 -34.98 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' HG ' HD13 ' A' ' 21' ' ' LEU . 61.0 mt -122.9 92.1 3.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.526 166.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.05 54.63 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 5.8 Cg_exo -75.19 123.47 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.669 1.579 . . . . 0.0 110.691 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.35 27.89 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.43 163.5 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.877 ' HB ' HG21 ' A' ' 71' ' ' THR . 6.7 t -107.88 161.9 14.5 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -172.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.789 HD12 ' HB ' ' A' ' 63' ' ' VAL . 4.2 mp -57.52 109.69 1.95 Allowed Pre-proline 0 N--CA 1.432 -1.357 0 CA-C-N 111.196 -2.729 . . . . 0.0 108.435 167.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.95 175.41 10.87 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 123.359 2.706 . . . . 0.0 113.225 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -64.69 158.12 25.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.49 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.31 -19.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.02 -52.99 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.21 -53.42 58.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.375 0.607 . . . . 0.0 111.08 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.695 HD11 ' H ' ' A' ' 39' ' ' ILE . 4.2 mp -56.05 -53.66 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.652 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 43.8 ttp180 -65.6 -40.03 92.22 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.79 -46.23 25.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -75.84 -56.45 4.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.938 0.399 . . . . 0.0 110.673 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.467 ' O ' HG22 ' A' ' 45' ' ' VAL . 5.2 m-85 -91.81 103.99 16.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.795 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.79 86.31 0.01 OUTLIER Glycine 0 CA--C 1.516 0.111 0 O-C-N 124.642 1.214 . . . . 0.0 114.459 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 43' ' ' PHE . 33.6 m -137.77 177.38 5.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -97.17 178.89 5.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.57 -33.11 58.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.096 0.474 . . . . 0.0 109.973 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.941 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -68.49 -36.79 79.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 175.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.725 HG23 ' HE ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -65.18 -53.3 46.88 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 46' ' ' ALA . 92.0 t -41.25 -52.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.596 -0.69 . . . . 0.0 111.189 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.639 ' HA ' HD13 ' A' ' 54' ' ' LEU . 47.9 t -60.75 -34.07 73.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.063 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.921 ' CZ ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -72.25 -31.31 65.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.548 -169.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.655 ' N ' ' HD2' ' A' ' 52' ' ' ARG . . . -91.12 -5.37 55.18 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.671 -0.643 . . . . 0.0 111.807 173.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.639 HD13 ' HA ' ' A' ' 51' ' ' SER . 44.5 mt -57.88 -35.05 70.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.708 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.16 -18.16 64.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.009 176.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 60' ' ' GLU . 34.3 t -90.46 -29.22 4.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.622 ' O ' HG21 ' A' ' 63' ' ' VAL . 1.2 mp -73.85 2.89 7.48 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.251 -174.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.97 -41.8 20.29 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.403 ' HG ' ' HB ' ' A' ' 78' ' ' ILE . 15.7 m -94.04 -41.68 9.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.773 0.797 . . . . 0.0 109.887 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.488 ' HB3' HG11 ' A' ' 56' ' ' VAL . 39.0 tp10 -89.6 -34.49 16.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.809 -175.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -90.72 -10.3 63.35 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.561 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 11.2 mp 79.36 12.78 1.19 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.789 ' HB ' HD12 ' A' ' 33' ' ' LEU . 9.3 m -100.91 154.62 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.647 -0.658 . . . . 0.0 109.5 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -128.28 179.01 5.86 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.611 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -52.47 122.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.829 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.777 ' HA ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -64.94 163.93 13.57 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.374 -168.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.79 -67.45 1.43 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.683 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.71 -16.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.711 0.767 . . . . 0.0 109.504 168.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -93.64 -39.21 10.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.404 -170.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.704 ' N ' ' HG3' ' A' ' 66' ' ' ARG . . . 143.33 -5.04 1.83 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.706 -166.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.877 HG21 ' HB ' ' A' ' 32' ' ' THR . 89.0 m -97.52 92.86 6.13 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.777 HG21 ' HA ' ' A' ' 66' ' ' ARG . 90.8 t -151.52 96.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 123.852 0.72 . . . . 0.0 112.095 156.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 60.5 t -89.07 130.38 38.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 159.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 29' ' ' PRO . 40.1 mt-10 -133.39 165.14 25.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -84.87 49.01 1.64 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 166.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -118.95 91.9 44.02 Favored Pre-proline 0 CA--C 1.515 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.477 -170.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.25 115.9 4.04 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.821 1.681 . . . . 0.0 109.473 171.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.403 ' HB ' ' HG ' ' A' ' 59' ' ' SER . 19.1 mt -70.74 100.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.984 -176.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 t 33.9 43.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 124.728 1.268 . . . . 0.0 111.335 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.434 ' O ' HG21 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -71.99 105.97 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 122.094 0.95 . . . . 0.0 109.291 -170.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 m -85.49 -59.49 2.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.841 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.71 123.14 1.29 Allowed Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.302 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.14 -13.76 23.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.417 0.627 . . . . 0.0 109.581 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -84.87 -3.92 58.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.513 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -60.66 -33.21 72.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.107 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.6 tp -85.21 152.22 23.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.583 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 113.92 4.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.929 0.395 . . . . 0.0 111.056 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 88' ' ' ARG . 21.3 mtm180 -76.98 -164.71 0.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 57.0 ttp -67.49 -17.52 64.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.149 0.499 . . . . 0.0 110.227 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.53 -58.23 6.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.801 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -80.43 104.51 11.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 110.851 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -79.74 100.05 7.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.836 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.71 141.04 15.61 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.719 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.87 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 5.5 mmt -90.62 69.66 6.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.232 0.539 . . . . 0.0 110.588 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -167.77 131.83 1.75 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.314 176.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -114.41 156.8 23.83 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.168 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -99.09 103.06 17.68 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -85.0 12.23 3.14 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.85 2.367 . . . . 0.0 112.648 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.2 77.47 0.25 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.056 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.102 177.693 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 mmt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.832 0.349 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -81.82 118.54 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.601 2.201 . . . . 0.0 111.449 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -72.83 127.56 32.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.643 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.81 117.88 24.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.851 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.1 167.44 21.61 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.427 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.48 92.09 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.339 2.026 . . . . 0.0 110.804 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.497 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 9.3 pt-20 -71.39 73.31 0.71 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.905 -176.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.83 16.55 68.31 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.67 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.497 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 60.1 pttt -124.25 147.63 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.541 0.21 . . . . 0.0 110.456 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.1 -137.69 7.18 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.13 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.401 ' HA ' HG21 ' A' ' 49' ' ' THR . 11.1 p90 -68.48 -9.55 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.789 0.328 . . . . 0.0 111.81 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.47 -17.44 56.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.849 0.357 . . . . 0.0 110.516 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 15.5 t70 -74.36 -51.56 14.74 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.909 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.64 HG22 ' HB2' ' A' ' 53' ' ' ALA . 2.2 m -68.86 -33.7 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.72 63.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.966 0.413 . . . . 0.0 110.578 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -74.16 -37.04 64.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.21 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -68.13 -36.41 79.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.493 ' CG ' HD22 ' A' ' 57' ' ' LEU . 5.2 m-85 -65.05 -44.28 89.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 0.0 110.14 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.595 ' HG2' ' HA2' ' A' ' 61' ' ' GLY . 73.8 mtp180 -53.11 -26.38 16.29 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.281 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.616 HG21 ' HB2' ' A' ' 24' ' ' SER . 13.1 m -88.53 -54.78 4.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.668 HD21 HD13 ' A' ' 27' ' ' LEU . 1.1 tp -52.55 -26.63 13.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.608 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 18' ' ' PHE . 1.3 mp -50.03 -58.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.688 0.28 . . . . 0.0 110.421 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.424 ' N ' HG22 ' A' ' 22' ' ' ILE . 16.5 ptpt -94.46 -29.54 14.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.616 ' HB2' HG21 ' A' ' 20' ' ' THR . 38.9 m -102.47 28.66 5.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.285 -171.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.66 ' HA3' HD12 ' A' ' 21' ' ' LEU . . . -165.1 20.57 0.12 Allowed Glycine 0 CA--C 1.505 -0.544 0 C-N-CA 119.37 -1.395 . . . . 0.0 112.239 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 64.92 10.35 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.56 -0.82 . . . . 0.0 112.852 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.668 HD13 HD21 ' A' ' 21' ' ' LEU . 23.2 mt -84.2 59.15 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 160.46 28.42 Favored Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 6.5 Cg_exo -75.09 136.77 20.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.944 1.763 . . . . 0.0 112.322 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.95 -17.75 11.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.717 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -95.55 159.89 14.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.606 HG23 HG11 ' A' ' 72' ' ' VAL . 36.8 p -78.66 165.06 24.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.636 0.255 . . . . 0.0 111.137 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.86 141.6 98.39 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 171.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.522 ' HG2' HD11 ' A' ' 39' ' ' ILE . 57.0 Cg_endo -77.71 163.86 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.379 2.052 . . . . 0.0 111.669 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 m -65.81 140.31 58.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.456 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HA ' HD12 ' A' ' 39' ' ' ILE . 31.0 m -52.07 -27.19 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.81 86.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -66.67 -48.8 68.2 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.283 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.608 ' H ' HD13 ' A' ' 39' ' ' ILE . 4.2 mp -55.02 -50.76 60.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.257 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 19.9 ptt180 -81.17 -9.75 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -173.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.01 -38.66 17.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.721 0.296 . . . . 0.0 110.282 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.647 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.1 OUTLIER -87.99 -59.13 2.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.637 0.732 . . . . 0.0 110.09 177.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.554 ' O ' HG21 ' A' ' 45' ' ' VAL . 21.0 m-85 -90.23 81.85 6.07 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.416 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.56 92.67 0.01 OUTLIER Glycine 0 CA--C 1.523 0.564 0 O-C-N 124.613 1.196 . . . . 0.0 115.274 -175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.674 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 14.7 m -139.01 178.71 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.19 -175.02 5.15 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.8 51.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.372 . . . . 0.0 111.246 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -90.24 -22.32 21.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.521 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.674 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.5 m -64.16 -35.34 80.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.539 -174.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.548 HG11 HG23 ' A' ' 39' ' ' ILE . 65.1 t -56.17 -59.1 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.331 0.586 . . . . 0.0 110.571 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.601 ' HA ' HD12 ' A' ' 54' ' ' LEU . 42.1 t -66.14 -14.26 61.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.815 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -77.17 -40.53 45.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 109.847 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.64 ' HB2' HG22 ' A' ' 14' ' ' VAL . . . -74.17 -30.67 62.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.562 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.601 HD12 ' HA ' ' A' ' 51' ' ' SER . 83.9 mt -51.92 -30.39 24.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.576 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . . . -68.59 -24.43 64.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.962 0.41 . . . . 0.0 111.096 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.93 -23.8 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.734 0.778 . . . . 0.0 109.448 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.674 ' HG ' ' HA3' ' A' ' 61' ' ' GLY . 4.5 mp -68.67 -19.49 64.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.019 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.576 ' HE3' ' HA ' ' A' ' 55' ' ' ALA . 73.8 mttt -54.42 -59.23 4.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.166 0.508 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -93.02 -41.24 10.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.95 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HG2' ' HD2' ' A' ' 19' ' ' ARG . 23.4 tt0 -93.2 -55.79 3.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.966 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.674 ' HA3' ' HG ' ' A' ' 57' ' ' LEU . . . -75.31 -10.23 84.38 Favored Glycine 0 N--CA 1.461 0.302 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.814 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.927 HD23 HG13 ' A' ' 78' ' ' ILE . 7.7 mt 69.74 80.33 0.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.686 0.755 . . . . 0.0 111.966 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.425 HG13 ' C ' ' A' ' 57' ' ' LEU . 9.0 p -140.32 161.29 25.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.2 m -141.77 102.23 4.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.215 0.531 . . . . 0.0 111.171 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 9.4 m -72.37 86.53 1.13 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 34.2 mmt180 -68.93 125.25 26.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.692 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.97 -9.0 87.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.925 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.54 -45.37 4.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.863 0.363 . . . . 0.0 110.999 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.34 -18.04 29.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.389 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 102.38 172.87 27.18 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 2.7 m -72.06 103.86 3.4 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.606 HG11 HG23 ' A' ' 32' ' ' THR . 23.1 m -121.96 169.5 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.238 -172.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 31.5 t -93.23 114.15 29.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.222 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.547 ' HG2' HG22 ' A' ' 72' ' ' VAL . 6.0 mm-40 -126.31 146.79 49.88 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -72.93 77.87 1.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 173.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.432 ' O ' HD22 ' A' ' 62' ' ' LEU . 59.9 t30 -64.65 132.69 95.49 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.05 113.97 1.71 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.076 1.184 . . . . 0.0 110.35 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.927 HG13 HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -64.09 127.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 172.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t -52.49 91.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 O-C-N 124.056 0.847 . . . . 0.0 110.638 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.581 HG13 HG23 ' A' ' 78' ' ' ILE . 69.7 mt -104.61 122.31 57.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.838 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.8 m -78.48 -43.49 26.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.818 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.85 55.91 3.73 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.991 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.86 -173.84 2.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.2 -12.53 59.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.816 0.341 . . . . 0.0 111.373 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.46 -52.53 17.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 172.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 57.18 -89.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.05 0.844 . . . . 0.0 111.347 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -155.77 122.49 5.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.58 32.86 5.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.711 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 64.7 mtt 70.23 -55.51 0.61 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.384 0.674 . . . . 0.0 110.734 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -62.31 -69.14 0.27 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.533 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 91' ' ' LYS . 25.2 mtpp -82.36 114.86 21.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.308 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -113.14 142.48 45.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.863 175.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.42 -165.55 13.2 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.462 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.16 58.57 2.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.646 0.736 . . . . 0.0 110.496 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -147.27 162.61 38.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.951 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.506 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 17.9 t80 -121.5 134.71 55.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.94 106.39 4.87 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 0.0 110.353 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 74.0 Cg_endo -83.22 -1.23 10.24 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.594 2.196 . . . . 0.0 112.016 -175.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.9 21.46 7.9 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.042 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.044 178.433 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.904 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 47.4 ttm . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 119.697 -0.192 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.904 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 12.5 Cg_exo -73.29 159.92 46.03 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.207 1.938 . . . . 0.0 111.631 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.539 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 6.3 p90 -90.91 153.47 20.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.211 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -93.36 137.99 32.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -78.63 146.65 69.78 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.132 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 2.7 Cg_exo -77.68 117.42 4.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.746 2.297 . . . . 0.0 112.622 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -86.95 -157.61 0.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.04 175.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.428 ' H ' ' CD ' ' A' ' 7' ' ' GLU . . . -74.58 60.46 2.45 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.545 ' HD2' ' O ' ' A' ' 44' ' ' GLY . 19.5 ptpt -122.53 178.37 5.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 0.0 110.249 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.27 -148.47 5.44 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.271 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.561 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -71.15 -10.68 60.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.65 -17.98 57.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 110.397 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' CG ' ' HZ2' ' A' ' 9' ' ' LYS . 26.9 t70 -71.08 -45.97 62.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.388 175.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.643 HG23 HG13 ' A' ' 45' ' ' VAL . 72.0 t -59.9 -40.25 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.065 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.58 ' HA ' HD13 ' A' ' 57' ' ' LEU . . . -57.2 -43.57 82.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -61.33 -34.77 75.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.708 ' CD2' ' HA ' ' A' ' 39' ' ' ILE . 5.2 t60 -67.53 -44.93 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.102 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.584 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-85 -69.21 -46.47 67.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.984 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -61.01 -19.43 61.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -85.66 -51.15 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.967 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.635 HD13 HD13 ' A' ' 27' ' ' LEU . 3.9 pp -71.84 -21.83 61.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 18' ' ' PHE . 26.5 mm -61.12 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 110.739 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -85.11 1.19 48.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.231 0.538 . . . . 0.0 110.525 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 26' ' ' GLU . 27.5 t -96.88 24.93 5.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.603 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 22.34 26.12 0.0 OUTLIER Glycine 0 N--CA 1.475 1.268 0 N-CA-C 117.374 1.71 . . . . 0.0 117.374 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 24' ' ' SER . 7.9 pt-20 -85.78 -34.66 21.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.671 HD21 ' HG3' ' A' ' 34' ' ' PRO . 9.9 mp -109.16 72.77 0.82 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 166.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.55 153.31 83.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.483 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.45 123.21 7.47 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.113 1.875 . . . . 0.0 111.284 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.55 -10.03 10.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.033 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.2 161.31 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.587 HG23 HG12 ' A' ' 72' ' ' VAL . 17.1 p -81.53 167.77 18.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.883 0.373 . . . . 0.0 111.478 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.77 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.4 mm? -65.12 140.08 97.87 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.336 175.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.671 ' HG3' HD21 ' A' ' 27' ' ' LEU . 57.3 Cg_endo -76.95 165.56 28.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.598 2.199 . . . . 0.0 111.565 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -74.08 156.09 37.81 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.405 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 28.0 m -52.48 -22.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.76 -52.57 64.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -58.16 -30.24 66.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.043 0.449 . . . . 0.0 110.974 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.708 ' HA ' ' CD2' ' A' ' 17' ' ' HIS . 4.3 mp -80.02 -59.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.519 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 33.5 ptt180 -79.03 -19.88 50.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -166.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . . . -76.69 -39.76 51.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.396 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -78.71 -62.07 1.81 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.708 . . . . 0.0 109.206 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 9.7 m-85 -92.17 105.1 17.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.956 176.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' A' ' 9' ' ' LYS . . . -60.41 91.56 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.157 0 CA-C-N 115.225 -0.898 . . . . 0.0 114.0 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.646 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 17.6 m -134.82 178.31 5.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.408 ' O ' HG22 ' A' ' 50' ' ' VAL . . . -94.98 -170.55 2.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.09 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -76.21 -22.71 54.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.646 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -65.68 -42.05 91.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 110.158 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.461 ' HA ' HG22 ' A' ' 14' ' ' VAL . 99.1 t -59.48 -55.84 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.715 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.7 t -66.9 -12.11 58.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.675 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -82.4 -36.13 27.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.038 0.446 . . . . 0.0 110.223 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.492 ' O ' HD11 ' A' ' 57' ' ' LEU . . . -74.3 -29.85 61.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.277 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 83.7 mt -49.28 -32.26 10.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.62 -28.63 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.076 0.465 . . . . 0.0 111.355 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.27 -25.16 5.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.877 0.846 . . . . 0.0 109.76 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.63 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -76.48 -5.04 45.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.46 -175.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -66.02 -40.11 90.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 p -93.14 -53.8 3.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.573 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -81.35 -38.32 26.87 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -172.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.63 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -90.49 -3.56 71.65 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.489 -174.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.665 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 10.1 mp 57.85 57.08 4.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.084 0.469 . . . . 0.0 111.808 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 57' ' ' LEU . 33.7 m -124.57 161.39 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.1 t -130.56 143.56 50.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.064 0.459 . . . . 0.0 111.337 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 p -82.78 103.04 11.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.551 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 12.1 tpp180 -118.43 48.43 1.43 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.3 4.12 2.07 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.978 -169.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.0 -47.02 21.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.05 -62.1 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 175.1 171.31 39.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.146 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.77 HG23 ' HB2' ' A' ' 33' ' ' LEU . 4.9 t -70.0 134.71 48.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 -174.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 32' ' ' THR . 34.3 m -131.47 162.51 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.311 -171.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -99.15 113.58 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -123.58 144.34 49.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -69.18 78.67 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.438 0.461 . . . . 0.0 110.858 -174.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.665 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 18.2 m-80 -73.6 116.54 52.54 Favored Pre-proline 0 CA--C 1.517 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.365 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.56 116.92 4.34 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.785 2.323 . . . . 0.0 111.264 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.633 HD12 HD13 ' A' ' 62' ' ' LEU . 1.2 mp -79.89 103.35 6.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.241 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.4 t 49.51 36.29 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.64 0.733 . . . . 0.0 110.374 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.7 mm -88.95 107.35 17.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.73 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 82' ' ' GLY . 3.2 t -158.87 -54.88 0.06 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.999 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 81' ' ' THR . . . -160.26 128.08 1.9 Allowed Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.889 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.91 171.37 8.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -90.62 8.76 32.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.118 0.485 . . . . 0.0 110.622 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 85' ' ' ARG . 6.2 tpm_? -69.86 -42.54 73.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.453 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.7 tp 59.45 -81.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.001 0.813 . . . . 0.0 110.478 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -87.61 106.13 17.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.716 ' HB2' ' HB2' ' A' ' 91' ' ' LYS . 68.3 mtp180 -65.3 148.39 51.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 54.3 tpp -58.13 108.65 0.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.895 0.378 . . . . 0.0 111.027 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 64.52 18.26 11.28 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.392 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.716 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 37.7 mttp -118.31 79.38 1.37 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.543 0.687 . . . . 0.0 111.669 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -128.94 99.25 5.22 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.242 171.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.63 -61.18 1.31 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.012 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.2 mtt -106.19 52.83 0.72 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.266 0.555 . . . . 0.0 109.562 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 95' ' ' ARG . 16.2 tpt180 -155.42 157.63 37.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.457 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -148.27 166.37 28.19 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.81 108.62 5.15 Favored Pre-proline 0 C--N 1.318 -0.779 0 O-C-N 123.541 0.526 . . . . 0.0 109.969 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.04 18.03 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.853 2.369 . . . . 0.0 112.287 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.33 44.21 0.78 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.785 -177.799 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.87 151.78 68.54 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.509 2.139 . . . . 0.0 112.143 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.61 109.18 17.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.928 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.47 115.28 12.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.305 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.6 99.43 52.8 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -99.29 172.08 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.669 2.913 . . . . 0.0 111.731 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 157.52 46.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.23 -10.09 43.02 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -108.84 167.27 10.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -146.13 6.69 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.297 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.579 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 4.6 p90 -71.92 -4.53 28.85 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.038 0.446 . . . . 0.0 110.373 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.29 -12.83 60.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.864 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.71 -60.99 1.96 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.738 HG13 HG11 ' A' ' 45' ' ' VAL . 35.6 m -67.05 -29.32 45.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.486 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.72 -39.63 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.226 0.536 . . . . 0.0 110.455 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 m -83.41 -39.23 20.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.432 ' HB3' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-70 -70.43 -20.41 62.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.761 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.45 ' HA ' HD13 ' A' ' 21' ' ' LEU . 1.4 m-85 -77.02 -25.66 52.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 111.239 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -70.96 -20.06 62.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.652 0.263 . . . . 0.0 111.377 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -13.59 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.502 . . . . 0.0 110.453 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.693 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 82.7 mt -85.5 -47.16 10.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.918 175.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 18' ' ' PHE . 17.5 mm -75.65 2.23 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.743 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HD2' ' HB2' ' A' ' 24' ' ' SER . 4.8 tmmt? -61.09 -81.04 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.526 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 23' ' ' LYS . 11.1 t -119.67 -31.7 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 118.732 -1.187 . . . . 0.0 113.809 -171.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.22 -20.9 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.065 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.693 ' HB2' ' HA ' ' A' ' 21' ' ' LEU . 33.2 mp0 -45.32 -45.44 12.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.729 0.812 . . . . 0.0 110.927 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.675 ' HG ' HG21 ' A' ' 73' ' ' VAL . 23.0 tp -133.87 91.03 2.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.4 152.29 89.92 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.185 -169.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 5.2 Cg_exo -76.81 129.39 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.005 2.47 . . . . 0.0 111.213 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.3 -15.43 17.99 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -95.7 162.08 13.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.575 HG22 HG11 ' A' ' 72' ' ' VAL . 25.2 p -81.95 160.83 23.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.432 0.158 . . . . 0.0 110.705 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.523 ' CD1' ' HG1' ' A' ' 71' ' ' THR . 10.9 mt -66.36 139.05 96.08 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.32 157.56 33.21 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.223 1.948 . . . . 0.0 111.834 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.8 t -69.31 155.36 40.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.532 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.6 m -54.85 -15.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.13 81.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.582 0.229 . . . . 0.0 111.404 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.96 -39.42 87.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 -176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.557 HD11 ' H ' ' A' ' 39' ' ' ILE . 4.5 mp -66.3 -57.04 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.91 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 8.6 ttp180 -62.71 -31.27 72.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -170.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.65 -41.68 17.51 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.967 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -81.57 -50.47 9.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.401 0.62 . . . . 0.0 109.56 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.582 ' O ' HG23 ' A' ' 45' ' ' VAL . 5.4 m-85 -92.07 101.9 14.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.355 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.413 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . -52.67 92.42 0.01 OUTLIER Glycine 0 CA--C 1.518 0.27 0 O-C-N 123.587 0.554 . . . . 0.0 113.865 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.738 HG11 HG13 ' A' ' 14' ' ' VAL . 17.6 m -146.85 178.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 123.042 0.537 . . . . 0.0 109.725 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.53 -174.99 3.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 -36.31 57.05 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.689 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -84.06 -15.11 48.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.94 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.683 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.9 m -68.5 -39.46 81.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.52 HG11 HG23 ' A' ' 39' ' ' ILE . 52.3 t -57.5 -58.29 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.314 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.561 ' HA ' ' CD1' ' A' ' 54' ' ' LEU . 24.8 t -59.38 -17.45 30.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.237 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.579 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 74.7 ttt180 -79.8 -44.6 20.3 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.377 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.628 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -79.68 -15.64 57.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 51' ' ' SER . 69.6 mt -48.64 -33.79 10.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.728 0.299 . . . . 0.0 111.407 174.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.482 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.17 -38.2 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.965 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.07 -28.56 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.45 0.643 . . . . 0.0 109.994 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.518 ' HA ' ' HA3' ' A' ' 61' ' ' GLY . 69.6 mt -73.28 -15.64 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.283 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 55' ' ' ALA . 49.2 mtmt -66.51 -48.13 70.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.338 0.59 . . . . 0.0 110.007 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.582 ' HB3' ' CG1' ' A' ' 80' ' ' ILE . 3.0 p -90.61 -54.88 3.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.649 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.34 -31.64 15.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.0 -169.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 57' ' ' LEU . . . -78.43 -29.48 52.77 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.128 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 77' ' ' PRO . 22.6 mt 75.16 80.05 0.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.159 0.984 . . . . 0.0 111.39 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 57' ' ' LEU . 36.0 m -145.92 172.85 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.174 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.0 m -146.6 116.21 7.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.39 0.614 . . . . 0.0 110.943 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.71 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 38.0 t -84.33 105.41 15.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.875 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.536 ' HD3' ' OE2' ' A' ' 74' ' ' GLU . 15.1 mmm-85 -83.79 119.14 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.39 34.7 1.34 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.127 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 66' ' ' ARG . . . -149.25 -68.3 0.21 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -69.92 -31.53 69.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.347 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.81 172.1 13.22 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.71 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 9.0 t -78.55 120.58 23.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.315 0.579 . . . . 0.0 109.441 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.575 HG11 HG22 ' A' ' 32' ' ' THR . 33.6 m -126.05 170.72 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.277 0.56 . . . . 0.0 111.387 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.675 HG21 ' HG ' ' A' ' 27' ' ' LEU . 29.4 t -93.87 120.42 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.131 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.536 ' OE2' ' HD3' ' A' ' 66' ' ' ARG . 48.6 mt-10 -131.57 158.87 39.84 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.061 0.457 . . . . 0.0 110.95 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -79.22 38.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 74' ' ' GLU . 66.8 m-20 -123.95 84.23 54.83 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.561 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.523 ' HB3' HD21 ' A' ' 62' ' ' LEU . 10.0 Cg_endo -52.2 116.07 2.58 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.003 2.468 . . . . 0.0 110.472 166.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.0 mm -64.61 127.79 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.24 74.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.561 0.696 . . . . 0.0 109.807 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.582 ' CG1' ' HB3' ' A' ' 59' ' ' SER . 38.5 mm -79.95 107.27 12.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.892 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -110.18 -69.26 0.87 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.31 149.13 20.36 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.735 ' HB1' ' HG ' ' A' ' 86' ' ' LEU . . . -109.55 163.89 13.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.97 0.385 . . . . 0.0 110.78 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -77.81 -34.0 52.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.253 0.549 . . . . 0.0 110.154 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -75.54 -21.24 58.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.357 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.735 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 48.5 mt -68.98 93.96 0.6 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.367 0.603 . . . . 0.0 110.375 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.693 ' HZ3' ' HB2' ' A' ' 87' ' ' LYS . 0.2 OUTLIER -161.99 -44.39 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.641 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -142.76 138.97 30.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.774 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.3 tpt -71.04 -46.77 61.47 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -91.47 76.92 5.81 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.49 113.23 2.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.861 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -81.38 142.01 33.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.753 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.14 -36.44 92.37 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.476 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.749 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 2.3 tpt -79.46 99.64 7.31 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -98.44 151.0 21.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.275 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.88 163.12 29.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.413 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.65 110.14 43.34 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.906 0.384 . . . . 0.0 110.279 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.568 ' HG3' ' HD2' ' A' ' 87' ' ' LYS . 95.3 Cg_endo -83.07 12.74 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.96 2.44 . . . . 0.0 112.544 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.12 35.46 1.9 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.862 -177.586 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 18.6 mmt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.636 0.255 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 7.6 Cg_exo -73.68 7.81 2.18 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.083 2.522 . . . . 0.0 112.621 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 96.0 m-85 -90.68 119.41 30.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.037 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -88.23 142.2 27.94 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.58 134.4 34.2 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 64.7 Cg_endo -78.14 111.48 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.339 2.026 . . . . 0.0 111.656 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -69.33 -77.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.039 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.11 -6.41 4.88 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.91 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.54 154.25 42.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.821 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.88 -135.27 3.68 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.81 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.547 ' HA ' HG11 ' A' ' 14' ' ' VAL . 3.0 p90 -74.24 -1.6 21.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.127 0.489 . . . . 0.0 111.011 -175.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.34 22.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.256 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.05 -36.65 13.91 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.64 0.733 . . . . 0.0 109.105 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.715 ' HB ' HG13 ' A' ' 45' ' ' VAL . 7.3 p -75.1 -32.6 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.856 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.67 -46.22 84.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.934 0.397 . . . . 0.0 110.681 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -71.46 -27.89 63.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.875 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -74.34 -20.84 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.834 0.35 . . . . 0.0 110.883 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.0 -24.07 65.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.886 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.1 m -75.27 -28.11 59.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.316 0.579 . . . . 0.0 110.038 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 1.017 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 67.5 mt -78.96 -28.84 43.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.87 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 tp -90.29 -7.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.364 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.06 -79.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 26' ' ' GLU . 8.5 t -119.71 -34.62 3.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 159.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.017 ' HA3' ' HA ' ' A' ' 21' ' ' LEU . . . 18.12 22.46 0.0 OUTLIER Glycine 0 C--N 1.354 1.561 0 C-N-CA 127.949 2.69 . . . . 0.0 118.652 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' SER . 33.0 mt-10 59.53 9.79 1.66 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 117.413 0.606 . . . . 0.0 111.225 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.668 HD13 HD21 ' A' ' 21' ' ' LEU . 8.3 mp -129.64 34.2 4.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.07 166.28 2.15 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.137 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 10.7 Cg_exo -73.53 123.81 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.744 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.03 5.5 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.929 -172.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -104.37 164.07 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.662 HG21 HG11 ' A' ' 72' ' ' VAL . 2.7 p -97.38 153.23 18.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.65 0.262 . . . . 0.0 110.953 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 10.5 mp -72.42 120.0 78.08 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 111.881 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.51 6.69 5.48 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 123.284 2.656 . . . . 0.0 111.871 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 1.104 ' HA ' HD11 ' A' ' 39' ' ' ILE . 5.7 p -79.04 59.15 2.61 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -160.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.87 -58.05 4.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.614 1.197 . . . . 0.0 110.008 142.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.32 -58.98 2.34 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.924 -166.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.65 -30.49 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.401 -174.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 1.104 HD11 ' HA ' ' A' ' 35' ' ' SER . 1.8 mp -86.1 -56.07 5.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.03 -173.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 4.2 ptm180 -66.01 -18.62 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.826 -172.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . . . -67.99 -57.53 6.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.513 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -81.16 -51.86 7.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.846 0.831 . . . . 0.0 110.065 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.688 ' HD2' HG23 ' A' ' 39' ' ' ILE . 4.8 m-85 -89.8 83.11 6.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.867 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.46 88.17 0.01 OUTLIER Glycine 0 N--CA 1.462 0.419 0 O-C-N 125.002 1.439 . . . . 0.0 115.182 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.715 HG13 ' HB ' ' A' ' 14' ' ' VAL . 17.4 m -142.02 178.11 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HB3' ' OG1' ' A' ' 49' ' ' THR . . . -89.08 -175.12 4.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.83 -35.17 51.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.277 0.56 . . . . 0.0 110.645 -174.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.893 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 10.5 mmpt? -85.12 -13.05 51.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.678 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.69 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 m -71.95 -40.07 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.678 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG12 HG22 ' A' ' 39' ' ' ILE . 48.7 t -55.16 -57.01 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.396 0.617 . . . . 0.0 110.375 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.706 ' HA ' HD12 ' A' ' 54' ' ' LEU . 36.0 t -64.16 -14.06 52.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.639 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 16.2 tpp180 -78.28 -44.14 26.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.68 ' HB3' HG13 ' A' ' 14' ' ' VAL . . . -66.58 -33.4 75.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.881 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.706 HD12 ' HA ' ' A' ' 51' ' ' SER . 69.1 mt -53.56 -31.33 46.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.628 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.527 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.6 -26.34 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.078 0.466 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.55 -29.98 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.647 0.737 . . . . 0.0 109.669 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -74.03 -13.8 60.91 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.624 -173.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.527 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 62.2 pttt -64.53 -36.69 85.04 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.602 173.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.701 ' HA ' HG13 ' A' ' 78' ' ' ILE . 6.1 m -93.09 -53.48 4.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.284 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -88.37 -31.02 19.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.005 -170.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.43 -12.52 59.64 Favored Glycine 0 C--O 1.229 -0.216 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.922 -176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp 63.49 52.43 2.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.874 0.368 . . . . 0.0 111.707 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.82 164.2 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.663 ' HB3' HG21 ' A' ' 72' ' ' VAL . 22.6 t -117.17 105.2 11.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.184 0.516 . . . . 0.0 110.608 -174.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.2 m -81.39 71.38 8.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 20.9 tpp180 -75.77 96.46 3.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.313 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.15 49.47 3.54 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.001 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.23 -47.26 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.96 -44.66 10.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.093 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 138.06 -177.6 19.87 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.692 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 33' ' ' LEU . 17.7 p -75.01 106.66 6.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.968 0.413 . . . . 0.0 110.466 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 64' ' ' SER . 18.2 m -123.05 150.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.101 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.482 HG11 ' O ' ' A' ' 27' ' ' LEU . 17.5 t -92.57 105.18 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -126.45 135.54 51.5 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 20.8 pttm -66.63 92.73 0.22 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.498 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 19.8 m-80 -90.35 110.86 43.78 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.056 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 76' ' ' ASN . 28.0 Cg_endo -62.64 115.38 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.021 1.814 . . . . 0.0 109.703 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.701 HG13 ' HA ' ' A' ' 59' ' ' SER . 13.1 mm -95.68 117.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.078 0.466 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m 44.77 31.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 113.682 -1.599 . . . . 0.0 111.658 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mm -76.12 118.62 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.062 -174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.7 m -117.17 -25.8 7.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.471 0.653 . . . . 0.0 109.812 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.52 112.48 3.55 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.589 176.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.05 -19.34 64.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.903 0.382 . . . . 0.0 111.091 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -79.54 -19.29 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.087 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -88.6 -1.64 58.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.782 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.0 tp -79.13 -22.72 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -115.81 -178.13 3.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.403 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -84.52 178.56 7.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.695 0.283 . . . . 0.0 110.944 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.5 tpt -68.97 -37.91 79.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -71.3 73.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.738 ' HZ1' ' HB2' ' A' ' 91' ' ' LYS . 4.8 ttmp? -90.92 132.06 36.17 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.652 -167.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.449 ' N ' HD21 ' A' ' 92' ' ' ASN . 0.9 OUTLIER -99.91 136.22 40.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.446 175.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.18 -27.38 66.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.797 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -174.77 3.52 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -64.46 143.32 57.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.198 0.523 . . . . 0.0 111.195 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.419 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 81.0 t80 -96.5 132.43 42.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.37 108.72 5.07 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 123.361 0.413 . . . . 0.0 110.728 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 64.1 Cg_endo -89.72 -2.06 5.77 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.883 2.389 . . . . 0.0 112.502 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.99 45.4 0.74 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.056 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.393 -0.813 . . . . 0.0 109.659 179.139 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' HB3' ' HD2' ' A' ' 3' ' ' TYR . 90.3 mtp . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.021 0.439 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.22 36.39 0.5 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.219 2.613 . . . . 0.0 112.858 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.463 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 93.7 m-85 -79.91 135.93 36.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.791 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -88.67 93.14 9.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.184 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.8 117.33 66.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.503 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 68.2 Cg_endo -91.77 178.79 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.414 2.742 . . . . 0.0 112.544 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -93.23 -89.45 0.21 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.76 101.27 0.61 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.5 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -123.48 150.97 43.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.969 0.414 . . . . 0.0 110.875 -174.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.34 -145.29 14.94 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 170.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.6 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 2.0 p90 -80.17 23.47 0.47 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.769 0.318 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.57 -46.46 8.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.857 0.361 . . . . 0.0 111.567 -172.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -77.45 -26.58 51.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.45 0.643 . . . . 0.0 110.157 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.981 ' HB ' HG11 ' A' ' 45' ' ' VAL . 12.8 p -75.1 -26.09 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.257 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 19' ' ' ARG . . . -63.16 -34.79 78.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.485 ' HB ' ' CE2' ' A' ' 43' ' ' PHE . 10.3 m -60.02 -26.59 66.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.11 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.507 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 53.9 t-80 -56.12 -48.47 76.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.65 ' HE2' HD22 ' A' ' 33' ' ' LEU . 74.7 m-85 -83.21 -35.71 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.523 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 72.4 mtp180 -57.08 -32.63 66.47 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 110.635 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.6 m -79.13 -55.55 5.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.827 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.554 HD12 HD23 ' A' ' 27' ' ' LEU . 31.1 mt -48.88 -46.91 43.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 61' ' ' GLY . 1.8 mp -68.97 -43.25 82.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -86.26 -7.07 58.79 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.454 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.2 p -105.23 17.53 23.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.54 27.49 0.0 OUTLIER Glycine 0 N--CA 1.469 0.88 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -169.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.07 -32.3 71.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.554 HD23 HD12 ' A' ' 21' ' ' LEU . 22.7 tp -102.95 95.58 6.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.52 153.92 95.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.518 -170.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.24 126.68 8.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.654 2.236 . . . . 0.0 110.914 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.45 -6.24 33.76 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -95.99 149.97 20.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.805 HG21 HG12 ' A' ' 72' ' ' VAL . 19.2 p -78.37 156.8 29.33 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.724 HD23 HG22 ' A' ' 63' ' ' VAL . 14.0 mt -60.63 139.39 92.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.814 172.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.06 168.13 25.53 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.336 2.024 . . . . 0.0 111.913 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.7 p -66.09 148.94 51.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.651 ' HA ' HD12 ' A' ' 39' ' ' ILE . 20.0 m -49.72 -28.11 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.306 0.378 . . . . 0.0 111.681 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.96 91.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.561 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.51 -23.67 63.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.651 HD12 ' HA ' ' A' ' 36' ' ' VAL . 3.8 mp -79.35 -55.67 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 7.1 ptm180 -77.64 -20.64 53.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.46 68.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.673 . . . . 0.0 110.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -83.16 -60.61 2.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.018 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 48.6 m-85 -92.54 99.06 11.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.777 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 6' ' ' PRO . . . -56.33 100.13 0.1 OUTLIER Glycine 0 CA--C 1.515 0.078 0 CA-C-N 115.299 -0.864 . . . . 0.0 114.044 -172.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.981 HG11 ' HB ' ' A' ' 14' ' ' VAL . 6.1 m -146.38 178.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 122.575 0.35 . . . . 0.0 110.141 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.92 175.15 7.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.8 -19.3 55.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.467 0.651 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.648 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 71.8 mmtt -74.36 -46.48 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.963 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.739 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.5 m -56.38 -43.06 78.84 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.833 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.763 ' HA ' HG22 ' A' ' 14' ' ' VAL . 93.5 t -52.83 -53.66 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.327 0.584 . . . . 0.0 110.95 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.546 ' HA ' HD13 ' A' ' 54' ' ' LEU . 23.2 t -70.48 -6.68 37.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.624 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.648 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 5.2 mmp_? -83.61 -47.05 11.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.122 -0.362 . . . . 0.0 110.293 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 14' ' ' VAL . . . -70.77 -20.11 62.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.791 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.546 HD13 ' HA ' ' A' ' 51' ' ' SER . 65.5 mt -53.22 -29.81 34.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.234 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.51 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -63.03 -30.87 71.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.146 0.498 . . . . 0.0 110.643 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.68 -31.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.369 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.628 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -75.36 -17.71 60.16 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -171.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.65 ' HZ3' ' HB3' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -66.41 -34.76 78.67 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.347 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 m -93.57 -51.74 4.81 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.31 0.576 . . . . 0.0 110.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -84.32 -53.5 5.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.008 -172.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.628 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -77.06 -7.02 86.62 Favored Glycine 0 C--O 1.225 -0.423 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.801 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 16.7 mt 63.29 78.28 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.375 0.67 . . . . 0.0 111.972 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.724 HG22 HD23 ' A' ' 33' ' ' LEU . 1.4 p -160.57 135.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.681 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 8.4 t 147.9 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.843 1.339 . . . . 0.0 111.687 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.589 ' CB ' HG23 ' A' ' 72' ' ' VAL . 3.8 t -94.82 -59.87 1.82 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.283 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 0.3 OUTLIER -118.72 135.28 54.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.214 0.53 . . . . 0.0 112.217 -169.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.74 -30.79 9.25 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 168.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.22 -61.35 2.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.88 -62.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 169.28 160.63 17.91 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.904 176.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 121.1 24.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.678 0.752 . . . . 0.0 109.829 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.805 HG12 HG21 ' A' ' 32' ' ' THR . 2.6 m -121.92 163.96 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.229 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.486 HG22 ' HG ' ' A' ' 27' ' ' LEU . 16.7 t -84.97 123.41 39.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.185 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -132.28 159.49 38.95 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -76.09 66.09 2.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.834 0.826 . . . . 0.0 110.128 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.453 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 7.5 m-20 -55.17 142.24 58.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.491 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.11 117.92 5.41 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.141 1.894 . . . . 0.0 111.51 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.444 HG23 HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -79.73 111.64 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.418 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.444 HG22 HG23 ' A' ' 78' ' ' ILE . 34.3 m 40.74 36.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.255 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.0 mm -81.41 139.69 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.496 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.9 m -142.53 -28.0 0.6 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.029 0.442 . . . . 0.0 111.158 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.54 56.59 0.74 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.823 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.01 -33.91 24.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.073 0.464 . . . . 0.0 110.297 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -80.01 -8.5 59.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.16 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -78.86 -44.72 22.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.903 0.382 . . . . 0.0 110.641 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.47 107.34 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.036 -172.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -157.91 -10.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.472 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -175.07 -55.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.207 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 47.5 ttm -149.92 -70.08 0.19 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.514 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -142.42 -74.33 0.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.711 ' HZ3' ' HB3' ' A' ' 91' ' ' LYS . 7.5 ttpm? -155.48 96.7 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.308 0.575 . . . . 0.0 110.872 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -81.45 139.22 35.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.428 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.09 44.9 2.69 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.59 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.6 mmt -121.86 130.31 53.28 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -70.86 106.41 3.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.539 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 79.9 t80 -81.85 130.61 35.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.16 105.68 3.11 Favored Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 123.366 0.416 . . . . 0.0 110.025 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 32.9 Cg_endo -92.79 17.25 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.04 2.494 . . . . 0.0 111.495 -175.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.34 78.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.185 -175.868 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.15 115.08 3.64 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.681 2.254 . . . . 0.0 111.085 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -75.13 143.75 43.16 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.965 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -93.67 128.63 39.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.705 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.45 118.27 60.75 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.604 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -88.31 160.55 6.88 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.938 2.425 . . . . 0.0 112.65 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.6 95.44 3.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.03 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.99 38.64 55.64 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.484 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.562 ' HD2' ' HB2' ' A' ' 13' ' ' ASP . 3.3 tppp? -104.44 108.66 20.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -157.86 33.39 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.868 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.507 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -71.92 0.51 9.07 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.622 0.369 . . . . 0.0 111.308 -177.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.5 50.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.687 0.28 . . . . 0.0 111.338 -169.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.562 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 40.3 t0 -76.1 -38.65 56.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.375 0.607 . . . . 0.0 109.511 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.659 HG21 ' HB1' ' A' ' 53' ' ' ALA . 3.8 m -85.19 -23.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.56 61.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.264 0.554 . . . . 0.0 109.873 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.654 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 5.1 m -104.13 -27.31 12.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.993 174.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.485 ' HD2' HG22 ' A' ' 39' ' ' ILE . 4.0 t60 -60.54 -21.22 62.28 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.693 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 24.8 p90 -58.21 -33.43 69.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.365 0.602 . . . . 0.0 110.453 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 16' ' ' THR . 2.6 ptm180 -68.25 -25.88 65.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.767 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.444 ' HB ' HD21 ' A' ' 21' ' ' LEU . 2.4 m -65.13 -35.63 81.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.219 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 1.137 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.1 mm? -91.93 -48.12 6.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.298 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' HB3' ' A' ' 27' ' ' LEU . 36.4 mm -67.52 -12.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.861 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 2.7 tmmt? -48.0 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.325 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 p -118.31 -32.08 4.77 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.73 -20.7 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.198 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.666 ' HG2' ' HA ' ' A' ' 21' ' ' LEU . 2.1 pm0 -63.37 -21.39 66.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -168.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 1.137 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.7 tp -121.59 83.4 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.24 141.34 80.66 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.508 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.64 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 3.0 Cg_exo -77.09 123.7 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 110.903 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.14 46.43 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -174.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -118.26 156.63 28.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 24.1 p -82.69 138.77 34.0 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.256 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 151.09 86.2 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.63 168.32 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.696 2.264 . . . . 0.0 112.694 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -76.73 -179.23 5.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.192 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.17 -19.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.924 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.63 75.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.53 -55.06 19.86 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.861 0.362 . . . . 0.0 111.058 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.64 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.4 mp -58.11 -39.83 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.047 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 5.2 tmm_? -79.76 -28.25 40.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.347 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.6 -31.73 28.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.48 -65.36 0.9 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.446 ' O ' HG21 ' A' ' 45' ' ' VAL . 3.1 m-85 -91.92 111.27 22.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.19 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.95 92.33 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 O-C-N 124.016 0.822 . . . . 0.0 113.363 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.489 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 18.8 m -138.81 -179.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.51 174.61 7.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.913 0.387 . . . . 0.0 110.535 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -14.62 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 44.0 m -73.15 -42.11 63.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 81.5 t -54.52 -61.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.484 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.598 ' HA ' HD12 ' A' ' 54' ' ' LEU . 13.0 t -57.48 -25.43 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.522 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 77.1 ttt180 -72.93 -48.29 38.19 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.099 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.659 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -63.58 -31.04 72.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.037 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.625 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 86.8 mt -58.18 -29.52 65.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.161 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.43 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -67.77 -28.84 67.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.354 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 26.3 t -84.84 -32.15 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 175.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.664 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.8 mp -77.51 4.46 11.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.828 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 41.4 mtmt -65.62 -56.63 11.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -93.85 -40.5 10.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.893 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 9.7 tp10 -73.62 -51.07 18.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.772 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.693 ' HA2' ' CD2' ' A' ' 18' ' ' PHE . . . -88.64 -13.23 63.3 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.877 -176.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.541 HD22 ' O ' ' A' ' 76' ' ' ASN . 63.9 mt 66.2 66.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.979 0.458 . . . . 0.0 111.826 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 57' ' ' LEU . 32.8 m -136.87 156.45 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.46 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -116.61 95.63 5.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.359 0.6 . . . . 0.0 109.842 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -84.86 109.17 17.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.92 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.41 108.6 20.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.141 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.15 47.24 2.58 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.164 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.76 -55.87 0.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.293 0.568 . . . . 0.0 109.613 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -85.81 -36.53 20.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.253 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.0 175.41 13.88 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.56 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.4 p -87.83 104.9 17.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 15.5 t -114.54 139.84 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.388 . . . . 0.0 110.267 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.643 HG23 ' HG ' ' A' ' 27' ' ' LEU . 21.4 t -90.84 91.0 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -94.51 138.81 31.97 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -71.31 84.73 0.78 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.541 ' O ' HD22 ' A' ' 62' ' ' LEU . 83.1 m-20 -67.97 140.13 93.5 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.615 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.475 ' HB2' HG13 ' A' ' 80' ' ' ILE . 6.3 Cg_exo -77.67 118.2 4.46 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.705 2.27 . . . . 0.0 110.055 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.492 HG12 HD23 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -58.88 115.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.743 -174.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 m 23.62 70.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.245 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.475 HG13 ' HB2' ' A' ' 77' ' ' PRO . 29.5 mm -88.08 107.58 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.347 0.594 . . . . 0.0 111.329 -173.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.526 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 6.6 p -104.43 -27.03 12.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.518 172.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.642 ' HA2' ' HB2' ' A' ' 86' ' ' LEU . . . -96.58 -148.58 24.38 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.834 177.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 61.52 -72.14 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.716 0.806 . . . . 0.0 112.624 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.518 ' HA ' ' HE3' ' A' ' 87' ' ' LYS . 31.1 t70 -103.83 -33.53 8.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.361 . . . . 0.0 111.16 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -90.81 -14.33 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.518 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.642 ' HB2' ' HA2' ' A' ' 82' ' ' GLY . 52.3 mt -115.62 94.52 4.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 84' ' ' ASP . 87.8 mttt -121.17 -66.64 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.989 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 67.46 -74.89 0.07 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.733 0.646 . . . . 0.0 110.803 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 tpt -167.99 156.38 8.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 75.2 -65.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.714 0.634 . . . . 0.0 111.523 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -90.35 119.98 31.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.344 0.592 . . . . 0.0 111.262 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -128.35 121.97 30.4 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.488 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.11 -89.2 1.39 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.921 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.476 ' HG2' ' H ' ' A' ' 95' ' ' ARG . 44.2 ttp -95.02 174.67 6.97 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.476 ' H ' ' HG2' ' A' ' 94' ' ' MET . 66.4 mtt85 -108.19 157.27 18.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -83.76 153.61 24.04 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.54 112.68 28.36 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.029 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.39 24.65 0.73 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.966 2.444 . . . . 0.0 112.23 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.67 27.37 2.07 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.719 -179.144 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.88 127.76 19.34 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.599 2.199 . . . . 0.0 111.16 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 66.5 t80 -85.62 128.66 34.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.176 0.512 . . . . 0.0 111.26 -175.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.93 114.12 26.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.401 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -81.89 122.28 79.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.731 0.301 . . . . 0.0 110.531 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.456 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 84.6 Cg_endo -95.53 134.08 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.199 2.6 . . . . 0.0 113.182 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -99.87 -73.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.11 92.08 1.71 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.663 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -75.92 178.55 6.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.196 0.998 . . . . 0.0 112.919 -172.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 168.57 151.13 6.98 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.122 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.446 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 9.3 p90 -70.66 8.03 0.96 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.419 0.609 . . . . 0.0 110.584 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . -79.78 -28.1 40.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.17 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 12.4 t70 -67.56 -50.08 60.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.026 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.531 HG12 HG12 ' A' ' 45' ' ' VAL . 2.3 m -71.02 -36.89 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.415 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -55.37 -48.76 73.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.036 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -80.05 -22.41 42.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.479 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 1.7 m170 -85.97 -30.3 22.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -73.27 -18.44 61.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.983 0.421 . . . . 0.0 110.625 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -63.18 -17.53 62.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.504 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.801 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 6.8 m -81.94 -26.48 33.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.137 0.494 . . . . 0.0 110.769 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.946 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.6 mm? -81.88 -51.81 7.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.474 HG23 ' HA2' ' A' ' 61' ' ' GLY . 11.2 tp -79.69 14.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.072 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.801 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 24.4 ttmm -67.64 -77.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 m -117.36 -29.79 5.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.6 -25.84 0.02 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 118.84 -1.648 . . . . 0.0 114.957 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -53.95 -42.74 69.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.025 0.412 . . . . 0.0 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.946 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -113.31 78.31 1.13 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.92 95.27 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.447 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.586 ' HA ' HG13 ' A' ' 73' ' ' VAL . 37.5 Cg_endo -70.93 136.84 30.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.032 2.488 . . . . 0.0 111.767 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.4 56.59 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.481 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.473 ' O ' HG11 ' A' ' 73' ' ' VAL . 4.8 t0 -122.77 164.19 18.81 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 22.1 p -78.87 152.81 31.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.969 0.414 . . . . 0.0 111.11 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.592 HD21 ' HB ' ' A' ' 73' ' ' VAL . 8.7 mt -85.94 152.12 55.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.287 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.49 168.09 24.41 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.594 2.196 . . . . 0.0 111.017 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 t -73.21 155.82 39.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.621 ' HA ' HD11 ' A' ' 39' ' ' ILE . 28.8 m -53.86 -21.21 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 O-C-N 123.28 0.363 . . . . 0.0 111.914 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.83 92.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.59 -51.88 63.38 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.393 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.645 HG22 HG12 ' A' ' 50' ' ' VAL . 4.4 mp -57.88 -54.51 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.218 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -73.26 -17.89 61.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -171.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 3' ' ' TYR . . . -82.57 -44.81 15.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.595 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.885 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -75.99 -52.24 10.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.534 ' HD2' HG23 ' A' ' 39' ' ' ILE . 2.9 m-85 -93.11 105.78 17.83 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.631 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 85.43 0.01 OUTLIER Glycine 0 CA--C 1.516 0.115 0 O-C-N 123.638 0.586 . . . . 0.0 113.926 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.784 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 27.8 m -142.03 179.12 2.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.61 -169.93 2.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.22 -40.36 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.987 0.422 . . . . 0.0 110.349 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -75.05 -31.07 61.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.604 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.784 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 5.4 m -58.06 -34.49 70.18 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.141 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.645 HG12 HG22 ' A' ' 39' ' ' ILE . 60.8 t -57.32 -59.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.376 0.608 . . . . 0.0 109.974 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.572 ' HA ' HD11 ' A' ' 54' ' ' LEU . 23.1 t -65.25 -11.9 46.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.612 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 49' ' ' THR . 32.2 tpt180 -76.74 -42.68 40.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.524 ' CB ' HG23 ' A' ' 14' ' ' VAL . . . -80.56 -19.66 45.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.437 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 63' ' ' VAL . 44.8 mt -57.31 -25.52 59.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -72.65 -20.71 61.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.078 0.466 . . . . 0.0 110.71 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.06 -39.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.648 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 4.8 mp -71.27 6.68 1.59 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.922 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.84 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 22.0 pttp -76.37 -42.37 44.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -92.7 -45.05 8.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.161 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -75.97 -46.42 29.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.088 0.47 . . . . 0.0 111.243 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.648 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.21 -13.52 58.65 Favored Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.605 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.759 HD23 HG12 ' A' ' 78' ' ' ILE . 22.2 mt 67.69 28.33 7.33 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.785 0.434 . . . . 0.0 111.742 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.787 HG13 HG22 ' A' ' 73' ' ' VAL . 8.6 m -108.81 143.38 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.903 0.383 . . . . 0.0 111.342 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 41.0 t -144.95 149.24 34.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 p -90.32 90.1 7.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 4.3 tpp180 -71.48 105.19 3.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.054 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.97 59.07 3.53 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.239 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.95 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.48 -28.1 37.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.753 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 128.51 -159.21 21.95 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.591 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.91 112.57 16.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 60.9 t -132.24 135.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -169.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.787 HG22 HG13 ' A' ' 63' ' ' VAL . 11.6 p -82.56 75.7 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 122.335 1.064 . . . . 0.0 110.856 -173.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -144.96 83.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.11 162.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.84 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 55.6 tptt -95.82 -81.1 0.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.764 0.792 . . . . 0.0 111.374 175.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.443 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 3.1 t-20 -130.7 91.96 35.89 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.839 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -40.06 122.41 1.14 Allowed 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.983 2.455 . . . . 0.0 111.23 175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.759 HG12 HD23 ' A' ' 62' ' ' LEU . 4.0 mm -55.41 118.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t -56.68 79.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 124.567 1.167 . . . . 0.0 111.384 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 78' ' ' ILE . 69.1 mt -78.92 112.84 17.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.072 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -83.38 38.88 0.63 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.654 0.74 . . . . 0.0 110.674 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.55 -127.04 0.87 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.266 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.481 ' O ' HD23 ' A' ' 86' ' ' LEU . . . -162.69 172.93 14.55 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.81 5.67 15.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.078 0.942 . . . . 0.0 109.852 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -76.44 -3.93 39.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.822 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 89' ' ' MET . 1.9 pt? -72.42 89.47 1.25 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.963 0.887 . . . . 0.0 110.887 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -69.48 -30.75 68.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.5 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -127.75 21.16 6.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.487 0.661 . . . . 0.0 109.596 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.614 ' HA ' HD11 ' A' ' 86' ' ' LEU . 47.5 ttm 63.36 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.56 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.83 46.48 1.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.251 0.548 . . . . 0.0 111.169 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -78.97 109.8 13.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -63.23 143.58 57.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.082 -177.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -42.92 -70.17 0.54 Allowed Glycine 0 C--N 1.333 0.396 0 O-C-N 123.854 0.721 . . . . 0.0 113.413 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 39.7 tpp -91.15 53.87 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.722 0.773 . . . . 0.0 110.325 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HG3' ' HB2' ' A' ' 92' ' ' ASN . 43.1 mmt180 -142.44 108.01 5.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.03 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -118.71 104.92 11.05 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.95 108.24 1.75 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.105 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -93.93 5.2 2.81 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.259 2.639 . . . . 0.0 112.736 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.78 43.0 1.29 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.41 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.234 177.061 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.757 0.789 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.68 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 23.3 ttpt -94.67 118.71 32.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.489 -170.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.44 142.67 50.47 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.005 -173.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.675 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 72.1 Cg_endo -79.33 112.18 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.757 2.305 . . . . 0.0 111.713 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -70.34 -56.21 7.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.414 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.88 34.98 0.62 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.92 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HD2' ' CB ' ' A' ' 13' ' ' ASP . 51.2 pttt -123.34 148.88 45.56 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.813 -0.227 . . . . 0.0 110.906 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.9 -140.52 10.08 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.615 ' HA ' HG12 ' A' ' 14' ' ' VAL . 4.2 p90 -80.29 10.83 4.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.849 0.459 . . . . 0.0 112.209 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.87 -38.82 19.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.485 ' CB ' ' HD2' ' A' ' 9' ' ' LYS . 24.4 t70 -70.57 -35.46 73.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.338 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.695 HG13 ' HB2' ' A' ' 53' ' ' ALA . 2.5 p -71.58 -42.81 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.499 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.82 -37.53 76.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.237 0.541 . . . . 0.0 109.859 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.3 m -67.83 -46.08 72.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.122 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -78.22 -20.8 51.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.513 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.578 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -69.74 -29.2 66.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.841 0.353 . . . . 0.0 110.397 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -61.68 -23.4 66.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.492 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m -80.49 -44.29 19.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -53.53 -40.76 65.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.29 0.567 . . . . 0.0 111.295 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.615 HD12 HG11 ' A' ' 73' ' ' VAL . 19.3 mm -72.82 -14.3 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.477 -176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -75.88 -75.93 0.17 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 26' ' ' GLU . 5.5 t -119.39 -31.87 4.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.951 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 26' ' ' GLU . . . 10.31 -41.01 0.0 OUTLIER Glycine 0 C--N 1.354 1.576 0 C-N-CA 129.745 3.545 . . . . 0.0 119.558 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 24' ' ' SER . 2.0 pt-20 111.79 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.834 2.054 . . . . 0.0 107.949 -162.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 32.4 tp -112.79 58.5 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.467 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.54 166.34 14.89 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.758 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 7.6 Cg_exo -74.01 121.25 6.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 120.948 1.098 . . . . 0.0 110.428 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.3 -6.48 12.93 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.673 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -108.65 158.7 17.35 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.823 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 6.3 m -94.35 148.47 22.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.734 0.302 . . . . 0.0 111.287 -172.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.3 mp -54.79 135.72 65.15 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.712 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HG2' HD11 ' A' ' 39' ' ' ILE . 72.7 Cg_endo -78.38 171.3 17.12 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.222 2.614 . . . . 0.0 112.051 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -72.31 156.94 38.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.414 ' HA ' HD13 ' A' ' 39' ' ' ILE . 27.3 m -54.98 -21.58 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 122.707 0.403 . . . . 0.0 112.066 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.15 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.8 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.38 -51.09 67.3 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 109.798 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.774 HG21 ' HB ' ' A' ' 50' ' ' VAL . 4.8 mp -56.96 -50.17 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.269 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.907 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . 63.0 ttt180 -44.71 -33.57 1.91 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.38 -33.89 13.68 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.926 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -75.14 -44.94 44.14 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.806 0.812 . . . . 0.0 109.052 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.907 ' CE1' ' HA ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -89.45 119.72 30.14 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 172.322 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.68 ' HA2' ' HB3' ' A' ' 4' ' ' LYS . . . -73.51 53.62 1.96 Allowed Glycine 0 C--N 1.302 -1.321 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.675 ' HA ' ' HB3' ' A' ' 6' ' ' PRO . 1.8 t -136.38 170.58 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -161.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' O ' ' CZ ' ' A' ' 43' ' ' PHE . . . -78.49 152.16 32.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.29 40.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.144 0.497 . . . . 0.0 110.9 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 5.4 tmmm? -92.61 -24.22 18.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.789 171.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 11' ' ' TYR . 4.1 m -69.34 -27.9 65.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.774 ' HB ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -61.59 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.624 ' HA ' HD12 ' A' ' 54' ' ' LEU . 32.3 t -63.5 -14.37 50.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.252 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 5.6 mmp_? -81.03 -58.17 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.683 0.278 . . . . 0.0 110.258 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.695 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -63.75 -25.41 68.18 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 41.4 mt -49.08 -38.91 25.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -18.93 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.988 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.06 -28.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.544 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.965 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -72.58 -1.93 17.94 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.988 -173.543 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 57.7 pttt -66.69 -42.35 86.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 78' ' ' ILE . 2.8 m -94.77 -36.17 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.003 0.906 . . . . 0.0 109.24 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 11.1 tp10 -83.95 -66.07 0.94 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.032 -169.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.965 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -83.29 1.18 89.12 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.635 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.865 HD21 HG13 ' A' ' 78' ' ' ILE . 20.7 mt 73.2 37.27 0.76 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 172.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 58' ' ' LYS . 8.4 p -113.15 150.16 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.739 -0.6 . . . . 0.0 111.332 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.834 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 31.8 t -148.32 145.28 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.385 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -67.9 106.8 2.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 7.0 ttm180 -114.3 97.38 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.996 -176.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.69 50.51 2.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.311 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.23 -63.89 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' HB2' HG21 ' A' ' 72' ' ' VAL . 71.0 mt -91.2 -14.36 31.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.543 176.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 114.11 -160.98 12.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.896 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.806 HG23 ' HB2' ' A' ' 33' ' ' LEU . 6.4 t -78.78 81.81 5.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.427 1.108 . . . . 0.0 109.611 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.823 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 38.5 t -92.94 141.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.671 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.615 HG11 HD12 ' A' ' 22' ' ' ILE . 4.5 t -88.22 75.67 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.815 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -146.56 80.31 1.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.737 158.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.834 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 88.2 tttt -98.85 -85.59 0.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.196 0.998 . . . . 0.0 111.745 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.421 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 5.9 t-20 -130.23 95.13 28.51 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.88 -165.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.437 ' HA ' HD22 ' A' ' 62' ' ' LEU . 84.1 Cg_exo -45.41 122.63 4.84 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.021 1.814 . . . . 0.0 111.059 175.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.865 HG13 HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -56.3 136.15 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -175.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 C--N 1.32 -0.687 0 O-C-N 124.395 1.059 . . . . 0.0 111.697 179.221 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.5 p90 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.657 ' HD3' ' H ' ' A' ' 44' ' ' GLY . 58.0 tttp -104.92 145.26 30.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.757 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 163.24 20.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.596 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 10.1 Cg_exo -76.08 96.24 1.06 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.121 1.88 . . . . 0.0 112.18 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.582 ' N ' ' HE3' ' A' ' 9' ' ' LYS . 1.8 mp0 -63.89 -65.38 0.69 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.18 54.1 0.31 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.039 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.792 ' HG3' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -123.42 164.98 17.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.918 0.389 . . . . 0.0 110.716 -176.233 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.39 -143.54 10.56 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.63 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 3.0 p90 -70.87 2.34 4.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.409 . . . . 0.0 111.524 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.26 54.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.569 . . . . 0.0 110.207 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.792 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 2.5 t70 -73.99 -47.99 33.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.778 HG13 HG11 ' A' ' 45' ' ' VAL . 33.0 m -70.22 -31.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.407 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.64 -45.15 89.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.253 0.549 . . . . 0.0 109.656 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -68.43 -34.43 75.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.704 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.692 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 45.0 t-80 -52.87 -54.38 35.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.954 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.429 ' CG ' HD13 ' A' ' 57' ' ' LEU . 5.7 m-85 -68.03 -40.17 82.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.811 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -60.88 -27.43 68.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.841 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.455 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 37.9 m -80.06 -36.01 36.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 0.0 109.95 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.892 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 68.8 mt -70.86 -44.81 65.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.223 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 61' ' ' GLY . 49.2 mm -68.69 -21.8 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.457 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 22.6 ttmm -56.78 -63.73 1.11 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.798 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -114.29 -33.16 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.8 -29.67 0.03 OUTLIER Glycine 0 CA--C 1.511 -0.177 0 C-N-CA 118.666 -1.731 . . . . 0.0 114.538 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.2 -57.57 12.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -164.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 tp -98.44 89.19 4.35 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.42 153.79 65.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.479 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 63.4 Cg_endo -77.31 137.63 17.04 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.102 1.868 . . . . 0.0 112.092 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.91 -24.99 9.14 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.007 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.41 161.85 14.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -79.03 161.23 26.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.731 0.3 . . . . 0.0 111.355 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.4 145.64 98.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.332 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.403 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 74.2 Cg_endo -78.11 171.49 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.826 2.351 . . . . 0.0 112.507 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.8 p -79.27 159.59 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.06 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.475 ' HA ' HD13 ' A' ' 39' ' ' ILE . 25.2 m -54.01 -26.25 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.9 82.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.131 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 16.6 m-20 -70.33 -29.66 66.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 110.297 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.692 ' HA ' ' CE1' ' A' ' 17' ' ' HIS . 3.7 mp -75.48 -49.94 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.244 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 22.0 ttm180 -66.93 -46.95 73.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.12 75.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 0.0 110.955 -170.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -84.39 -65.96 0.95 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.175 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.433 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 18.8 m-85 -93.48 102.12 14.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.269 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.657 ' H ' ' HD3' ' A' ' 4' ' ' LYS . . . -57.37 99.56 0.1 Allowed Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.624 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.778 HG11 HG13 ' A' ' 14' ' ' VAL . 19.4 m -140.73 179.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.115 0.483 . . . . 0.0 111.384 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -97.89 176.35 5.82 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.44 52.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.79 0.329 . . . . 0.0 110.748 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -79.16 -29.72 43.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 109.955 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.8 m -63.69 -43.58 96.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.539 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.674 ' HA ' HG11 ' A' ' 14' ' ' VAL . 96.4 t -55.81 -58.86 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.782 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.698 ' HA ' HD12 ' A' ' 54' ' ' LEU . 26.0 t -68.37 -6.41 24.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.871 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 4.6 tpm_? -77.74 -50.67 11.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.542 0.211 . . . . 0.0 110.678 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.756 ' HB3' HG23 ' A' ' 14' ' ' VAL . . . -90.74 -9.89 45.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 51' ' ' SER . 95.5 mt -51.6 -31.06 23.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.825 0.284 . . . . 0.0 111.486 174.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.845 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 44.2 t -80.73 -30.39 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.742 0.782 . . . . 0.0 109.514 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.64 HD21 ' HA ' ' A' ' 15' ' ' ALA . 86.9 mt -76.06 1.27 15.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.632 -173.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -66.04 -56.45 11.5 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.4 p -93.57 -34.43 13.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.481 0.657 . . . . 0.0 110.356 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.4 tp10 -77.07 -52.14 9.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.722 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.59 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -90.52 -7.4 67.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.977 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp 63.04 66.7 0.72 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.812 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 57' ' ' LEU . 31.1 m -136.14 162.49 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.681 175.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.8 m -144.59 128.5 17.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.139 0.495 . . . . 0.0 111.372 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -78.53 92.76 4.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.535 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 9.9 tpt180 -85.45 101.87 12.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.92 50.66 2.28 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.647 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.87 -60.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.05 -16.23 44.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.434 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 109.53 178.42 21.21 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.666 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.66 99.26 3.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 19.5 m -117.61 159.94 17.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 111.417 -170.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 22.3 t -85.68 93.82 3.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.789 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' A' ' 72' ' ' VAL . 31.2 mt-10 -102.64 151.3 22.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.679 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 57.6 mtpt -68.51 88.55 0.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -94.75 96.04 1.76 Allowed Pre-proline 0 CA--C 1.503 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 50.8 Cg_exo -56.39 151.34 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.216 1.944 . . . . 0.0 112.405 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -55.7 105.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.052 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 t . . . . . 0 C--N 1.32 -0.703 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.642 -179.589 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 121.026 0.441 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -85.05 134.88 34.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.958 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -96.35 150.05 36.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.451 0.167 . . . . 0.0 111.182 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 6.2 Cg_exo -78.59 118.45 4.21 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.067 2.512 . . . . 0.0 111.681 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -99.66 -74.41 0.6 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.707 -175.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.96 29.52 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.405 -176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -116.61 156.66 26.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.09 -107.7 2.66 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.898 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -95.85 -12.25 25.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 174.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.51 9.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.501 0.667 . . . . 0.0 111.141 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.488 ' OD1' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -91.14 -52.8 4.65 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.388 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.679 HG13 HH22 ' A' ' 52' ' ' ARG . 2.0 m -68.74 -34.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.642 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.63 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -55.73 -44.71 77.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.64 170.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -64.57 -39.11 93.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 22.9 t60 -57.62 -48.01 80.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.471 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.37 -40.31 85.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.192 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -56.66 -27.57 58.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.588 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 m -85.33 -54.02 4.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.802 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . 3.3 pp -75.64 -12.04 60.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.554 -172.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.02 -41.48 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 110.452 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -92.9 -13.34 29.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.218 0.533 . . . . 0.0 110.513 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.775 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 23.0 t -86.54 26.79 1.03 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.317 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.15 25.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.2 mt-10 -69.79 -34.98 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HG ' HD13 ' A' ' 21' ' ' LEU . 61.0 mt -122.9 92.1 3.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.526 166.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.05 54.63 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.751 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 5.8 Cg_exo -75.19 123.47 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.669 1.579 . . . . 0.0 110.691 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.35 27.89 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.43 163.5 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 1.007 ' HB ' HG23 ' A' ' 71' ' ' THR . 6.7 t -107.88 161.9 14.5 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -172.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.795 HD11 ' HB ' ' A' ' 63' ' ' VAL . 4.2 mp -57.52 109.69 1.95 Allowed Pre-proline 0 N--CA 1.432 -1.357 0 CA-C-N 111.196 -2.729 . . . . 0.0 108.435 167.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.95 175.41 10.87 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 123.359 2.706 . . . . 0.0 113.225 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -64.69 158.12 25.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.49 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.31 -19.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.02 -52.99 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.21 -53.42 58.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.375 0.607 . . . . 0.0 111.08 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.782 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -56.05 -53.66 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.652 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 43.8 ttp180 -65.6 -40.03 92.22 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.79 -46.23 25.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -75.84 -56.45 4.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.938 0.399 . . . . 0.0 110.673 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.471 ' O ' HG22 ' A' ' 45' ' ' VAL . 5.2 m-85 -91.81 103.99 16.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.795 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.79 86.31 0.01 OUTLIER Glycine 0 CA--C 1.516 0.111 0 O-C-N 124.642 1.214 . . . . 0.0 114.459 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 43' ' ' PHE . 33.6 m -137.77 177.38 5.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -97.17 178.89 5.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.57 -33.11 58.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.096 0.474 . . . . 0.0 109.973 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.966 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -68.49 -36.79 79.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 175.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.813 HG22 ' HE ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -65.18 -53.3 46.88 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 46' ' ' ALA . 92.0 t -41.25 -52.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.596 -0.69 . . . . 0.0 111.189 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.646 ' HA ' HD12 ' A' ' 54' ' ' LEU . 47.9 t -60.75 -34.07 73.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.063 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.898 ' CZ ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -72.25 -31.31 65.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.548 -169.381 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.664 ' N ' ' HD2' ' A' ' 52' ' ' ARG . . . -91.12 -5.37 55.18 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.671 -0.643 . . . . 0.0 111.807 173.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 51' ' ' SER . 44.5 mt -57.88 -35.05 70.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.708 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.16 -18.16 64.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.009 176.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 60' ' ' GLU . 34.3 t -90.46 -29.22 4.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.63 HD11 ' HA ' ' A' ' 15' ' ' ALA . 1.2 mp -73.85 2.89 7.48 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.251 -174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.97 -41.8 20.29 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' A' ' 78' ' ' ILE . 15.7 m -94.04 -41.68 9.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.773 0.797 . . . . 0.0 109.887 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' HB3' HG12 ' A' ' 56' ' ' VAL . 39.0 tp10 -89.6 -34.49 16.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.809 -175.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -90.72 -10.3 63.35 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.561 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 11.2 mp 79.36 12.78 1.19 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.795 ' HB ' HD11 ' A' ' 33' ' ' LEU . 9.3 m -100.91 154.62 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.647 -0.658 . . . . 0.0 109.5 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -128.28 179.01 5.86 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.611 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -52.47 122.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.829 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HA ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -64.94 163.93 13.57 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.374 -168.253 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.79 -67.45 1.43 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.683 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.448 ' H ' ' H ' ' A' ' 69' ' ' LEU . . . -160.71 -16.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.711 0.767 . . . . 0.0 109.504 168.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' H ' ' H ' ' A' ' 68' ' ' ALA . 2.5 mm? -93.64 -39.21 10.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.404 -170.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.696 ' N ' ' HG3' ' A' ' 66' ' ' ARG . . . 143.33 -5.04 1.83 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.706 -166.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 1.007 HG23 ' HB ' ' A' ' 32' ' ' THR . 89.0 m -97.52 92.86 6.13 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.806 HG23 ' HA ' ' A' ' 66' ' ' ARG . 90.8 t -151.52 96.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 123.852 0.72 . . . . 0.0 112.095 156.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 60.5 t -89.07 130.38 38.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 159.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 29' ' ' PRO . 40.1 mt-10 -133.39 165.14 25.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HA ' HD23 ' A' ' 62' ' ' LEU . 52.0 tttm -84.87 49.01 1.64 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 166.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -118.95 91.9 44.02 Favored Pre-proline 0 CA--C 1.515 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.477 -170.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.25 115.9 4.04 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.821 1.681 . . . . 0.0 109.473 171.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.461 ' H ' ' HA ' ' A' ' 59' ' ' SER . 19.1 mt -70.74 100.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.984 -176.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.47 0.553 0 O-C-N 124.728 1.268 . . . . 0.0 111.335 177.836 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.3 t80 . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.81 117.88 24.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.851 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.1 167.44 21.61 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.427 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.48 92.09 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.339 2.026 . . . . 0.0 110.804 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 9.3 pt-20 -71.39 73.31 0.71 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.905 -176.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.83 16.55 68.31 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.67 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.509 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 60.1 pttt -124.25 147.63 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.541 0.21 . . . . 0.0 110.456 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.1 -137.69 7.18 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.13 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.402 ' HA ' HG22 ' A' ' 49' ' ' THR . 11.1 p90 -68.48 -9.55 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.789 0.328 . . . . 0.0 111.81 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.47 -17.44 56.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.849 0.357 . . . . 0.0 110.516 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 15.5 t70 -74.36 -51.56 14.74 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.909 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.621 HG23 ' HB2' ' A' ' 53' ' ' ALA . 2.2 m -68.86 -33.7 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.72 63.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.966 0.413 . . . . 0.0 110.578 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -74.16 -37.04 64.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.21 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -68.13 -36.41 79.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CG ' HD21 ' A' ' 57' ' ' LEU . 5.2 m-85 -65.05 -44.28 89.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 0.0 110.14 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.624 ' HG2' ' HA2' ' A' ' 61' ' ' GLY . 73.8 mtp180 -53.11 -26.38 16.29 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.281 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.63 HG22 ' HB2' ' A' ' 24' ' ' SER . 13.1 m -88.53 -54.78 4.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.685 HD12 ' HA3' ' A' ' 25' ' ' GLY . 1.1 tp -52.55 -26.63 13.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.608 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 23' ' ' LYS . 1.3 mp -50.03 -58.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.688 0.28 . . . . 0.0 110.421 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.442 ' N ' HG22 ' A' ' 22' ' ' ILE . 16.5 ptpt -94.46 -29.54 14.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.63 ' HB2' HG22 ' A' ' 20' ' ' THR . 38.9 m -102.47 28.66 5.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.285 -171.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.685 ' HA3' HD12 ' A' ' 21' ' ' LEU . . . -165.1 20.57 0.12 Allowed Glycine 0 CA--C 1.505 -0.544 0 C-N-CA 119.37 -1.395 . . . . 0.0 112.239 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 64.92 10.35 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.56 -0.82 . . . . 0.0 112.852 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.62 HD12 HD21 ' A' ' 21' ' ' LEU . 23.2 mt -84.2 59.15 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 160.46 28.42 Favored Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 6.5 Cg_exo -75.09 136.77 20.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.944 1.763 . . . . 0.0 112.322 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.95 -17.75 11.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.717 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -95.55 159.89 14.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.606 HG22 HG12 ' A' ' 72' ' ' VAL . 36.8 p -78.66 165.06 24.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.636 0.255 . . . . 0.0 111.137 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.86 141.6 98.39 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 171.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.53 ' HG2' HD11 ' A' ' 39' ' ' ILE . 57.0 Cg_endo -77.71 163.86 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.379 2.052 . . . . 0.0 111.669 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 m -65.81 140.31 58.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.456 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.599 ' HA ' HD13 ' A' ' 39' ' ' ILE . 31.0 m -52.07 -27.19 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.81 86.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -66.67 -48.8 68.2 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.283 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -55.02 -50.76 60.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.257 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 19.9 ptt180 -81.17 -9.75 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -173.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.01 -38.66 17.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.721 0.296 . . . . 0.0 110.282 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -87.99 -59.13 2.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.637 0.732 . . . . 0.0 110.09 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 45' ' ' VAL . 21.0 m-85 -90.23 81.85 6.07 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.416 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.412 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . -39.56 92.67 0.01 OUTLIER Glycine 0 CA--C 1.523 0.564 0 O-C-N 124.613 1.196 . . . . 0.0 115.274 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 14.7 m -139.01 178.71 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' OG1' ' A' ' 49' ' ' THR . . . -87.19 -175.02 5.15 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.8 51.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.372 . . . . 0.0 111.246 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -90.24 -22.32 21.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.521 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.675 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.5 m -64.16 -35.34 80.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.539 -174.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG13 HG21 ' A' ' 39' ' ' ILE . 65.1 t -56.17 -59.1 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.331 0.586 . . . . 0.0 110.571 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.606 ' HA ' HD12 ' A' ' 54' ' ' LEU . 42.1 t -66.14 -14.26 61.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.815 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -77.17 -40.53 45.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 109.847 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.621 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -74.17 -30.67 62.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.562 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 51' ' ' SER . 83.9 mt -51.92 -30.39 24.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.613 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . . . -68.59 -24.43 64.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.962 0.41 . . . . 0.0 111.096 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.93 -23.8 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.734 0.778 . . . . 0.0 109.448 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.694 ' HG ' ' HA3' ' A' ' 61' ' ' GLY . 4.5 mp -68.67 -19.49 64.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.019 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 55' ' ' ALA . 73.8 mttt -54.42 -59.23 4.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.166 0.508 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -93.02 -41.24 10.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.95 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.492 ' HG2' ' HD2' ' A' ' 19' ' ' ARG . 23.4 tt0 -93.2 -55.79 3.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.966 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.694 ' HA3' ' HG ' ' A' ' 57' ' ' LEU . . . -75.31 -10.23 84.38 Favored Glycine 0 N--CA 1.461 0.302 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.814 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.968 HD21 HG13 ' A' ' 78' ' ' ILE . 7.7 mt 69.74 80.33 0.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.686 0.755 . . . . 0.0 111.966 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.444 HG12 ' C ' ' A' ' 57' ' ' LEU . 9.0 p -140.32 161.29 25.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.2 m -141.77 102.23 4.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.215 0.531 . . . . 0.0 111.171 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 9.4 m -72.37 86.53 1.13 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 34.2 mmt180 -68.93 125.25 26.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.692 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.97 -9.0 87.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.925 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.54 -45.37 4.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.863 0.363 . . . . 0.0 110.999 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.34 -18.04 29.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.389 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 102.38 172.87 27.18 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 2.7 m -72.06 103.86 3.4 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.606 HG12 HG22 ' A' ' 32' ' ' THR . 23.1 m -121.96 169.5 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.238 -172.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 31.5 t -93.23 114.15 29.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.222 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.572 ' HG2' HG23 ' A' ' 72' ' ' VAL . 6.0 mm-40 -126.31 146.79 49.88 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -72.93 77.87 1.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 173.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.49 ' O ' HD22 ' A' ' 62' ' ' LEU . 59.9 t30 -64.65 132.69 95.49 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.05 113.97 1.71 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.076 1.184 . . . . 0.0 110.35 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.968 HG13 HD21 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -64.09 127.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 172.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.322 -0.606 0 O-C-N 124.056 0.847 . . . . 0.0 110.638 178.256 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.573 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 6.3 p90 . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -93.36 137.99 32.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -78.63 146.65 69.78 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.132 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 2.7 Cg_exo -77.68 117.42 4.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.746 2.297 . . . . 0.0 112.622 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -86.95 -157.61 0.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.04 175.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 7' ' ' GLU . . . -74.58 60.46 2.45 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 44' ' ' GLY . 19.5 ptpt -122.53 178.37 5.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 0.0 110.249 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.27 -148.47 5.44 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.271 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -71.15 -10.68 60.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.65 -17.98 57.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 110.397 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' CB ' ' HD3' ' A' ' 9' ' ' LYS . 26.9 t70 -71.08 -45.97 62.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.388 175.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.673 HG23 HG11 ' A' ' 45' ' ' VAL . 72.0 t -59.9 -40.25 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.065 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.594 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -57.2 -43.57 82.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -61.33 -34.77 75.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.711 ' CD2' ' HA ' ' A' ' 39' ' ' ILE . 5.2 t60 -67.53 -44.93 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.102 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.604 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-85 -69.21 -46.47 67.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.984 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -61.01 -19.43 61.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -85.66 -51.15 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.967 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD13 HD13 ' A' ' 27' ' ' LEU . 3.9 pp -71.84 -21.83 61.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 18' ' ' PHE . 26.5 mm -61.12 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 110.739 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -85.11 1.19 48.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.231 0.538 . . . . 0.0 110.525 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.424 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 27.5 t -96.88 24.93 5.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.603 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 22.34 26.12 0.0 OUTLIER Glycine 0 N--CA 1.475 1.268 0 N-CA-C 117.374 1.71 . . . . 0.0 117.374 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 24' ' ' SER . 7.9 pt-20 -85.78 -34.66 21.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.672 HD21 ' HG3' ' A' ' 34' ' ' PRO . 9.9 mp -109.16 72.77 0.82 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 166.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.55 153.31 83.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.483 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.45 123.21 7.47 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.113 1.875 . . . . 0.0 111.284 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.55 -10.03 10.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.033 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.2 161.31 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.661 HG22 HG12 ' A' ' 72' ' ' VAL . 17.1 p -81.53 167.77 18.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.883 0.373 . . . . 0.0 111.478 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.803 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.4 mm? -65.12 140.08 97.87 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.336 175.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.672 ' HG3' HD21 ' A' ' 27' ' ' LEU . 57.3 Cg_endo -76.95 165.56 28.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.598 2.199 . . . . 0.0 111.565 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -74.08 156.09 37.81 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.0 m -52.48 -22.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.76 -52.57 64.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -58.16 -30.24 66.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.043 0.449 . . . . 0.0 110.974 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.711 ' HA ' ' CD2' ' A' ' 17' ' ' HIS . 4.3 mp -80.02 -59.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.519 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 33.5 ptt180 -79.03 -19.88 50.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -166.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . . . -76.69 -39.76 51.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.396 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -78.71 -62.07 1.81 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.708 . . . . 0.0 109.206 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 9.7 m-85 -92.17 105.1 17.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.956 176.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' A' ' 9' ' ' LYS . . . -60.41 91.56 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.157 0 CA-C-N 115.225 -0.898 . . . . 0.0 114.0 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.673 HG11 HG23 ' A' ' 14' ' ' VAL . 17.6 m -134.82 178.31 5.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -94.98 -170.55 2.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.09 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -76.21 -22.71 54.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.647 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -65.68 -42.05 91.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 110.158 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HA ' HG21 ' A' ' 14' ' ' VAL . 99.1 t -59.48 -55.84 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.715 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 54' ' ' LEU . 29.7 t -66.9 -12.11 58.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.675 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -82.4 -36.13 27.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.038 0.446 . . . . 0.0 110.223 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' HD13 ' A' ' 57' ' ' LEU . . . -74.3 -29.85 61.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.277 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 83.7 mt -49.28 -32.26 10.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.62 -28.63 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.076 0.465 . . . . 0.0 111.355 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.27 -25.16 5.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.877 0.846 . . . . 0.0 109.76 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.706 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -76.48 -5.04 45.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.46 -175.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -66.02 -40.11 90.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 p -93.14 -53.8 3.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.573 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -81.35 -38.32 26.87 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -172.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.706 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -90.49 -3.56 71.65 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.489 -174.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.689 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 10.1 mp 57.85 57.08 4.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.084 0.469 . . . . 0.0 111.808 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 57' ' ' LEU . 33.7 m -124.57 161.39 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.1 t -130.56 143.56 50.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.064 0.459 . . . . 0.0 111.337 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 p -82.78 103.04 11.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 12.1 tpp180 -118.43 48.43 1.43 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.3 4.12 2.07 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.978 -169.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.0 -47.02 21.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.05 -62.1 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 175.1 171.31 39.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.146 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.803 HG23 ' HB2' ' A' ' 33' ' ' LEU . 4.9 t -70.0 134.71 48.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 -174.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.661 HG12 HG22 ' A' ' 32' ' ' THR . 34.3 m -131.47 162.51 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.311 -171.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -99.15 113.58 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -123.58 144.34 49.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -69.18 78.67 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.438 0.461 . . . . 0.0 110.858 -174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 18.2 m-80 -73.6 116.54 52.54 Favored Pre-proline 0 CA--C 1.517 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.365 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.56 116.92 4.34 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.785 2.323 . . . . 0.0 111.264 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.618 HD11 HD11 ' A' ' 62' ' ' LEU . 1.2 mp -79.89 103.35 6.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.241 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.64 0.733 . . . . 0.0 110.374 179.609 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.233 0.222 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.47 115.28 12.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.305 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.6 99.43 52.8 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -99.29 172.08 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.669 2.913 . . . . 0.0 111.731 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 157.52 46.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.23 -10.09 43.02 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -108.84 167.27 10.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -146.13 6.69 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.297 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.57 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 4.6 p90 -71.92 -4.53 28.85 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.038 0.446 . . . . 0.0 110.373 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.29 -12.83 60.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.864 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.71 -60.99 1.96 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG13 HG11 ' A' ' 45' ' ' VAL . 35.6 m -67.05 -29.32 45.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.486 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.72 -39.63 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.226 0.536 . . . . 0.0 110.455 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 m -83.41 -39.23 20.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.443 ' HB3' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-70 -70.43 -20.41 62.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.761 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.476 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.4 m-85 -77.02 -25.66 52.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 111.239 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 19' ' ' ARG . 24.0 mmm180 -70.96 -20.06 62.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.652 0.263 . . . . 0.0 111.377 -177.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -13.59 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.502 . . . . 0.0 110.453 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.714 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 82.7 mt -85.5 -47.16 10.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.918 175.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 18' ' ' PHE . 17.5 mm -75.65 2.23 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.743 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HD2' ' HB2' ' A' ' 24' ' ' SER . 4.8 tmmt? -61.09 -81.04 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.526 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.51 ' HB2' ' HD2' ' A' ' 23' ' ' LYS . 11.1 t -119.67 -31.7 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 118.732 -1.187 . . . . 0.0 113.809 -171.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.22 -20.9 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.065 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.714 ' HB2' ' HA ' ' A' ' 21' ' ' LEU . 33.2 mp0 -45.32 -45.44 12.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.729 0.812 . . . . 0.0 110.927 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.676 ' HG ' HG21 ' A' ' 73' ' ' VAL . 23.0 tp -133.87 91.03 2.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.4 152.29 89.92 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.185 -169.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 5.2 Cg_exo -76.81 129.39 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.005 2.47 . . . . 0.0 111.213 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.3 -15.43 17.99 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -95.7 162.08 13.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 72' ' ' VAL . 25.2 p -81.95 160.83 23.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.432 0.158 . . . . 0.0 110.705 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HB2' HG23 ' A' ' 71' ' ' THR . 10.9 mt -66.36 139.05 96.08 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.32 157.56 33.21 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.223 1.948 . . . . 0.0 111.834 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.8 t -69.31 155.36 40.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.6 m -54.85 -15.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.13 81.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.582 0.229 . . . . 0.0 111.404 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.96 -39.42 87.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 -176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.609 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.5 mp -66.3 -57.04 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.91 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 8.6 ttp180 -62.71 -31.27 72.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -170.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.65 -41.68 17.51 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.967 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -81.57 -50.47 9.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.401 0.62 . . . . 0.0 109.56 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 45' ' ' VAL . 5.4 m-85 -92.07 101.9 14.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.355 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.433 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . -52.67 92.42 0.01 OUTLIER Glycine 0 CA--C 1.518 0.27 0 O-C-N 123.587 0.554 . . . . 0.0 113.865 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.777 HG11 HG13 ' A' ' 14' ' ' VAL . 17.6 m -146.85 178.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 123.042 0.537 . . . . 0.0 109.725 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.53 -174.99 3.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 -36.31 57.05 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.689 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -84.06 -15.11 48.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.94 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.697 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.9 m -68.5 -39.46 81.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 39' ' ' ILE . 52.3 t -57.5 -58.29 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.314 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 54' ' ' LEU . 24.8 t -59.38 -17.45 30.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.237 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 74.7 ttt180 -79.8 -44.6 20.3 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.377 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 14' ' ' VAL . . . -79.68 -15.64 57.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.577 HD23 HD12 ' A' ' 57' ' ' LEU . 69.6 mt -48.64 -33.79 10.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.728 0.299 . . . . 0.0 111.407 174.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.493 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.17 -38.2 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.965 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.07 -28.56 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.45 0.643 . . . . 0.0 109.994 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.577 HD12 HD23 ' A' ' 54' ' ' LEU . 69.6 mt -73.28 -15.64 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.283 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 55' ' ' ALA . 49.2 mtmt -66.51 -48.13 70.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.338 0.59 . . . . 0.0 110.007 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -90.61 -54.88 3.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.649 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.34 -31.64 15.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.0 -169.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 57' ' ' LEU . . . -78.43 -29.48 52.77 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.128 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 77' ' ' PRO . 22.6 mt 75.16 80.05 0.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.159 0.984 . . . . 0.0 111.39 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 57' ' ' LEU . 36.0 m -145.92 172.85 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.174 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.0 m -146.6 116.21 7.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.39 0.614 . . . . 0.0 110.943 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.753 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 38.0 t -84.33 105.41 15.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.875 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.548 ' HD3' ' OE2' ' A' ' 74' ' ' GLU . 15.1 mmm-85 -83.79 119.14 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.39 34.7 1.34 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.127 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.25 -68.3 0.21 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -69.92 -31.53 69.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.347 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.81 172.1 13.22 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 9.0 t -78.55 120.58 23.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.315 0.579 . . . . 0.0 109.441 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.613 HG12 HG22 ' A' ' 32' ' ' THR . 33.6 m -126.05 170.72 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.277 0.56 . . . . 0.0 111.387 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.676 HG21 ' HG ' ' A' ' 27' ' ' LEU . 29.4 t -93.87 120.42 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.131 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 66' ' ' ARG . 48.6 mt-10 -131.57 158.87 39.84 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.061 0.457 . . . . 0.0 110.95 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -79.22 38.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 74' ' ' GLU . 66.8 m-20 -123.95 84.23 54.83 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.561 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.508 ' HB3' HD22 ' A' ' 62' ' ' LEU . 10.0 Cg_endo -52.2 116.07 2.58 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.003 2.468 . . . . 0.0 110.472 166.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.0 mm -64.61 127.79 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-O 121.561 0.696 . . . . 0.0 109.807 177.018 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 96.0 m-85 . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -88.23 142.2 27.94 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.58 134.4 34.2 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 64.7 Cg_endo -78.14 111.48 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.339 2.026 . . . . 0.0 111.656 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -69.33 -77.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.039 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.11 -6.41 4.88 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.91 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.54 154.25 42.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.821 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.88 -135.27 3.68 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.81 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.597 ' HA ' HG12 ' A' ' 14' ' ' VAL . 3.0 p90 -74.24 -1.6 21.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.127 0.489 . . . . 0.0 111.011 -175.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.34 22.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.256 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.05 -36.65 13.91 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.64 0.733 . . . . 0.0 109.105 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.722 ' HB ' HG11 ' A' ' 45' ' ' VAL . 7.3 p -75.1 -32.6 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.856 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.67 -46.22 84.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.934 0.397 . . . . 0.0 110.681 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -71.46 -27.89 63.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.875 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -74.34 -20.84 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.834 0.35 . . . . 0.0 110.883 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.0 -24.07 65.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.886 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.1 m -75.27 -28.11 59.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.316 0.579 . . . . 0.0 110.038 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.038 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 67.5 mt -78.96 -28.84 43.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.87 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 tp -90.29 -7.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.364 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.06 -79.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 26' ' ' GLU . 8.5 t -119.71 -34.62 3.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 159.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.038 ' HA3' ' HA ' ' A' ' 21' ' ' LEU . . . 18.12 22.46 0.0 OUTLIER Glycine 0 C--N 1.354 1.561 0 C-N-CA 127.949 2.69 . . . . 0.0 118.652 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' SER . 33.0 mt-10 59.53 9.79 1.66 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 117.413 0.606 . . . . 0.0 111.225 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 21' ' ' LEU . 8.3 mp -129.64 34.2 4.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.07 166.28 2.15 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.137 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 10.7 Cg_exo -73.53 123.81 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.744 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.03 5.5 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.929 -172.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -104.37 164.07 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.689 HG22 HG12 ' A' ' 72' ' ' VAL . 2.7 p -97.38 153.23 18.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.65 0.262 . . . . 0.0 110.953 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 10.5 mp -72.42 120.0 78.08 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 111.881 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.51 6.69 5.48 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 123.284 2.656 . . . . 0.0 111.871 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 1.127 ' HA ' HD13 ' A' ' 39' ' ' ILE . 5.7 p -79.04 59.15 2.61 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -160.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 37' ' ' ALA . 2.4 m -100.87 -58.05 4.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.614 1.197 . . . . 0.0 110.008 142.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' H ' HG23 ' A' ' 36' ' ' VAL . . . -89.32 -58.98 2.34 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.924 -166.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.65 -30.49 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.401 -174.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.127 HD13 ' HA ' ' A' ' 35' ' ' SER . 1.8 mp -86.1 -56.07 5.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.03 -173.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 4.2 ptm180 -66.01 -18.62 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.826 -172.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . . . -67.99 -57.53 6.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.513 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -81.16 -51.86 7.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.846 0.831 . . . . 0.0 110.065 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.702 ' HD2' HG23 ' A' ' 39' ' ' ILE . 4.8 m-85 -89.8 83.11 6.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.867 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.46 88.17 0.01 OUTLIER Glycine 0 N--CA 1.462 0.419 0 O-C-N 125.002 1.439 . . . . 0.0 115.182 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.722 HG11 ' HB ' ' A' ' 14' ' ' VAL . 17.4 m -142.02 178.11 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB3' ' OG1' ' A' ' 49' ' ' THR . . . -89.08 -175.12 4.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.83 -35.17 51.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.277 0.56 . . . . 0.0 110.645 -174.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.924 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 10.5 mmpt? -85.12 -13.05 51.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.678 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.689 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 m -71.95 -40.07 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.678 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG13 HG21 ' A' ' 39' ' ' ILE . 48.7 t -55.16 -57.01 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.396 0.617 . . . . 0.0 110.375 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.708 ' HA ' HD12 ' A' ' 54' ' ' LEU . 36.0 t -64.16 -14.06 52.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.639 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 16.2 tpp180 -78.28 -44.14 26.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -66.58 -33.4 75.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.881 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 51' ' ' SER . 69.1 mt -53.56 -31.33 46.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.628 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.534 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.6 -26.34 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.078 0.466 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.55 -29.98 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.647 0.737 . . . . 0.0 109.669 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -74.03 -13.8 60.91 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.624 -173.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.534 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 62.2 pttt -64.53 -36.69 85.04 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.602 173.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.701 ' HA ' HG13 ' A' ' 78' ' ' ILE . 6.1 m -93.09 -53.48 4.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.284 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -88.37 -31.02 19.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.005 -170.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.548 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.43 -12.52 59.64 Favored Glycine 0 C--O 1.229 -0.216 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.922 -176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp 63.49 52.43 2.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.874 0.368 . . . . 0.0 111.707 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.82 164.2 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.68 ' HB3' HG23 ' A' ' 72' ' ' VAL . 22.6 t -117.17 105.2 11.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.184 0.516 . . . . 0.0 110.608 -174.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.2 m -81.39 71.38 8.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 20.9 tpp180 -75.77 96.46 3.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.313 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.15 49.47 3.54 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.001 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.23 -47.26 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.96 -44.66 10.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.093 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 138.06 -177.6 19.87 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.692 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 33' ' ' LEU . 17.7 p -75.01 106.66 6.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.968 0.413 . . . . 0.0 110.466 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.689 HG12 HG22 ' A' ' 32' ' ' THR . 18.2 m -123.05 150.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.101 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 27' ' ' LEU . 17.5 t -92.57 105.18 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -126.45 135.54 51.5 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 20.8 pttm -66.63 92.73 0.22 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.503 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 19.8 m-80 -90.35 110.86 43.78 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.056 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 76' ' ' ASN . 28.0 Cg_endo -62.64 115.38 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.021 1.814 . . . . 0.0 109.703 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.701 HG13 ' HA ' ' A' ' 59' ' ' SER . 13.1 mm -95.68 117.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.078 0.466 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 113.682 -1.599 . . . . 0.0 111.658 -177.151 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.612 0.244 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -88.67 93.14 9.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.184 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.8 117.33 66.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 68.2 Cg_endo -91.77 178.79 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.414 2.742 . . . . 0.0 112.544 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.41 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 3.1 mp0 -93.23 -89.45 0.21 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 7' ' ' GLU . . . -125.76 101.27 0.61 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.617 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -123.48 150.97 43.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.969 0.414 . . . . 0.0 110.875 -174.014 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.34 -145.29 14.94 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 170.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.673 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 2.0 p90 -80.17 23.47 0.47 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.769 0.318 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.57 -46.46 8.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.857 0.361 . . . . 0.0 111.567 -172.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -77.45 -26.58 51.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.45 0.643 . . . . 0.0 110.157 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.991 ' HB ' HG11 ' A' ' 45' ' ' VAL . 12.8 p -75.1 -26.09 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.257 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 19' ' ' ARG . . . -63.16 -34.79 78.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.498 ' HB ' ' CE2' ' A' ' 43' ' ' PHE . 10.3 m -60.02 -26.59 66.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.11 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 53.9 t-80 -56.12 -48.47 76.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.65 ' HE2' HD22 ' A' ' 33' ' ' LEU . 74.7 m-85 -83.21 -35.71 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.523 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 72.4 mtp180 -57.08 -32.63 66.47 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 110.635 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.6 m -79.13 -55.55 5.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.827 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 HD13 HD22 ' A' ' 27' ' ' LEU . 31.1 mt -48.88 -46.91 43.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 61' ' ' GLY . 1.8 mp -68.97 -43.25 82.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -86.26 -7.07 58.79 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.454 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.2 p -105.23 17.53 23.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.54 27.49 0.0 OUTLIER Glycine 0 N--CA 1.469 0.88 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -169.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.07 -32.3 71.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 21' ' ' LEU . 22.7 tp -102.95 95.58 6.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.52 153.92 95.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.518 -170.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.24 126.68 8.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.654 2.236 . . . . 0.0 110.914 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.45 -6.24 33.76 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -95.99 149.97 20.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.816 HG22 HG12 ' A' ' 72' ' ' VAL . 19.2 p -78.37 156.8 29.33 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.717 HD21 HG21 ' A' ' 63' ' ' VAL . 14.0 mt -60.63 139.39 92.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.814 172.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.06 168.13 25.53 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.336 2.024 . . . . 0.0 111.913 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.7 p -66.09 148.94 51.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.668 ' HA ' HD13 ' A' ' 39' ' ' ILE . 20.0 m -49.72 -28.11 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.306 0.378 . . . . 0.0 111.681 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.96 91.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.561 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.51 -23.67 63.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.668 HD13 ' HA ' ' A' ' 36' ' ' VAL . 3.8 mp -79.35 -55.67 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 7.1 ptm180 -77.64 -20.64 53.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.46 68.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.673 . . . . 0.0 110.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -83.16 -60.61 2.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.018 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 48.6 m-85 -92.54 99.06 11.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.777 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 6' ' ' PRO . . . -56.33 100.13 0.1 OUTLIER Glycine 0 CA--C 1.515 0.078 0 CA-C-N 115.299 -0.864 . . . . 0.0 114.044 -172.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.991 HG11 ' HB ' ' A' ' 14' ' ' VAL . 6.1 m -146.38 178.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 122.575 0.35 . . . . 0.0 110.141 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -90.92 175.15 7.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.8 -19.3 55.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.467 0.651 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 71.8 mmtt -74.36 -46.48 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.963 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.745 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.5 m -56.38 -43.06 78.84 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.833 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.755 ' HA ' HG21 ' A' ' 14' ' ' VAL . 93.5 t -52.83 -53.66 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.327 0.584 . . . . 0.0 110.95 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.566 ' HA ' HD12 ' A' ' 54' ' ' LEU . 23.2 t -70.48 -6.68 37.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.624 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 5.2 mmp_? -83.61 -47.05 11.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.122 -0.362 . . . . 0.0 110.293 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.518 ' CB ' HG13 ' A' ' 14' ' ' VAL . . . -70.77 -20.11 62.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.791 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 51' ' ' SER . 65.5 mt -53.22 -29.81 34.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.234 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.535 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -63.03 -30.87 71.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.146 0.498 . . . . 0.0 110.643 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.68 -31.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.369 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.705 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -75.36 -17.71 60.16 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -171.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -66.41 -34.76 78.67 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.347 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 m -93.57 -51.74 4.81 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.31 0.576 . . . . 0.0 110.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -84.32 -53.5 5.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.008 -172.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.705 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -77.06 -7.02 86.62 Favored Glycine 0 C--O 1.225 -0.423 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.801 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 16.7 mt 63.29 78.28 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.375 0.67 . . . . 0.0 111.972 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.717 HG21 HD21 ' A' ' 33' ' ' LEU . 1.4 p -160.57 135.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.7 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 8.4 t 147.9 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.843 1.339 . . . . 0.0 111.687 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.6 ' CB ' HG22 ' A' ' 72' ' ' VAL . 3.8 t -94.82 -59.87 1.82 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.283 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.596 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -118.72 135.28 54.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.214 0.53 . . . . 0.0 112.217 -169.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.74 -30.79 9.25 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 168.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.22 -61.35 2.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.88 -62.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 169.28 160.63 17.91 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.904 176.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 121.1 24.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.678 0.752 . . . . 0.0 109.829 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.816 HG12 HG22 ' A' ' 32' ' ' THR . 2.6 m -121.92 163.96 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.229 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.481 HG21 ' HG ' ' A' ' 27' ' ' LEU . 16.7 t -84.97 123.41 39.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.185 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -132.28 159.49 38.95 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -76.09 66.09 2.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.834 0.826 . . . . 0.0 110.128 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 7.5 m-20 -55.17 142.24 58.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.491 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 76' ' ' ASN . 9.8 Cg_exo -71.11 117.92 5.41 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.141 1.894 . . . . 0.0 111.51 175.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.435 HG23 HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -79.73 111.64 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.418 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 78' ' ' ILE . 34.3 m . . . . . 0 N--CA 1.468 0.433 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.255 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 47.9 p90 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.965 0.412 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -93.67 128.63 39.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.705 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.45 118.27 60.75 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.604 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -88.31 160.55 6.88 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.938 2.425 . . . . 0.0 112.65 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.6 95.44 3.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.03 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.99 38.64 55.64 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.484 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.568 ' HD2' ' HB2' ' A' ' 13' ' ' ASP . 3.3 tppp? -104.44 108.66 20.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -157.86 33.39 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.868 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.555 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -71.92 0.51 9.07 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.622 0.369 . . . . 0.0 111.308 -177.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.5 50.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.687 0.28 . . . . 0.0 111.338 -169.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.568 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 40.3 t0 -76.1 -38.65 56.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.375 0.607 . . . . 0.0 109.511 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.651 HG23 ' HB2' ' A' ' 53' ' ' ALA . 3.8 m -85.19 -23.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.56 61.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.264 0.554 . . . . 0.0 109.873 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.643 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 5.1 m -104.13 -27.31 12.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.993 174.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.521 ' HD2' HG23 ' A' ' 39' ' ' ILE . 4.0 t60 -60.54 -21.22 62.28 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.709 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 24.8 p90 -58.21 -33.43 69.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.365 0.602 . . . . 0.0 110.453 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 16' ' ' THR . 2.6 ptm180 -68.25 -25.88 65.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.767 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.458 ' HB ' HD22 ' A' ' 21' ' ' LEU . 2.4 m -65.13 -35.63 81.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.219 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.137 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.1 mm? -91.93 -48.12 6.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.298 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' A' ' 27' ' ' LEU . 36.4 mm -67.52 -12.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.861 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 2.7 tmmt? -48.0 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.325 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 p -118.31 -32.08 4.77 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.73 -20.7 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.198 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.701 ' HG2' ' HA ' ' A' ' 21' ' ' LEU . 2.1 pm0 -63.37 -21.39 66.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -168.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.137 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.7 tp -121.59 83.4 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.24 141.34 80.66 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.508 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 3.0 Cg_exo -77.09 123.7 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 110.903 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.14 46.43 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -174.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -118.26 156.63 28.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 24.1 p -82.69 138.77 34.0 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.256 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 151.09 86.2 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.63 168.32 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.696 2.264 . . . . 0.0 112.694 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -76.73 -179.23 5.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.192 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.17 -19.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.924 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.63 75.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.53 -55.06 19.86 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.861 0.362 . . . . 0.0 111.058 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.725 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.4 mp -58.11 -39.83 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.047 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 5.2 tmm_? -79.76 -28.25 40.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.347 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . . . -82.6 -31.73 28.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.48 -65.36 0.9 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 45' ' ' VAL . 3.1 m-85 -91.92 111.27 22.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.19 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.95 92.33 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 O-C-N 124.016 0.822 . . . . 0.0 113.363 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 18.8 m -138.81 -179.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.51 174.61 7.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.913 0.387 . . . . 0.0 110.535 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -76.45 -14.62 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 176.019 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 44.0 m -73.15 -42.11 63.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 81.5 t -54.52 -61.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.484 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.621 ' HA ' HD12 ' A' ' 54' ' ' LEU . 13.0 t -57.48 -25.43 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.522 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 77.1 ttt180 -72.93 -48.29 38.19 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.099 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -63.58 -31.04 72.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.037 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.647 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 86.8 mt -58.18 -29.52 65.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.161 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -67.77 -28.84 67.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.354 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 26.3 t -84.84 -32.15 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 175.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.721 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.8 mp -77.51 4.46 11.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.828 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 41.4 mtmt -65.62 -56.63 11.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -93.85 -40.5 10.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.893 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 9.7 tp10 -73.62 -51.07 18.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.772 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.721 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -88.64 -13.23 63.3 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.877 -176.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 76' ' ' ASN . 63.9 mt 66.2 66.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.979 0.458 . . . . 0.0 111.826 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 57' ' ' LEU . 32.8 m -136.87 156.45 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.46 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -116.61 95.63 5.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.359 0.6 . . . . 0.0 109.842 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -84.86 109.17 17.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.92 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.41 108.6 20.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.141 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.15 47.24 2.58 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.164 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.76 -55.87 0.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.293 0.568 . . . . 0.0 109.613 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -85.81 -36.53 20.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.253 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.0 175.41 13.88 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.56 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.4 p -87.83 104.9 17.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 15.5 t -114.54 139.84 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.388 . . . . 0.0 110.267 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 21.4 t -90.84 91.0 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -94.51 138.81 31.97 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.475 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -71.31 84.73 0.78 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.547 ' O ' HD22 ' A' ' 62' ' ' LEU . 83.1 m-20 -67.97 140.13 93.5 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.615 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 76' ' ' ASN . 6.3 Cg_exo -77.67 118.2 4.46 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.705 2.27 . . . . 0.0 110.055 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.517 HG12 HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -58.88 115.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.743 -174.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.471 0.611 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.245 179.048 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 66.5 t80 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.176 0.512 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.93 114.12 26.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.401 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -81.89 122.28 79.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.731 0.301 . . . . 0.0 110.531 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.504 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 84.6 Cg_endo -95.53 134.08 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.199 2.6 . . . . 0.0 113.182 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -99.87 -73.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.11 92.08 1.71 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.66 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -75.92 178.55 6.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.196 0.998 . . . . 0.0 112.919 -172.677 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 168.57 151.13 6.98 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.122 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 9.3 p90 -70.66 8.03 0.96 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.419 0.609 . . . . 0.0 110.584 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . -79.78 -28.1 40.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.17 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 12.4 t70 -67.56 -50.08 60.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.026 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.551 HG23 ' CB ' ' A' ' 53' ' ' ALA . 2.3 m -71.02 -36.89 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.415 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -55.37 -48.76 73.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.036 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -80.05 -22.41 42.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.486 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 1.7 m170 -85.97 -30.3 22.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -73.27 -18.44 61.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.983 0.421 . . . . 0.0 110.625 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -63.18 -17.53 62.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.504 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.83 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 6.8 m -81.94 -26.48 33.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.137 0.494 . . . . 0.0 110.769 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.955 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.6 mm? -81.88 -51.81 7.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.496 HG21 ' HA2' ' A' ' 61' ' ' GLY . 11.2 tp -79.69 14.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.072 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.83 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 24.4 ttmm -67.64 -77.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 m -117.36 -29.79 5.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.6 -25.84 0.02 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 118.84 -1.648 . . . . 0.0 114.957 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -53.95 -42.74 69.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.025 0.412 . . . . 0.0 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.955 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -113.31 78.31 1.13 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.92 95.27 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.447 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.894 ' HA ' HG13 ' A' ' 73' ' ' VAL . 37.5 Cg_endo -70.93 136.84 30.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.032 2.488 . . . . 0.0 111.767 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.4 56.59 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.481 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 73' ' ' VAL . 4.8 t0 -122.77 164.19 18.81 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 22.1 p -78.87 152.81 31.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.969 0.414 . . . . 0.0 111.11 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.66 HD21 ' HB ' ' A' ' 73' ' ' VAL . 8.7 mt -85.94 152.12 55.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.287 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.49 168.09 24.41 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.594 2.196 . . . . 0.0 111.017 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 t -73.21 155.82 39.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.8 m -53.86 -21.21 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 O-C-N 123.28 0.363 . . . . 0.0 111.914 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.83 92.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.59 -51.88 63.38 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.393 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.4 mp -57.88 -54.51 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.218 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -73.26 -17.89 61.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -171.389 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 3' ' ' TYR . . . -82.57 -44.81 15.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.595 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -75.99 -52.24 10.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.579 ' HD2' HG23 ' A' ' 39' ' ' ILE . 2.9 m-85 -93.11 105.78 17.83 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.631 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 85.43 0.01 OUTLIER Glycine 0 CA--C 1.516 0.115 0 O-C-N 123.638 0.586 . . . . 0.0 113.926 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.787 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 27.8 m -142.03 179.12 2.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.61 -169.93 2.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.22 -40.36 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.987 0.422 . . . . 0.0 110.349 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -75.05 -31.07 61.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.604 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.787 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 5.4 m -58.06 -34.49 70.18 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.141 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.641 HG13 HG21 ' A' ' 39' ' ' ILE . 60.8 t -57.32 -59.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.376 0.608 . . . . 0.0 109.974 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.561 ' HA ' HD12 ' A' ' 54' ' ' LEU . 23.1 t -65.25 -11.9 46.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.612 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 49' ' ' THR . 32.2 tpt180 -76.74 -42.68 40.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.551 ' CB ' HG23 ' A' ' 14' ' ' VAL . . . -80.56 -19.66 45.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.437 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.686 HD22 HG21 ' A' ' 63' ' ' VAL . 44.8 mt -57.31 -25.52 59.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.512 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -72.65 -20.71 61.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.078 0.466 . . . . 0.0 110.71 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.06 -39.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.715 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 4.8 mp -71.27 6.68 1.59 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.922 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.877 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 22.0 pttp -76.37 -42.37 44.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -92.7 -45.05 8.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.161 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -75.97 -46.42 29.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.088 0.47 . . . . 0.0 111.243 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.715 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.21 -13.52 58.65 Favored Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.605 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.797 HD21 HG12 ' A' ' 78' ' ' ILE . 22.2 mt 67.69 28.33 7.33 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.785 0.434 . . . . 0.0 111.742 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.805 HG12 HG23 ' A' ' 73' ' ' VAL . 8.6 m -108.81 143.38 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.903 0.383 . . . . 0.0 111.342 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 41.0 t -144.95 149.24 34.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 p -90.32 90.1 7.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.526 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 4.3 tpp180 -71.48 105.19 3.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.054 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.97 59.07 3.53 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.239 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.95 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.48 -28.1 37.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.753 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 128.51 -159.21 21.95 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.591 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.91 112.57 16.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 60.9 t -132.24 135.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -169.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 29' ' ' PRO . 11.6 p -82.56 75.7 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 122.335 1.064 . . . . 0.0 110.856 -173.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -144.96 83.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.11 162.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.877 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 55.6 tptt -95.82 -81.1 0.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.764 0.792 . . . . 0.0 111.374 175.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.462 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 67.3 t30 -130.7 91.96 35.89 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.839 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 76' ' ' ASN . 3.6 Cg_exo -40.06 122.41 1.14 Allowed 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.983 2.455 . . . . 0.0 111.23 175.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.797 HG12 HD21 ' A' ' 62' ' ' LEU . 4.0 mm -55.41 118.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t . . . . . 0 C--O 1.235 0.331 0 O-C-N 124.567 1.167 . . . . 0.0 111.384 -177.184 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.804 0.335 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -91.98 116.24 0.4 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.095 2.53 . . . . 0.0 111.246 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -69.56 102.57 1.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.757 0.789 . . . . 0.0 110.155 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.68 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 23.3 ttpt -94.67 118.71 32.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.489 -170.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.44 142.67 50.47 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.005 -173.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.675 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 72.1 Cg_endo -79.33 112.18 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.757 2.305 . . . . 0.0 111.713 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -70.34 -56.21 7.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.414 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.88 34.98 0.62 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.92 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HD2' ' CB ' ' A' ' 13' ' ' ASP . 51.2 pttt -123.34 148.88 45.56 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.813 -0.227 . . . . 0.0 110.906 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.9 -140.52 10.08 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.615 ' HA ' HG12 ' A' ' 14' ' ' VAL . 4.2 p90 -80.29 10.83 4.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.849 0.459 . . . . 0.0 112.209 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.87 -38.82 19.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.485 ' CB ' ' HD2' ' A' ' 9' ' ' LYS . 24.4 t70 -70.57 -35.46 73.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.338 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.695 HG13 ' HB2' ' A' ' 53' ' ' ALA . 2.5 p -71.58 -42.81 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.499 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.82 -37.53 76.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.237 0.541 . . . . 0.0 109.859 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.3 m -67.83 -46.08 72.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.122 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -78.22 -20.8 51.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.513 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.578 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -69.74 -29.2 66.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.841 0.353 . . . . 0.0 110.397 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -61.68 -23.4 66.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.492 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m -80.49 -44.29 19.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -53.53 -40.76 65.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.29 0.567 . . . . 0.0 111.295 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.615 HD12 HG11 ' A' ' 73' ' ' VAL . 19.3 mm -72.82 -14.3 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.477 -176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -75.88 -75.93 0.17 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 26' ' ' GLU . 5.5 t -119.39 -31.87 4.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.951 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 26' ' ' GLU . . . 10.31 -41.01 0.0 OUTLIER Glycine 0 C--N 1.354 1.576 0 C-N-CA 129.745 3.545 . . . . 0.0 119.558 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 24' ' ' SER . 2.0 pt-20 111.79 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.834 2.054 . . . . 0.0 107.949 -162.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 32.4 tp -112.79 58.5 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.467 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.54 166.34 14.89 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.758 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 7.6 Cg_exo -74.01 121.25 6.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 120.948 1.098 . . . . 0.0 110.428 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.3 -6.48 12.93 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.673 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -108.65 158.7 17.35 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.823 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 6.3 m -94.35 148.47 22.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.734 0.302 . . . . 0.0 111.287 -172.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.3 mp -54.79 135.72 65.15 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.712 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HG2' HD11 ' A' ' 39' ' ' ILE . 72.7 Cg_endo -78.38 171.3 17.12 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.222 2.614 . . . . 0.0 112.051 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -72.31 156.94 38.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.414 ' HA ' HD13 ' A' ' 39' ' ' ILE . 27.3 m -54.98 -21.58 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 122.707 0.403 . . . . 0.0 112.066 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.15 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.8 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.38 -51.09 67.3 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 109.798 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.774 HG21 ' HB ' ' A' ' 50' ' ' VAL . 4.8 mp -56.96 -50.17 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.269 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.907 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . 63.0 ttt180 -44.71 -33.57 1.91 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.38 -33.89 13.68 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.926 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -75.14 -44.94 44.14 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.806 0.812 . . . . 0.0 109.052 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.907 ' CE1' ' HA ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -89.45 119.72 30.14 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 172.322 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.68 ' HA2' ' HB3' ' A' ' 4' ' ' LYS . . . -73.51 53.62 1.96 Allowed Glycine 0 C--N 1.302 -1.321 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.675 ' HA ' ' HB3' ' A' ' 6' ' ' PRO . 1.8 t -136.38 170.58 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -161.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' O ' ' CZ ' ' A' ' 43' ' ' PHE . . . -78.49 152.16 32.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.29 40.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.144 0.497 . . . . 0.0 110.9 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 5.4 tmmm? -92.61 -24.22 18.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.789 171.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 11' ' ' TYR . 4.1 m -69.34 -27.9 65.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.774 ' HB ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -61.59 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.624 ' HA ' HD12 ' A' ' 54' ' ' LEU . 32.3 t -63.5 -14.37 50.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.252 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 5.6 mmp_? -81.03 -58.17 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.683 0.278 . . . . 0.0 110.258 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.695 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -63.75 -25.41 68.18 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 41.4 mt -49.08 -38.91 25.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -18.93 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.988 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.06 -28.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.544 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.965 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -72.58 -1.93 17.94 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.988 -173.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 57.7 pttt -66.69 -42.35 86.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 78' ' ' ILE . 2.8 m -94.77 -36.17 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.003 0.906 . . . . 0.0 109.24 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 11.1 tp10 -83.95 -66.07 0.94 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.032 -169.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.965 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -83.29 1.18 89.12 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.635 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.865 HD21 HG13 ' A' ' 78' ' ' ILE . 20.7 mt 73.2 37.27 0.76 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 172.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 58' ' ' LYS . 8.4 p -113.15 150.16 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.739 -0.6 . . . . 0.0 111.332 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.834 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 31.8 t -148.32 145.28 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.385 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -67.9 106.8 2.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 7.0 ttm180 -114.3 97.38 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.996 -176.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.69 50.51 2.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.311 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.23 -63.89 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' HB2' HG21 ' A' ' 72' ' ' VAL . 71.0 mt -91.2 -14.36 31.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.543 176.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 114.11 -160.98 12.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.896 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.806 HG23 ' HB2' ' A' ' 33' ' ' LEU . 6.4 t -78.78 81.81 5.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.427 1.108 . . . . 0.0 109.611 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.823 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 38.5 t -92.94 141.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.671 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.615 HG11 HD12 ' A' ' 22' ' ' ILE . 4.5 t -88.22 75.67 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.815 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -146.56 80.31 1.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.737 158.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.834 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 88.2 tttt -98.85 -85.59 0.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.196 0.998 . . . . 0.0 111.745 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.421 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 5.9 t-20 -130.23 95.13 28.51 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.88 -165.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.437 ' HA ' HD22 ' A' ' 62' ' ' LEU . 84.1 Cg_exo -45.41 122.63 4.84 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.021 1.814 . . . . 0.0 111.059 175.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.865 HG13 HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -56.3 136.15 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -175.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.7 t -55.3 79.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 124.395 1.059 . . . . 0.0 111.697 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 85' ' ' ARG . 41.1 mm -113.43 106.77 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.948 175.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.1 t -120.04 -0.76 10.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.725 0.774 . . . . 0.0 109.034 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.17 171.28 36.41 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.073 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.06 -0.54 36.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.176 0.512 . . . . 0.0 111.205 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.98 -35.12 57.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.768 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.58 ' HB2' HD13 ' A' ' 80' ' ' ILE . 22.4 mmm180 -73.52 -32.53 64.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.976 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.4 tp -100.36 -40.71 7.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.029 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -94.11 -30.41 14.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.044 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.443 ' HG2' ' H ' ' A' ' 90' ' ' GLU . 22.7 ttm-85 66.53 111.23 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.907 0.754 . . . . 0.0 111.08 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -0.8 13.48 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.443 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 27.9 mt-10 -75.99 -39.58 55.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.39 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -100.88 167.1 10.49 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.879 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.11 138.58 55.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.719 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.96 67.82 2.61 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.955 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 73.4 mtm -86.4 171.31 11.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.324 -0.251 . . . . 0.0 110.324 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -59.03 129.96 44.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.242 0.544 . . . . 0.0 112.444 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -112.99 166.41 11.43 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.86 106.46 0.88 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.742 0.306 . . . . 0.0 110.68 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.5 -4.07 4.23 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.028 2.485 . . . . 0.0 113.095 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.81 43.12 0.51 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.194 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 C--O 1.25 1.12 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.126 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.495 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 23.6 ptm . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 5.1 Cg_exo -78.73 98.19 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.786 2.324 . . . . 0.0 111.161 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -72.31 141.8 48.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.657 ' HD3' ' H ' ' A' ' 44' ' ' GLY . 58.0 tttp -104.92 145.26 30.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.757 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 163.24 20.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.596 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 10.1 Cg_exo -76.08 96.24 1.06 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.121 1.88 . . . . 0.0 112.18 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.582 ' N ' ' HE3' ' A' ' 9' ' ' LYS . 1.8 mp0 -63.89 -65.38 0.69 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.18 54.1 0.31 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.039 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.792 ' HG3' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -123.42 164.98 17.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.918 0.389 . . . . 0.0 110.716 -176.233 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.39 -143.54 10.56 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.63 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 3.0 p90 -70.87 2.34 4.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.409 . . . . 0.0 111.524 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.26 54.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.569 . . . . 0.0 110.207 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.792 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 2.5 t70 -73.99 -47.99 33.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.778 HG13 HG11 ' A' ' 45' ' ' VAL . 33.0 m -70.22 -31.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.407 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.64 -45.15 89.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.253 0.549 . . . . 0.0 109.656 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -68.43 -34.43 75.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.704 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.692 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 45.0 t-80 -52.87 -54.38 35.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.954 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.429 ' CG ' HD13 ' A' ' 57' ' ' LEU . 5.7 m-85 -68.03 -40.17 82.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.811 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -60.88 -27.43 68.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.841 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.455 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 37.9 m -80.06 -36.01 36.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 0.0 109.95 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.892 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 68.8 mt -70.86 -44.81 65.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.223 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 61' ' ' GLY . 49.2 mm -68.69 -21.8 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.457 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 22.6 ttmm -56.78 -63.73 1.11 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.798 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -114.29 -33.16 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.8 -29.67 0.03 OUTLIER Glycine 0 CA--C 1.511 -0.177 0 C-N-CA 118.666 -1.731 . . . . 0.0 114.538 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.2 -57.57 12.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -164.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 tp -98.44 89.19 4.35 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.42 153.79 65.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.479 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 63.4 Cg_endo -77.31 137.63 17.04 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.102 1.868 . . . . 0.0 112.092 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.91 -24.99 9.14 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.007 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.41 161.85 14.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -79.03 161.23 26.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.731 0.3 . . . . 0.0 111.355 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.4 145.64 98.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.332 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.403 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 74.2 Cg_endo -78.11 171.49 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.826 2.351 . . . . 0.0 112.507 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.8 p -79.27 159.59 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.06 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.475 ' HA ' HD13 ' A' ' 39' ' ' ILE . 25.2 m -54.01 -26.25 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.9 82.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.131 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 16.6 m-20 -70.33 -29.66 66.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 110.297 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.692 ' HA ' ' CE1' ' A' ' 17' ' ' HIS . 3.7 mp -75.48 -49.94 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.244 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 22.0 ttm180 -66.93 -46.95 73.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.12 75.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 0.0 110.955 -170.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -84.39 -65.96 0.95 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.175 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.433 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 18.8 m-85 -93.48 102.12 14.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.269 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.657 ' H ' ' HD3' ' A' ' 4' ' ' LYS . . . -57.37 99.56 0.1 Allowed Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.624 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.778 HG11 HG13 ' A' ' 14' ' ' VAL . 19.4 m -140.73 179.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.115 0.483 . . . . 0.0 111.384 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -97.89 176.35 5.82 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.44 52.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.79 0.329 . . . . 0.0 110.748 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -79.16 -29.72 43.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 109.955 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.8 m -63.69 -43.58 96.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.539 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.674 ' HA ' HG11 ' A' ' 14' ' ' VAL . 96.4 t -55.81 -58.86 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.782 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.698 ' HA ' HD12 ' A' ' 54' ' ' LEU . 26.0 t -68.37 -6.41 24.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.871 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' A' ' 52' ' ' ARG . 4.6 tpm_? -77.74 -50.67 11.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.542 0.211 . . . . 0.0 110.678 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.756 ' HB3' HG23 ' A' ' 14' ' ' VAL . . . -90.74 -9.89 45.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 51' ' ' SER . 95.5 mt -51.6 -31.06 23.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.825 0.284 . . . . 0.0 111.486 174.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.845 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 44.2 t -80.73 -30.39 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.742 0.782 . . . . 0.0 109.514 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.64 HD21 ' HA ' ' A' ' 15' ' ' ALA . 86.9 mt -76.06 1.27 15.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.632 -173.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -66.04 -56.45 11.5 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.4 p -93.57 -34.43 13.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.481 0.657 . . . . 0.0 110.356 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.4 tp10 -77.07 -52.14 9.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.722 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.59 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -90.52 -7.4 67.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.977 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp 63.04 66.7 0.72 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.812 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 57' ' ' LEU . 31.1 m -136.14 162.49 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.681 175.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.8 m -144.59 128.5 17.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.139 0.495 . . . . 0.0 111.372 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -78.53 92.76 4.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.535 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 9.9 tpt180 -85.45 101.87 12.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.92 50.66 2.28 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.647 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.87 -60.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.05 -16.23 44.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.434 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 109.53 178.42 21.21 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.666 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.66 99.26 3.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 19.5 m -117.61 159.94 17.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 111.417 -170.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 22.3 t -85.68 93.82 3.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.789 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' A' ' 72' ' ' VAL . 31.2 mt-10 -102.64 151.3 22.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.679 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 57.6 mtpt -68.51 88.55 0.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -94.75 96.04 1.76 Allowed Pre-proline 0 CA--C 1.503 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 50.8 Cg_exo -56.39 151.34 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.216 1.944 . . . . 0.0 112.405 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -55.7 105.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.052 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 t 65.85 72.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.642 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.676 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.9 mm -115.61 128.68 72.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.752 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.2 t -91.79 152.57 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.15 120.96 5.41 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.866 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.42 -55.14 3.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -101.75 -14.32 17.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.244 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -82.51 -6.54 59.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.522 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.1 tp -101.58 116.39 32.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.905 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -84.93 130.16 34.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.712 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -82.15 -173.48 4.55 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 62.0 mtm -97.0 -51.99 4.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.192 0.52 . . . . 0.0 110.314 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 90' ' ' GLU . 1.1 pm0 -72.66 -35.72 67.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.386 -175.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -108.89 102.6 11.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.964 0.411 . . . . 0.0 111.138 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -105.15 98.66 8.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.995 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.0 -26.19 22.56 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.516 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.8 ttm -105.24 171.78 7.14 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -69.79 160.05 32.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.265 0.555 . . . . 0.0 111.609 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -131.77 166.74 20.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.379 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 100' ' ' GLU . . . -82.06 110.87 22.87 Favored Pre-proline 0 C--N 1.321 -0.659 0 O-C-N 123.325 0.391 . . . . 0.0 110.327 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -87.74 27.08 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.091 2.528 . . . . 0.0 112.072 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.76 -47.23 0.43 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HB2' ' HB1' ' A' ' 97' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.615 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 27.2 ttt . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.491 0.186 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 23.4 Cg_exo -64.93 142.66 76.32 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.776 2.317 . . . . 0.0 111.991 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -73.12 155.89 39.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.492 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -85.05 134.88 34.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.958 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -96.35 150.05 36.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.451 0.167 . . . . 0.0 111.182 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 6.2 Cg_exo -78.59 118.45 4.21 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.067 2.512 . . . . 0.0 111.681 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -99.66 -74.41 0.6 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.707 -175.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.96 29.52 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.405 -176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -116.61 156.66 26.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.09 -107.7 2.66 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.898 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -95.85 -12.25 25.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 174.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.51 9.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.501 0.667 . . . . 0.0 111.141 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.488 ' OD1' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -91.14 -52.8 4.65 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.388 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.679 HG13 HH22 ' A' ' 52' ' ' ARG . 2.0 m -68.74 -34.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.642 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.63 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -55.73 -44.71 77.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.64 170.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -64.57 -39.11 93.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 22.9 t60 -57.62 -48.01 80.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.471 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.37 -40.31 85.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.192 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -56.66 -27.57 58.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.588 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 m -85.33 -54.02 4.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.802 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . 3.3 pp -75.64 -12.04 60.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.554 -172.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.02 -41.48 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 110.452 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -92.9 -13.34 29.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.218 0.533 . . . . 0.0 110.513 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.775 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 23.0 t -86.54 26.79 1.03 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.317 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.15 25.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.2 mt-10 -69.79 -34.98 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HG ' HD13 ' A' ' 21' ' ' LEU . 61.0 mt -122.9 92.1 3.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.526 166.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.05 54.63 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.751 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 5.8 Cg_exo -75.19 123.47 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.669 1.579 . . . . 0.0 110.691 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.35 27.89 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.43 163.5 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 1.007 ' HB ' HG23 ' A' ' 71' ' ' THR . 6.7 t -107.88 161.9 14.5 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -172.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.795 HD11 ' HB ' ' A' ' 63' ' ' VAL . 4.2 mp -57.52 109.69 1.95 Allowed Pre-proline 0 N--CA 1.432 -1.357 0 CA-C-N 111.196 -2.729 . . . . 0.0 108.435 167.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.95 175.41 10.87 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 123.359 2.706 . . . . 0.0 113.225 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -64.69 158.12 25.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.49 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.31 -19.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.02 -52.99 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.21 -53.42 58.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.375 0.607 . . . . 0.0 111.08 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.782 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -56.05 -53.66 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.652 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 43.8 ttp180 -65.6 -40.03 92.22 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.79 -46.23 25.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -75.84 -56.45 4.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.938 0.399 . . . . 0.0 110.673 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.471 ' O ' HG22 ' A' ' 45' ' ' VAL . 5.2 m-85 -91.81 103.99 16.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.795 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.79 86.31 0.01 OUTLIER Glycine 0 CA--C 1.516 0.111 0 O-C-N 124.642 1.214 . . . . 0.0 114.459 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 43' ' ' PHE . 33.6 m -137.77 177.38 5.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -97.17 178.89 5.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.57 -33.11 58.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.096 0.474 . . . . 0.0 109.973 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.966 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -68.49 -36.79 79.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 175.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.813 HG22 ' HE ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -65.18 -53.3 46.88 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 46' ' ' ALA . 92.0 t -41.25 -52.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.596 -0.69 . . . . 0.0 111.189 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.646 ' HA ' HD12 ' A' ' 54' ' ' LEU . 47.9 t -60.75 -34.07 73.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.063 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.898 ' CZ ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -72.25 -31.31 65.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.548 -169.381 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.664 ' N ' ' HD2' ' A' ' 52' ' ' ARG . . . -91.12 -5.37 55.18 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.671 -0.643 . . . . 0.0 111.807 173.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 51' ' ' SER . 44.5 mt -57.88 -35.05 70.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.708 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.16 -18.16 64.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.009 176.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 60' ' ' GLU . 34.3 t -90.46 -29.22 4.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.63 HD11 ' HA ' ' A' ' 15' ' ' ALA . 1.2 mp -73.85 2.89 7.48 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.251 -174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.97 -41.8 20.29 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' A' ' 78' ' ' ILE . 15.7 m -94.04 -41.68 9.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.773 0.797 . . . . 0.0 109.887 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' HB3' HG12 ' A' ' 56' ' ' VAL . 39.0 tp10 -89.6 -34.49 16.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.809 -175.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -90.72 -10.3 63.35 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.561 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 11.2 mp 79.36 12.78 1.19 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.795 ' HB ' HD11 ' A' ' 33' ' ' LEU . 9.3 m -100.91 154.62 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.647 -0.658 . . . . 0.0 109.5 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -128.28 179.01 5.86 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.611 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -52.47 122.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.829 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HA ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -64.94 163.93 13.57 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.374 -168.253 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.79 -67.45 1.43 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.683 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.448 ' H ' ' H ' ' A' ' 69' ' ' LEU . . . -160.71 -16.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.711 0.767 . . . . 0.0 109.504 168.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' H ' ' H ' ' A' ' 68' ' ' ALA . 2.5 mm? -93.64 -39.21 10.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.404 -170.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.696 ' N ' ' HG3' ' A' ' 66' ' ' ARG . . . 143.33 -5.04 1.83 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.706 -166.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 1.007 HG23 ' HB ' ' A' ' 32' ' ' THR . 89.0 m -97.52 92.86 6.13 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.806 HG23 ' HA ' ' A' ' 66' ' ' ARG . 90.8 t -151.52 96.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 123.852 0.72 . . . . 0.0 112.095 156.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 60.5 t -89.07 130.38 38.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 159.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 29' ' ' PRO . 40.1 mt-10 -133.39 165.14 25.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HA ' HD23 ' A' ' 62' ' ' LEU . 52.0 tttm -84.87 49.01 1.64 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 166.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -118.95 91.9 44.02 Favored Pre-proline 0 CA--C 1.515 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.477 -170.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HB2' HG22 ' A' ' 80' ' ' ILE . 6.0 Cg_exo -77.25 115.9 4.04 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.821 1.681 . . . . 0.0 109.473 171.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.461 ' H ' ' HA ' ' A' ' 59' ' ' SER . 19.1 mt -70.74 100.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.984 -176.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 t 33.9 43.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 124.728 1.268 . . . . 0.0 111.335 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -71.99 105.97 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 122.094 0.95 . . . . 0.0 109.291 -170.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 m -85.49 -59.49 2.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.841 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.71 123.14 1.29 Allowed Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.302 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.14 -13.76 23.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.417 0.627 . . . . 0.0 109.581 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -84.87 -3.92 58.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.513 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -60.66 -33.21 72.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.107 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.6 tp -85.21 152.22 23.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.583 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 113.92 4.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.929 0.395 . . . . 0.0 111.056 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 88' ' ' ARG . 21.3 mtm180 -76.98 -164.71 0.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 57.0 ttp -67.49 -17.52 64.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.149 0.499 . . . . 0.0 110.227 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.53 -58.23 6.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.801 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -80.43 104.51 11.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 110.851 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -79.74 100.05 7.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.836 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.71 141.04 15.61 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.719 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.606 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 5.5 mmt -90.62 69.66 6.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.232 0.539 . . . . 0.0 110.588 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -167.77 131.83 1.75 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.314 176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -114.41 156.8 23.83 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.168 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -99.09 103.06 17.68 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -85.0 12.23 3.14 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.85 2.367 . . . . 0.0 112.648 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.2 77.47 0.25 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.056 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.102 177.693 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 mmt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.832 0.349 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -81.82 118.54 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.601 2.201 . . . . 0.0 111.449 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -72.83 127.56 32.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.643 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.81 117.88 24.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.851 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.1 167.44 21.61 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.427 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.48 92.09 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.339 2.026 . . . . 0.0 110.804 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 9.3 pt-20 -71.39 73.31 0.71 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.905 -176.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.83 16.55 68.31 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.67 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.509 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 60.1 pttt -124.25 147.63 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.541 0.21 . . . . 0.0 110.456 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.1 -137.69 7.18 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.13 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' HA ' HG22 ' A' ' 49' ' ' THR . 11.1 p90 -68.48 -9.55 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.789 0.328 . . . . 0.0 111.81 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.47 -17.44 56.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.849 0.357 . . . . 0.0 110.516 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 15.5 t70 -74.36 -51.56 14.74 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.909 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.621 HG23 ' HB2' ' A' ' 53' ' ' ALA . 2.2 m -68.86 -33.7 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.72 63.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.966 0.413 . . . . 0.0 110.578 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -74.16 -37.04 64.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.21 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -68.13 -36.41 79.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CG ' HD21 ' A' ' 57' ' ' LEU . 5.2 m-85 -65.05 -44.28 89.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 0.0 110.14 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.624 ' HG2' ' HA2' ' A' ' 61' ' ' GLY . 73.8 mtp180 -53.11 -26.38 16.29 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.281 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.63 HG22 ' HB2' ' A' ' 24' ' ' SER . 13.1 m -88.53 -54.78 4.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.685 HD12 ' HA3' ' A' ' 25' ' ' GLY . 1.1 tp -52.55 -26.63 13.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.608 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 23' ' ' LYS . 1.3 mp -50.03 -58.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.688 0.28 . . . . 0.0 110.421 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.442 ' N ' HG22 ' A' ' 22' ' ' ILE . 16.5 ptpt -94.46 -29.54 14.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.63 ' HB2' HG22 ' A' ' 20' ' ' THR . 38.9 m -102.47 28.66 5.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.285 -171.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.685 ' HA3' HD12 ' A' ' 21' ' ' LEU . . . -165.1 20.57 0.12 Allowed Glycine 0 CA--C 1.505 -0.544 0 C-N-CA 119.37 -1.395 . . . . 0.0 112.239 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 64.92 10.35 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.56 -0.82 . . . . 0.0 112.852 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.62 HD12 HD21 ' A' ' 21' ' ' LEU . 23.2 mt -84.2 59.15 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 160.46 28.42 Favored Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 6.5 Cg_exo -75.09 136.77 20.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.944 1.763 . . . . 0.0 112.322 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.95 -17.75 11.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.717 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -95.55 159.89 14.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.606 HG22 HG12 ' A' ' 72' ' ' VAL . 36.8 p -78.66 165.06 24.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.636 0.255 . . . . 0.0 111.137 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.86 141.6 98.39 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 171.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.53 ' HG2' HD11 ' A' ' 39' ' ' ILE . 57.0 Cg_endo -77.71 163.86 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.379 2.052 . . . . 0.0 111.669 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 m -65.81 140.31 58.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.456 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.599 ' HA ' HD13 ' A' ' 39' ' ' ILE . 31.0 m -52.07 -27.19 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.81 86.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -66.67 -48.8 68.2 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.283 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -55.02 -50.76 60.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.257 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 19.9 ptt180 -81.17 -9.75 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -173.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.01 -38.66 17.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.721 0.296 . . . . 0.0 110.282 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -87.99 -59.13 2.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.637 0.732 . . . . 0.0 110.09 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 45' ' ' VAL . 21.0 m-85 -90.23 81.85 6.07 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.416 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.412 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . -39.56 92.67 0.01 OUTLIER Glycine 0 CA--C 1.523 0.564 0 O-C-N 124.613 1.196 . . . . 0.0 115.274 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 14.7 m -139.01 178.71 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' OG1' ' A' ' 49' ' ' THR . . . -87.19 -175.02 5.15 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.8 51.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.372 . . . . 0.0 111.246 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -90.24 -22.32 21.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.521 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.675 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.5 m -64.16 -35.34 80.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.539 -174.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG13 HG21 ' A' ' 39' ' ' ILE . 65.1 t -56.17 -59.1 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.331 0.586 . . . . 0.0 110.571 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.606 ' HA ' HD12 ' A' ' 54' ' ' LEU . 42.1 t -66.14 -14.26 61.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.815 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -77.17 -40.53 45.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 109.847 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.621 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -74.17 -30.67 62.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.562 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 51' ' ' SER . 83.9 mt -51.92 -30.39 24.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.613 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . . . -68.59 -24.43 64.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.962 0.41 . . . . 0.0 111.096 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.93 -23.8 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.734 0.778 . . . . 0.0 109.448 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.694 ' HG ' ' HA3' ' A' ' 61' ' ' GLY . 4.5 mp -68.67 -19.49 64.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.019 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 55' ' ' ALA . 73.8 mttt -54.42 -59.23 4.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.166 0.508 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -93.02 -41.24 10.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.95 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' HG2' ' HD2' ' A' ' 19' ' ' ARG . 23.4 tt0 -93.2 -55.79 3.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.966 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.694 ' HA3' ' HG ' ' A' ' 57' ' ' LEU . . . -75.31 -10.23 84.38 Favored Glycine 0 N--CA 1.461 0.302 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.814 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.968 HD21 HG13 ' A' ' 78' ' ' ILE . 7.7 mt 69.74 80.33 0.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.686 0.755 . . . . 0.0 111.966 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.444 HG12 ' C ' ' A' ' 57' ' ' LEU . 9.0 p -140.32 161.29 25.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.2 m -141.77 102.23 4.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.215 0.531 . . . . 0.0 111.171 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 9.4 m -72.37 86.53 1.13 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 34.2 mmt180 -68.93 125.25 26.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.692 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.97 -9.0 87.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.925 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.54 -45.37 4.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.863 0.363 . . . . 0.0 110.999 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.34 -18.04 29.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.389 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 102.38 172.87 27.18 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 2.7 m -72.06 103.86 3.4 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.606 HG12 HG22 ' A' ' 32' ' ' THR . 23.1 m -121.96 169.5 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.238 -172.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 31.5 t -93.23 114.15 29.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.222 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.572 ' HG2' HG23 ' A' ' 72' ' ' VAL . 6.0 mm-40 -126.31 146.79 49.88 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -72.93 77.87 1.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 173.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.49 ' O ' HD22 ' A' ' 62' ' ' LEU . 59.9 t30 -64.65 132.69 95.49 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.05 113.97 1.71 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.076 1.184 . . . . 0.0 110.35 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.968 HG13 HD21 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -64.09 127.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 172.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t -52.49 91.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 O-C-N 124.056 0.847 . . . . 0.0 110.638 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.612 HG13 HG22 ' A' ' 78' ' ' ILE . 69.7 mt -104.61 122.31 57.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.838 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.8 m -78.48 -43.49 26.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.818 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.85 55.91 3.73 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.991 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.86 -173.84 2.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.2 -12.53 59.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.816 0.341 . . . . 0.0 111.373 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.46 -52.53 17.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 172.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB3' ' H ' ' A' ' 87' ' ' LYS . 0.9 OUTLIER 57.18 -89.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.05 0.844 . . . . 0.0 111.347 177.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.441 ' H ' ' HB3' ' A' ' 86' ' ' LEU . 4.9 ttpm? -155.77 122.49 5.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.58 32.86 5.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.711 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 64.7 mtt 70.23 -55.51 0.61 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.384 0.674 . . . . 0.0 110.734 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -62.31 -69.14 0.27 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.533 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 91' ' ' LYS . 25.2 mtpp -82.36 114.86 21.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.308 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -113.14 142.48 45.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.863 175.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.42 -165.55 13.2 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.462 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.16 58.57 2.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.646 0.736 . . . . 0.0 110.496 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -147.27 162.61 38.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.951 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.512 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 17.9 t80 -121.5 134.71 55.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.94 106.39 4.87 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 0.0 110.353 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 74.0 Cg_endo -83.22 -1.23 10.24 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.594 2.196 . . . . 0.0 112.016 -175.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.9 21.46 7.9 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.042 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.044 178.433 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.902 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 47.4 ttm . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 119.697 -0.192 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.902 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 12.5 Cg_exo -73.29 159.92 46.03 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.207 1.938 . . . . 0.0 111.631 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.573 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 6.3 p90 -90.91 153.47 20.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.211 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -93.36 137.99 32.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -78.63 146.65 69.78 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.132 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 2.7 Cg_exo -77.68 117.42 4.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.746 2.297 . . . . 0.0 112.622 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -86.95 -157.61 0.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.04 175.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 7' ' ' GLU . . . -74.58 60.46 2.45 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 44' ' ' GLY . 19.5 ptpt -122.53 178.37 5.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 0.0 110.249 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.27 -148.47 5.44 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.271 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -71.15 -10.68 60.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.65 -17.98 57.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 110.397 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' CB ' ' HD3' ' A' ' 9' ' ' LYS . 26.9 t70 -71.08 -45.97 62.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.388 175.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.673 HG23 HG11 ' A' ' 45' ' ' VAL . 72.0 t -59.9 -40.25 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.065 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.594 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -57.2 -43.57 82.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -61.33 -34.77 75.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.711 ' CD2' ' HA ' ' A' ' 39' ' ' ILE . 5.2 t60 -67.53 -44.93 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.102 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.604 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-85 -69.21 -46.47 67.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.984 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -61.01 -19.43 61.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -85.66 -51.15 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.967 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD13 HD13 ' A' ' 27' ' ' LEU . 3.9 pp -71.84 -21.83 61.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 18' ' ' PHE . 26.5 mm -61.12 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 110.739 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -85.11 1.19 48.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.231 0.538 . . . . 0.0 110.525 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.424 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 27.5 t -96.88 24.93 5.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.603 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 22.34 26.12 0.0 OUTLIER Glycine 0 N--CA 1.475 1.268 0 N-CA-C 117.374 1.71 . . . . 0.0 117.374 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 24' ' ' SER . 7.9 pt-20 -85.78 -34.66 21.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.672 HD21 ' HG3' ' A' ' 34' ' ' PRO . 9.9 mp -109.16 72.77 0.82 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 166.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.55 153.31 83.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.483 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.45 123.21 7.47 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.113 1.875 . . . . 0.0 111.284 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.55 -10.03 10.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.033 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.2 161.31 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.661 HG22 HG12 ' A' ' 72' ' ' VAL . 17.1 p -81.53 167.77 18.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.883 0.373 . . . . 0.0 111.478 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.803 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.4 mm? -65.12 140.08 97.87 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.336 175.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.672 ' HG3' HD21 ' A' ' 27' ' ' LEU . 57.3 Cg_endo -76.95 165.56 28.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.598 2.199 . . . . 0.0 111.565 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -74.08 156.09 37.81 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.0 m -52.48 -22.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.76 -52.57 64.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -58.16 -30.24 66.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.043 0.449 . . . . 0.0 110.974 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.711 ' HA ' ' CD2' ' A' ' 17' ' ' HIS . 4.3 mp -80.02 -59.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.519 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 33.5 ptt180 -79.03 -19.88 50.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -166.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . . . -76.69 -39.76 51.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.396 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -78.71 -62.07 1.81 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.708 . . . . 0.0 109.206 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 9.7 m-85 -92.17 105.1 17.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.956 176.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' A' ' 9' ' ' LYS . . . -60.41 91.56 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.157 0 CA-C-N 115.225 -0.898 . . . . 0.0 114.0 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.673 HG11 HG23 ' A' ' 14' ' ' VAL . 17.6 m -134.82 178.31 5.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -94.98 -170.55 2.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.09 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -76.21 -22.71 54.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.647 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -65.68 -42.05 91.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 110.158 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HA ' HG21 ' A' ' 14' ' ' VAL . 99.1 t -59.48 -55.84 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.715 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 54' ' ' LEU . 29.7 t -66.9 -12.11 58.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.675 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -82.4 -36.13 27.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.038 0.446 . . . . 0.0 110.223 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' HD13 ' A' ' 57' ' ' LEU . . . -74.3 -29.85 61.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.277 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 83.7 mt -49.28 -32.26 10.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.62 -28.63 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.076 0.465 . . . . 0.0 111.355 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.27 -25.16 5.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.877 0.846 . . . . 0.0 109.76 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.706 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -76.48 -5.04 45.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.46 -175.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -66.02 -40.11 90.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 p -93.14 -53.8 3.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.573 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -81.35 -38.32 26.87 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -172.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.706 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -90.49 -3.56 71.65 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.489 -174.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.689 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 10.1 mp 57.85 57.08 4.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.084 0.469 . . . . 0.0 111.808 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 57' ' ' LEU . 33.7 m -124.57 161.39 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.1 t -130.56 143.56 50.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.064 0.459 . . . . 0.0 111.337 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 p -82.78 103.04 11.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 12.1 tpp180 -118.43 48.43 1.43 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.3 4.12 2.07 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.978 -169.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.0 -47.02 21.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.05 -62.1 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 175.1 171.31 39.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.146 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.803 HG23 ' HB2' ' A' ' 33' ' ' LEU . 4.9 t -70.0 134.71 48.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 -174.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.661 HG12 HG22 ' A' ' 32' ' ' THR . 34.3 m -131.47 162.51 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.311 -171.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -99.15 113.58 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -123.58 144.34 49.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -69.18 78.67 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.438 0.461 . . . . 0.0 110.858 -174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 18.2 m-80 -73.6 116.54 52.54 Favored Pre-proline 0 CA--C 1.517 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.365 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.56 116.92 4.34 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.785 2.323 . . . . 0.0 111.264 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.618 HD11 HD11 ' A' ' 62' ' ' LEU . 1.2 mp -79.89 103.35 6.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.241 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.4 t 49.51 36.29 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.64 0.733 . . . . 0.0 110.374 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.7 mm -88.95 107.35 17.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.73 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 82' ' ' GLY . 3.2 t -158.87 -54.88 0.06 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.999 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 81' ' ' THR . . . -160.26 128.08 1.9 Allowed Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.889 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.91 171.37 8.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -90.62 8.76 32.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.118 0.485 . . . . 0.0 110.622 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.52 ' NE ' ' HA ' ' A' ' 85' ' ' ARG . 6.2 tpm_? -69.86 -42.54 73.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.453 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.7 tp 59.45 -81.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.001 0.813 . . . . 0.0 110.478 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -87.61 106.13 17.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.753 ' HB2' ' HB2' ' A' ' 91' ' ' LYS . 68.3 mtp180 -65.3 148.39 51.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 54.3 tpp -58.13 108.65 0.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.895 0.378 . . . . 0.0 111.027 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 64.52 18.26 11.28 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.392 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 37.7 mttp -118.31 79.38 1.37 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.543 0.687 . . . . 0.0 111.669 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -128.94 99.25 5.22 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.242 171.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.63 -61.18 1.31 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.012 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.2 mtt -106.19 52.83 0.72 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.266 0.555 . . . . 0.0 109.562 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HD2' ' HA ' ' A' ' 95' ' ' ARG . 16.2 tpt180 -155.42 157.63 37.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.457 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -148.27 166.37 28.19 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.81 108.62 5.15 Favored Pre-proline 0 C--N 1.318 -0.779 0 O-C-N 123.541 0.526 . . . . 0.0 109.969 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.04 18.03 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.853 2.369 . . . . 0.0 112.287 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.33 44.21 0.78 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.785 -177.799 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.87 151.78 68.54 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.509 2.139 . . . . 0.0 112.143 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.61 109.18 17.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.928 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.47 115.28 12.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.305 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.6 99.43 52.8 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -99.29 172.08 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.669 2.913 . . . . 0.0 111.731 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 157.52 46.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.23 -10.09 43.02 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -108.84 167.27 10.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -146.13 6.69 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.297 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.57 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 4.6 p90 -71.92 -4.53 28.85 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.038 0.446 . . . . 0.0 110.373 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.29 -12.83 60.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.864 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.71 -60.99 1.96 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG13 HG11 ' A' ' 45' ' ' VAL . 35.6 m -67.05 -29.32 45.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.486 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.72 -39.63 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.226 0.536 . . . . 0.0 110.455 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 m -83.41 -39.23 20.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.443 ' HB3' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-70 -70.43 -20.41 62.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.761 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.476 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.4 m-85 -77.02 -25.66 52.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 111.239 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 19' ' ' ARG . 24.0 mmm180 -70.96 -20.06 62.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.652 0.263 . . . . 0.0 111.377 -177.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -13.59 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.502 . . . . 0.0 110.453 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.714 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 82.7 mt -85.5 -47.16 10.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.918 175.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 18' ' ' PHE . 17.5 mm -75.65 2.23 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.743 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HD2' ' HB2' ' A' ' 24' ' ' SER . 4.8 tmmt? -61.09 -81.04 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.526 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.51 ' HB2' ' HD2' ' A' ' 23' ' ' LYS . 11.1 t -119.67 -31.7 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 118.732 -1.187 . . . . 0.0 113.809 -171.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.22 -20.9 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.065 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.714 ' HB2' ' HA ' ' A' ' 21' ' ' LEU . 33.2 mp0 -45.32 -45.44 12.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.729 0.812 . . . . 0.0 110.927 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.676 ' HG ' HG21 ' A' ' 73' ' ' VAL . 23.0 tp -133.87 91.03 2.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.4 152.29 89.92 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.185 -169.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 5.2 Cg_exo -76.81 129.39 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.005 2.47 . . . . 0.0 111.213 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.3 -15.43 17.99 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -95.7 162.08 13.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 72' ' ' VAL . 25.2 p -81.95 160.83 23.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.432 0.158 . . . . 0.0 110.705 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HB2' HG23 ' A' ' 71' ' ' THR . 10.9 mt -66.36 139.05 96.08 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.32 157.56 33.21 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.223 1.948 . . . . 0.0 111.834 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.8 t -69.31 155.36 40.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.6 m -54.85 -15.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.13 81.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.582 0.229 . . . . 0.0 111.404 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.96 -39.42 87.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 -176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.609 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.5 mp -66.3 -57.04 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.91 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 8.6 ttp180 -62.71 -31.27 72.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -170.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.65 -41.68 17.51 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.967 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -81.57 -50.47 9.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.401 0.62 . . . . 0.0 109.56 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 45' ' ' VAL . 5.4 m-85 -92.07 101.9 14.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.355 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.433 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . -52.67 92.42 0.01 OUTLIER Glycine 0 CA--C 1.518 0.27 0 O-C-N 123.587 0.554 . . . . 0.0 113.865 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.777 HG11 HG13 ' A' ' 14' ' ' VAL . 17.6 m -146.85 178.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 123.042 0.537 . . . . 0.0 109.725 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.53 -174.99 3.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 -36.31 57.05 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.689 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -84.06 -15.11 48.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.94 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.697 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.9 m -68.5 -39.46 81.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 39' ' ' ILE . 52.3 t -57.5 -58.29 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.314 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 54' ' ' LEU . 24.8 t -59.38 -17.45 30.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.237 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 74.7 ttt180 -79.8 -44.6 20.3 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.377 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 14' ' ' VAL . . . -79.68 -15.64 57.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.577 HD23 HD12 ' A' ' 57' ' ' LEU . 69.6 mt -48.64 -33.79 10.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.728 0.299 . . . . 0.0 111.407 174.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.493 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.17 -38.2 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.965 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.07 -28.56 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.45 0.643 . . . . 0.0 109.994 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.577 HD12 HD23 ' A' ' 54' ' ' LEU . 69.6 mt -73.28 -15.64 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.283 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 55' ' ' ALA . 49.2 mtmt -66.51 -48.13 70.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.338 0.59 . . . . 0.0 110.007 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.585 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 3.0 p -90.61 -54.88 3.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.649 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.34 -31.64 15.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.0 -169.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 57' ' ' LEU . . . -78.43 -29.48 52.77 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.128 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 77' ' ' PRO . 22.6 mt 75.16 80.05 0.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.159 0.984 . . . . 0.0 111.39 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 57' ' ' LEU . 36.0 m -145.92 172.85 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.174 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.0 m -146.6 116.21 7.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.39 0.614 . . . . 0.0 110.943 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.753 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 38.0 t -84.33 105.41 15.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.875 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.548 ' HD3' ' OE2' ' A' ' 74' ' ' GLU . 15.1 mmm-85 -83.79 119.14 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.39 34.7 1.34 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.127 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.25 -68.3 0.21 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -69.92 -31.53 69.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.347 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.81 172.1 13.22 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 9.0 t -78.55 120.58 23.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.315 0.579 . . . . 0.0 109.441 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.613 HG12 HG22 ' A' ' 32' ' ' THR . 33.6 m -126.05 170.72 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.277 0.56 . . . . 0.0 111.387 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.676 HG21 ' HG ' ' A' ' 27' ' ' LEU . 29.4 t -93.87 120.42 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.131 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 66' ' ' ARG . 48.6 mt-10 -131.57 158.87 39.84 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.061 0.457 . . . . 0.0 110.95 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -79.22 38.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 74' ' ' GLU . 66.8 m-20 -123.95 84.23 54.83 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.561 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.508 ' HB3' HD22 ' A' ' 62' ' ' LEU . 10.0 Cg_endo -52.2 116.07 2.58 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.003 2.468 . . . . 0.0 110.472 166.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.0 mm -64.61 127.79 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.24 74.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.561 0.696 . . . . 0.0 109.807 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.585 ' HB ' ' HB3' ' A' ' 59' ' ' SER . 38.5 mm -79.95 107.27 12.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.892 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -110.18 -69.26 0.87 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.31 149.13 20.36 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.755 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . . . -109.55 163.89 13.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.97 0.385 . . . . 0.0 110.78 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -77.81 -34.0 52.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.253 0.549 . . . . 0.0 110.154 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -75.54 -21.24 58.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.357 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.755 ' HG ' ' HB3' ' A' ' 83' ' ' ALA . 48.5 mt -68.98 93.96 0.6 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.367 0.603 . . . . 0.0 110.375 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.59 ' HD2' ' HG3' ' A' ' 98' ' ' PRO . 0.2 OUTLIER -161.99 -44.39 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.641 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -142.76 138.97 30.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.774 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.3 tpt -71.04 -46.77 61.47 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -91.47 76.92 5.81 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.49 113.23 2.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.861 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -81.38 142.01 33.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.753 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.14 -36.44 92.37 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.476 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 2.3 tpt -79.46 99.64 7.31 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -98.44 151.0 21.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.275 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.88 163.12 29.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.413 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.65 110.14 43.34 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.906 0.384 . . . . 0.0 110.279 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.59 ' HG3' ' HD2' ' A' ' 87' ' ' LYS . 95.3 Cg_endo -83.07 12.74 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.96 2.44 . . . . 0.0 112.544 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.12 35.46 1.9 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.862 -177.586 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 18.6 mmt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.636 0.255 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 7.6 Cg_exo -73.68 7.81 2.18 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.083 2.522 . . . . 0.0 112.621 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 96.0 m-85 -90.68 119.41 30.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.037 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -88.23 142.2 27.94 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.58 134.4 34.2 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 64.7 Cg_endo -78.14 111.48 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.339 2.026 . . . . 0.0 111.656 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -69.33 -77.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.039 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.11 -6.41 4.88 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.91 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.54 154.25 42.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.821 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.88 -135.27 3.68 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.81 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.597 ' HA ' HG12 ' A' ' 14' ' ' VAL . 3.0 p90 -74.24 -1.6 21.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.127 0.489 . . . . 0.0 111.011 -175.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.34 22.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.256 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.05 -36.65 13.91 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.64 0.733 . . . . 0.0 109.105 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.722 ' HB ' HG11 ' A' ' 45' ' ' VAL . 7.3 p -75.1 -32.6 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.856 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.67 -46.22 84.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.934 0.397 . . . . 0.0 110.681 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -71.46 -27.89 63.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.875 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -74.34 -20.84 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.834 0.35 . . . . 0.0 110.883 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.0 -24.07 65.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.886 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.1 m -75.27 -28.11 59.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.316 0.579 . . . . 0.0 110.038 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.038 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 67.5 mt -78.96 -28.84 43.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.87 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 tp -90.29 -7.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.364 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.06 -79.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 26' ' ' GLU . 8.5 t -119.71 -34.62 3.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 159.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.038 ' HA3' ' HA ' ' A' ' 21' ' ' LEU . . . 18.12 22.46 0.0 OUTLIER Glycine 0 C--N 1.354 1.561 0 C-N-CA 127.949 2.69 . . . . 0.0 118.652 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' SER . 33.0 mt-10 59.53 9.79 1.66 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 117.413 0.606 . . . . 0.0 111.225 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 21' ' ' LEU . 8.3 mp -129.64 34.2 4.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.07 166.28 2.15 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.137 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 10.7 Cg_exo -73.53 123.81 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.744 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.03 5.5 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.929 -172.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -104.37 164.07 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.689 HG22 HG12 ' A' ' 72' ' ' VAL . 2.7 p -97.38 153.23 18.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.65 0.262 . . . . 0.0 110.953 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 10.5 mp -72.42 120.0 78.08 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 111.881 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.51 6.69 5.48 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 123.284 2.656 . . . . 0.0 111.871 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 1.127 ' HA ' HD13 ' A' ' 39' ' ' ILE . 5.7 p -79.04 59.15 2.61 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -160.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 37' ' ' ALA . 2.4 m -100.87 -58.05 4.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.614 1.197 . . . . 0.0 110.008 142.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' H ' HG23 ' A' ' 36' ' ' VAL . . . -89.32 -58.98 2.34 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.924 -166.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.65 -30.49 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.401 -174.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.127 HD13 ' HA ' ' A' ' 35' ' ' SER . 1.8 mp -86.1 -56.07 5.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.03 -173.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 4.2 ptm180 -66.01 -18.62 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.826 -172.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . . . -67.99 -57.53 6.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.513 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -81.16 -51.86 7.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.846 0.831 . . . . 0.0 110.065 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.702 ' HD2' HG23 ' A' ' 39' ' ' ILE . 4.8 m-85 -89.8 83.11 6.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.867 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.46 88.17 0.01 OUTLIER Glycine 0 N--CA 1.462 0.419 0 O-C-N 125.002 1.439 . . . . 0.0 115.182 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.722 HG11 ' HB ' ' A' ' 14' ' ' VAL . 17.4 m -142.02 178.11 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB3' ' OG1' ' A' ' 49' ' ' THR . . . -89.08 -175.12 4.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.83 -35.17 51.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.277 0.56 . . . . 0.0 110.645 -174.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.924 ' HA ' ' HE2' ' A' ' 48' ' ' LYS . 10.5 mmpt? -85.12 -13.05 51.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.678 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.689 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 m -71.95 -40.07 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.678 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG13 HG21 ' A' ' 39' ' ' ILE . 48.7 t -55.16 -57.01 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.396 0.617 . . . . 0.0 110.375 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.708 ' HA ' HD12 ' A' ' 54' ' ' LEU . 36.0 t -64.16 -14.06 52.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.639 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 16.2 tpp180 -78.28 -44.14 26.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -66.58 -33.4 75.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.881 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 51' ' ' SER . 69.1 mt -53.56 -31.33 46.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.628 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.534 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.6 -26.34 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.078 0.466 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.55 -29.98 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.647 0.737 . . . . 0.0 109.669 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -74.03 -13.8 60.91 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.624 -173.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.534 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 62.2 pttt -64.53 -36.69 85.04 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.602 173.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.701 ' HA ' HG13 ' A' ' 78' ' ' ILE . 6.1 m -93.09 -53.48 4.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.284 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -88.37 -31.02 19.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.005 -170.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.548 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.43 -12.52 59.64 Favored Glycine 0 C--O 1.229 -0.216 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.922 -176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp 63.49 52.43 2.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.874 0.368 . . . . 0.0 111.707 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.82 164.2 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.68 ' HB3' HG23 ' A' ' 72' ' ' VAL . 22.6 t -117.17 105.2 11.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.184 0.516 . . . . 0.0 110.608 -174.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.2 m -81.39 71.38 8.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 20.9 tpp180 -75.77 96.46 3.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.313 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.15 49.47 3.54 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.001 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.23 -47.26 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.96 -44.66 10.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.093 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 138.06 -177.6 19.87 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.692 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 33' ' ' LEU . 17.7 p -75.01 106.66 6.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.968 0.413 . . . . 0.0 110.466 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.689 HG12 HG22 ' A' ' 32' ' ' THR . 18.2 m -123.05 150.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.101 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 27' ' ' LEU . 17.5 t -92.57 105.18 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -126.45 135.54 51.5 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 20.8 pttm -66.63 92.73 0.22 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.503 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 19.8 m-80 -90.35 110.86 43.78 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.056 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 76' ' ' ASN . 28.0 Cg_endo -62.64 115.38 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.021 1.814 . . . . 0.0 109.703 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.701 HG13 ' HA ' ' A' ' 59' ' ' SER . 13.1 mm -95.68 117.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.078 0.466 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m 44.77 31.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 113.682 -1.599 . . . . 0.0 111.658 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mm -76.12 118.62 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.062 -174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.7 m -117.17 -25.8 7.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.471 0.653 . . . . 0.0 109.812 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.52 112.48 3.55 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.589 176.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.05 -19.34 64.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.903 0.382 . . . . 0.0 111.091 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -79.54 -19.29 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.087 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -88.6 -1.64 58.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.782 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.0 tp -79.13 -22.72 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -115.81 -178.13 3.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.403 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -84.52 178.56 7.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.695 0.283 . . . . 0.0 110.944 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.5 tpt -68.97 -37.91 79.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -71.3 73.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.425 ' HB2' ' NZ ' ' A' ' 91' ' ' LYS . 4.8 ttmp? -90.92 132.06 36.17 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.652 -167.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -99.91 136.22 40.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.446 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.18 -27.38 66.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.797 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -174.77 3.52 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -64.46 143.32 57.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.198 0.523 . . . . 0.0 111.195 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 81.0 t80 -96.5 132.43 42.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 100' ' ' GLU . . . -73.37 108.72 5.07 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 123.361 0.413 . . . . 0.0 110.728 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 64.1 Cg_endo -89.72 -2.06 5.77 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.883 2.389 . . . . 0.0 112.502 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.99 45.4 0.74 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.056 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.425 ' HB2' ' HB1' ' A' ' 97' ' ' ALA . 30.6 tt0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.393 -0.813 . . . . 0.0 109.659 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.473 ' HB3' ' HD2' ' A' ' 3' ' ' TYR . 90.3 mtp . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.021 0.439 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.22 36.39 0.5 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.219 2.613 . . . . 0.0 112.858 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.473 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 93.7 m-85 -79.91 135.93 36.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.791 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -88.67 93.14 9.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.184 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.8 117.33 66.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 68.2 Cg_endo -91.77 178.79 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.414 2.742 . . . . 0.0 112.544 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.41 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 3.1 mp0 -93.23 -89.45 0.21 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 7' ' ' GLU . . . -125.76 101.27 0.61 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.617 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -123.48 150.97 43.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.969 0.414 . . . . 0.0 110.875 -174.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.34 -145.29 14.94 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 170.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.673 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 2.0 p90 -80.17 23.47 0.47 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.769 0.318 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.57 -46.46 8.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.857 0.361 . . . . 0.0 111.567 -172.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -77.45 -26.58 51.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.45 0.643 . . . . 0.0 110.157 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.991 ' HB ' HG11 ' A' ' 45' ' ' VAL . 12.8 p -75.1 -26.09 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.257 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 19' ' ' ARG . . . -63.16 -34.79 78.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.498 ' HB ' ' CE2' ' A' ' 43' ' ' PHE . 10.3 m -60.02 -26.59 66.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.11 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 53.9 t-80 -56.12 -48.47 76.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.65 ' HE2' HD22 ' A' ' 33' ' ' LEU . 74.7 m-85 -83.21 -35.71 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.523 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 72.4 mtp180 -57.08 -32.63 66.47 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 110.635 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.6 m -79.13 -55.55 5.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.827 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 HD13 HD22 ' A' ' 27' ' ' LEU . 31.1 mt -48.88 -46.91 43.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 61' ' ' GLY . 1.8 mp -68.97 -43.25 82.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -86.26 -7.07 58.79 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.454 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.2 p -105.23 17.53 23.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.54 27.49 0.0 OUTLIER Glycine 0 N--CA 1.469 0.88 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -169.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.07 -32.3 71.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 21' ' ' LEU . 22.7 tp -102.95 95.58 6.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.52 153.92 95.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.518 -170.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.24 126.68 8.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.654 2.236 . . . . 0.0 110.914 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.45 -6.24 33.76 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -95.99 149.97 20.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.816 HG22 HG12 ' A' ' 72' ' ' VAL . 19.2 p -78.37 156.8 29.33 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.717 HD21 HG21 ' A' ' 63' ' ' VAL . 14.0 mt -60.63 139.39 92.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.814 172.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.06 168.13 25.53 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.336 2.024 . . . . 0.0 111.913 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.7 p -66.09 148.94 51.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.668 ' HA ' HD13 ' A' ' 39' ' ' ILE . 20.0 m -49.72 -28.11 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.306 0.378 . . . . 0.0 111.681 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.96 91.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.561 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.51 -23.67 63.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.668 HD13 ' HA ' ' A' ' 36' ' ' VAL . 3.8 mp -79.35 -55.67 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 7.1 ptm180 -77.64 -20.64 53.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.46 68.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.673 . . . . 0.0 110.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -83.16 -60.61 2.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.018 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 48.6 m-85 -92.54 99.06 11.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.777 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 6' ' ' PRO . . . -56.33 100.13 0.1 OUTLIER Glycine 0 CA--C 1.515 0.078 0 CA-C-N 115.299 -0.864 . . . . 0.0 114.044 -172.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.991 HG11 ' HB ' ' A' ' 14' ' ' VAL . 6.1 m -146.38 178.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 122.575 0.35 . . . . 0.0 110.141 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -90.92 175.15 7.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.8 -19.3 55.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.467 0.651 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 71.8 mmtt -74.36 -46.48 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.963 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.745 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.5 m -56.38 -43.06 78.84 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.833 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.755 ' HA ' HG21 ' A' ' 14' ' ' VAL . 93.5 t -52.83 -53.66 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.327 0.584 . . . . 0.0 110.95 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.566 ' HA ' HD12 ' A' ' 54' ' ' LEU . 23.2 t -70.48 -6.68 37.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.624 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 5.2 mmp_? -83.61 -47.05 11.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.122 -0.362 . . . . 0.0 110.293 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.518 ' CB ' HG13 ' A' ' 14' ' ' VAL . . . -70.77 -20.11 62.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.791 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 51' ' ' SER . 65.5 mt -53.22 -29.81 34.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.234 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.535 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -63.03 -30.87 71.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.146 0.498 . . . . 0.0 110.643 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.68 -31.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.369 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.705 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -75.36 -17.71 60.16 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -171.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -66.41 -34.76 78.67 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.347 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 m -93.57 -51.74 4.81 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.31 0.576 . . . . 0.0 110.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -84.32 -53.5 5.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.008 -172.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.705 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -77.06 -7.02 86.62 Favored Glycine 0 C--O 1.225 -0.423 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.801 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 16.7 mt 63.29 78.28 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.375 0.67 . . . . 0.0 111.972 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.717 HG21 HD21 ' A' ' 33' ' ' LEU . 1.4 p -160.57 135.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.7 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 8.4 t 147.9 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.843 1.339 . . . . 0.0 111.687 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.6 ' CB ' HG22 ' A' ' 72' ' ' VAL . 3.8 t -94.82 -59.87 1.82 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.283 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.596 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -118.72 135.28 54.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.214 0.53 . . . . 0.0 112.217 -169.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.74 -30.79 9.25 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 168.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.22 -61.35 2.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.88 -62.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 169.28 160.63 17.91 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.904 176.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 121.1 24.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.678 0.752 . . . . 0.0 109.829 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.816 HG12 HG22 ' A' ' 32' ' ' THR . 2.6 m -121.92 163.96 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.229 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.481 HG21 ' HG ' ' A' ' 27' ' ' LEU . 16.7 t -84.97 123.41 39.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.185 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -132.28 159.49 38.95 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -76.09 66.09 2.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.834 0.826 . . . . 0.0 110.128 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 7.5 m-20 -55.17 142.24 58.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.491 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 76' ' ' ASN . 9.8 Cg_exo -71.11 117.92 5.41 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.141 1.894 . . . . 0.0 111.51 175.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.435 HG23 HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -79.73 111.64 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.418 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 78' ' ' ILE . 34.3 m 40.74 36.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.255 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.0 mm -81.41 139.69 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.496 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.9 m -142.53 -28.0 0.6 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.029 0.442 . . . . 0.0 111.158 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.54 56.59 0.74 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.823 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.01 -33.91 24.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.073 0.464 . . . . 0.0 110.297 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -80.01 -8.5 59.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.16 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -78.86 -44.72 22.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.903 0.382 . . . . 0.0 110.641 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.47 107.34 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.036 -172.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' A' ' 88' ' ' ARG . 7.4 ptpp? -157.91 -10.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.472 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.409 ' H ' ' H ' ' A' ' 87' ' ' LYS . 21.2 ttt180 -175.07 -55.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.207 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 47.5 ttm -149.92 -70.08 0.19 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.514 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -142.42 -74.33 0.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -155.48 96.7 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.308 0.575 . . . . 0.0 110.872 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -81.45 139.22 35.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.428 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.09 44.9 2.69 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.59 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.6 mmt -121.86 130.31 53.28 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -70.86 106.41 3.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.529 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 79.9 t80 -81.85 130.61 35.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.16 105.68 3.11 Favored Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 123.366 0.416 . . . . 0.0 110.025 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 32.9 Cg_endo -92.79 17.25 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.04 2.494 . . . . 0.0 111.495 -175.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.34 78.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.185 -175.868 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.15 115.08 3.64 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.681 2.254 . . . . 0.0 111.085 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 47.9 p90 -75.13 143.75 43.16 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.965 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -93.67 128.63 39.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.705 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.45 118.27 60.75 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.604 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -88.31 160.55 6.88 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.938 2.425 . . . . 0.0 112.65 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.6 95.44 3.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.03 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.99 38.64 55.64 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.484 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.568 ' HD2' ' HB2' ' A' ' 13' ' ' ASP . 3.3 tppp? -104.44 108.66 20.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -157.86 33.39 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.868 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.555 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -71.92 0.51 9.07 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.622 0.369 . . . . 0.0 111.308 -177.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.5 50.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.687 0.28 . . . . 0.0 111.338 -169.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.568 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 40.3 t0 -76.1 -38.65 56.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.375 0.607 . . . . 0.0 109.511 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.651 HG23 ' HB2' ' A' ' 53' ' ' ALA . 3.8 m -85.19 -23.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.56 61.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.264 0.554 . . . . 0.0 109.873 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.643 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 5.1 m -104.13 -27.31 12.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.993 174.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.521 ' HD2' HG23 ' A' ' 39' ' ' ILE . 4.0 t60 -60.54 -21.22 62.28 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.709 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 24.8 p90 -58.21 -33.43 69.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.365 0.602 . . . . 0.0 110.453 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 16' ' ' THR . 2.6 ptm180 -68.25 -25.88 65.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.767 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.458 ' HB ' HD22 ' A' ' 21' ' ' LEU . 2.4 m -65.13 -35.63 81.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.219 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.137 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.1 mm? -91.93 -48.12 6.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.298 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' A' ' 27' ' ' LEU . 36.4 mm -67.52 -12.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.861 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 2.7 tmmt? -48.0 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.325 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 p -118.31 -32.08 4.77 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.73 -20.7 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.198 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.701 ' HG2' ' HA ' ' A' ' 21' ' ' LEU . 2.1 pm0 -63.37 -21.39 66.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -168.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.137 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.7 tp -121.59 83.4 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.24 141.34 80.66 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.508 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 3.0 Cg_exo -77.09 123.7 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 110.903 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.14 46.43 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -174.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -118.26 156.63 28.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 24.1 p -82.69 138.77 34.0 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.256 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 151.09 86.2 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.63 168.32 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.696 2.264 . . . . 0.0 112.694 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -76.73 -179.23 5.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.192 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.17 -19.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.924 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.63 75.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.53 -55.06 19.86 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.861 0.362 . . . . 0.0 111.058 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.725 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.4 mp -58.11 -39.83 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.047 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 5.2 tmm_? -79.76 -28.25 40.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.347 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . . . -82.6 -31.73 28.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.48 -65.36 0.9 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 45' ' ' VAL . 3.1 m-85 -91.92 111.27 22.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.19 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.95 92.33 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 O-C-N 124.016 0.822 . . . . 0.0 113.363 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 18.8 m -138.81 -179.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.51 174.61 7.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.913 0.387 . . . . 0.0 110.535 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -76.45 -14.62 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 176.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 44.0 m -73.15 -42.11 63.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 81.5 t -54.52 -61.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.484 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.621 ' HA ' HD12 ' A' ' 54' ' ' LEU . 13.0 t -57.48 -25.43 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.522 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 77.1 ttt180 -72.93 -48.29 38.19 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.099 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -63.58 -31.04 72.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.037 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.647 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 86.8 mt -58.18 -29.52 65.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.161 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -67.77 -28.84 67.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.354 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 26.3 t -84.84 -32.15 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 175.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.721 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.8 mp -77.51 4.46 11.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.828 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 41.4 mtmt -65.62 -56.63 11.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -93.85 -40.5 10.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.893 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 9.7 tp10 -73.62 -51.07 18.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.772 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.721 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -88.64 -13.23 63.3 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.877 -176.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 76' ' ' ASN . 63.9 mt 66.2 66.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.979 0.458 . . . . 0.0 111.826 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 57' ' ' LEU . 32.8 m -136.87 156.45 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.46 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -116.61 95.63 5.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.359 0.6 . . . . 0.0 109.842 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -84.86 109.17 17.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.92 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.41 108.6 20.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.141 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.15 47.24 2.58 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.164 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.76 -55.87 0.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.293 0.568 . . . . 0.0 109.613 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -85.81 -36.53 20.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.253 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.0 175.41 13.88 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.56 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.4 p -87.83 104.9 17.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 15.5 t -114.54 139.84 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.388 . . . . 0.0 110.267 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 21.4 t -90.84 91.0 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -94.51 138.81 31.97 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.475 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -71.31 84.73 0.78 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.547 ' O ' HD22 ' A' ' 62' ' ' LEU . 83.1 m-20 -67.97 140.13 93.5 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.615 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HB2' HG13 ' A' ' 80' ' ' ILE . 6.3 Cg_exo -77.67 118.2 4.46 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.705 2.27 . . . . 0.0 110.055 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.517 HG12 HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -58.88 115.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.743 -174.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 m 23.62 70.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.245 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.522 HG13 ' HB2' ' A' ' 77' ' ' PRO . 29.5 mm -88.08 107.58 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.347 0.594 . . . . 0.0 111.329 -173.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.533 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 6.6 p -104.43 -27.03 12.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.518 172.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.652 ' HA2' ' HB2' ' A' ' 86' ' ' LEU . . . -96.58 -148.58 24.38 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.834 177.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 61.52 -72.14 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.716 0.806 . . . . 0.0 112.624 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.552 ' HA ' ' HE3' ' A' ' 87' ' ' LYS . 31.1 t70 -103.83 -33.53 8.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.361 . . . . 0.0 111.16 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -90.81 -14.33 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.518 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.652 ' HB2' ' HA2' ' A' ' 82' ' ' GLY . 52.3 mt -115.62 94.52 4.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.552 ' HE3' ' HA ' ' A' ' 84' ' ' ASP . 87.8 mttt -121.17 -66.64 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.989 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 67.46 -74.89 0.07 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.733 0.646 . . . . 0.0 110.803 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.403 ' O ' ' HB3' ' A' ' 90' ' ' GLU . 12.7 tpt -167.99 156.38 8.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -174.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 89' ' ' MET . 23.0 tt0 75.2 -65.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.714 0.634 . . . . 0.0 111.523 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -90.35 119.98 31.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.344 0.592 . . . . 0.0 111.262 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -128.35 121.97 30.4 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.488 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.11 -89.2 1.39 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.921 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.479 ' HG2' ' H ' ' A' ' 95' ' ' ARG . 44.2 ttp -95.02 174.67 6.97 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 94' ' ' MET . 66.4 mtt85 -108.19 157.27 18.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -83.76 153.61 24.04 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.54 112.68 28.36 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.029 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.39 24.65 0.73 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.966 2.444 . . . . 0.0 112.23 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.67 27.37 2.07 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.719 -179.144 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.88 127.76 19.34 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.599 2.199 . . . . 0.0 111.16 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 66.5 t80 -85.62 128.66 34.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.176 0.512 . . . . 0.0 111.26 -175.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.93 114.12 26.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.401 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -81.89 122.28 79.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.731 0.301 . . . . 0.0 110.531 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.504 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 84.6 Cg_endo -95.53 134.08 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.199 2.6 . . . . 0.0 113.182 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -99.87 -73.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.11 92.08 1.71 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.66 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -75.92 178.55 6.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.196 0.998 . . . . 0.0 112.919 -172.677 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 168.57 151.13 6.98 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.122 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 9.3 p90 -70.66 8.03 0.96 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.419 0.609 . . . . 0.0 110.584 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . -79.78 -28.1 40.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.17 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 12.4 t70 -67.56 -50.08 60.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.026 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.551 HG23 ' CB ' ' A' ' 53' ' ' ALA . 2.3 m -71.02 -36.89 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.415 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -55.37 -48.76 73.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.036 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -80.05 -22.41 42.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.486 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 1.7 m170 -85.97 -30.3 22.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -73.27 -18.44 61.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.983 0.421 . . . . 0.0 110.625 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -63.18 -17.53 62.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.504 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.83 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 6.8 m -81.94 -26.48 33.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.137 0.494 . . . . 0.0 110.769 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.955 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.6 mm? -81.88 -51.81 7.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.496 HG21 ' HA2' ' A' ' 61' ' ' GLY . 11.2 tp -79.69 14.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.072 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.83 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 24.4 ttmm -67.64 -77.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 m -117.36 -29.79 5.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.6 -25.84 0.02 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 118.84 -1.648 . . . . 0.0 114.957 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -53.95 -42.74 69.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.025 0.412 . . . . 0.0 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.955 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -113.31 78.31 1.13 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.92 95.27 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.447 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.894 ' HA ' HG13 ' A' ' 73' ' ' VAL . 37.5 Cg_endo -70.93 136.84 30.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.032 2.488 . . . . 0.0 111.767 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.4 56.59 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.481 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 73' ' ' VAL . 4.8 t0 -122.77 164.19 18.81 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 22.1 p -78.87 152.81 31.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.969 0.414 . . . . 0.0 111.11 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.66 HD21 ' HB ' ' A' ' 73' ' ' VAL . 8.7 mt -85.94 152.12 55.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.287 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.49 168.09 24.41 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.594 2.196 . . . . 0.0 111.017 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 t -73.21 155.82 39.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.8 m -53.86 -21.21 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 O-C-N 123.28 0.363 . . . . 0.0 111.914 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.83 92.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.59 -51.88 63.38 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.393 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.4 mp -57.88 -54.51 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.218 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -73.26 -17.89 61.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -171.389 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 3' ' ' TYR . . . -82.57 -44.81 15.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.595 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -75.99 -52.24 10.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.579 ' HD2' HG23 ' A' ' 39' ' ' ILE . 2.9 m-85 -93.11 105.78 17.83 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.631 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 85.43 0.01 OUTLIER Glycine 0 CA--C 1.516 0.115 0 O-C-N 123.638 0.586 . . . . 0.0 113.926 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.787 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 27.8 m -142.03 179.12 2.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.61 -169.93 2.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.22 -40.36 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.987 0.422 . . . . 0.0 110.349 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -75.05 -31.07 61.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.604 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.787 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 5.4 m -58.06 -34.49 70.18 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.141 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.641 HG13 HG21 ' A' ' 39' ' ' ILE . 60.8 t -57.32 -59.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.376 0.608 . . . . 0.0 109.974 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.561 ' HA ' HD12 ' A' ' 54' ' ' LEU . 23.1 t -65.25 -11.9 46.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.612 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 49' ' ' THR . 32.2 tpt180 -76.74 -42.68 40.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.551 ' CB ' HG23 ' A' ' 14' ' ' VAL . . . -80.56 -19.66 45.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.437 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.686 HD22 HG21 ' A' ' 63' ' ' VAL . 44.8 mt -57.31 -25.52 59.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.512 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -72.65 -20.71 61.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.078 0.466 . . . . 0.0 110.71 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.06 -39.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.715 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 4.8 mp -71.27 6.68 1.59 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.922 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.877 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 22.0 pttp -76.37 -42.37 44.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -92.7 -45.05 8.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.161 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -75.97 -46.42 29.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.088 0.47 . . . . 0.0 111.243 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.715 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.21 -13.52 58.65 Favored Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.605 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.797 HD21 HG12 ' A' ' 78' ' ' ILE . 22.2 mt 67.69 28.33 7.33 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.785 0.434 . . . . 0.0 111.742 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.805 HG12 HG23 ' A' ' 73' ' ' VAL . 8.6 m -108.81 143.38 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.903 0.383 . . . . 0.0 111.342 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 41.0 t -144.95 149.24 34.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 p -90.32 90.1 7.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.526 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 4.3 tpp180 -71.48 105.19 3.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.054 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.97 59.07 3.53 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.239 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.95 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.48 -28.1 37.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.753 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 128.51 -159.21 21.95 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.591 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.91 112.57 16.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 60.9 t -132.24 135.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -169.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 29' ' ' PRO . 11.6 p -82.56 75.7 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 122.335 1.064 . . . . 0.0 110.856 -173.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -144.96 83.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.11 162.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.877 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 55.6 tptt -95.82 -81.1 0.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.764 0.792 . . . . 0.0 111.374 175.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.462 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 67.3 t30 -130.7 91.96 35.89 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.839 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 76' ' ' ASN . 3.6 Cg_exo -40.06 122.41 1.14 Allowed 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.983 2.455 . . . . 0.0 111.23 175.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.797 HG12 HD21 ' A' ' 62' ' ' LEU . 4.0 mm -55.41 118.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t -56.68 79.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 124.567 1.167 . . . . 0.0 111.384 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 78' ' ' ILE . 69.1 mt -78.92 112.84 17.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.072 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -83.38 38.88 0.63 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.654 0.74 . . . . 0.0 110.674 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.55 -127.04 0.87 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.266 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' O ' HD22 ' A' ' 86' ' ' LEU . . . -162.69 172.93 14.55 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.81 5.67 15.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.078 0.942 . . . . 0.0 109.852 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -76.44 -3.93 39.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.822 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' A' ' 89' ' ' MET . 1.9 pt? -72.42 89.47 1.25 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.963 0.887 . . . . 0.0 110.887 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -69.48 -30.75 68.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.5 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 88' ' ' ARG . 6.5 tpp180 -127.75 21.16 6.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.487 0.661 . . . . 0.0 109.596 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.63 ' HA ' HD12 ' A' ' 86' ' ' LEU . 47.5 ttm 63.36 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.56 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.83 46.48 1.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.251 0.548 . . . . 0.0 111.169 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -78.97 109.8 13.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.495 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 5.5 m-20 -63.23 143.58 57.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.082 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -42.92 -70.17 0.54 Allowed Glycine 0 C--N 1.333 0.396 0 O-C-N 123.854 0.721 . . . . 0.0 113.413 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 39.7 tpp -91.15 53.87 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.722 0.773 . . . . 0.0 110.325 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.495 ' HG3' ' HB2' ' A' ' 92' ' ' ASN . 43.1 mmt180 -142.44 108.01 5.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.03 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -118.71 104.92 11.05 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.95 108.24 1.75 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.105 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -93.93 5.2 2.81 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.259 2.639 . . . . 0.0 112.736 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.78 43.0 1.29 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.41 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.234 177.061 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.757 0.789 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.68 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 23.3 ttpt -94.67 118.71 32.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.489 -170.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.44 142.67 50.47 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.005 -173.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.675 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 72.1 Cg_endo -79.33 112.18 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.757 2.305 . . . . 0.0 111.713 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -70.34 -56.21 7.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.414 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.88 34.98 0.62 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.92 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HD2' ' CB ' ' A' ' 13' ' ' ASP . 51.2 pttt -123.34 148.88 45.56 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.813 -0.227 . . . . 0.0 110.906 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.9 -140.52 10.08 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.615 ' HA ' HG12 ' A' ' 14' ' ' VAL . 4.2 p90 -80.29 10.83 4.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.849 0.459 . . . . 0.0 112.209 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.87 -38.82 19.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.485 ' CB ' ' HD2' ' A' ' 9' ' ' LYS . 24.4 t70 -70.57 -35.46 73.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.338 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.695 HG13 ' HB2' ' A' ' 53' ' ' ALA . 2.5 p -71.58 -42.81 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.499 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.82 -37.53 76.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.237 0.541 . . . . 0.0 109.859 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.3 m -67.83 -46.08 72.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.122 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -78.22 -20.8 51.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.513 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.578 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -69.74 -29.2 66.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.841 0.353 . . . . 0.0 110.397 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -61.68 -23.4 66.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.492 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m -80.49 -44.29 19.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -53.53 -40.76 65.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.29 0.567 . . . . 0.0 111.295 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.615 HD12 HG11 ' A' ' 73' ' ' VAL . 19.3 mm -72.82 -14.3 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.477 -176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -75.88 -75.93 0.17 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 26' ' ' GLU . 5.5 t -119.39 -31.87 4.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.951 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 26' ' ' GLU . . . 10.31 -41.01 0.0 OUTLIER Glycine 0 C--N 1.354 1.576 0 C-N-CA 129.745 3.545 . . . . 0.0 119.558 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 24' ' ' SER . 2.0 pt-20 111.79 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.834 2.054 . . . . 0.0 107.949 -162.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 32.4 tp -112.79 58.5 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.467 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.54 166.34 14.89 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.758 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 7.6 Cg_exo -74.01 121.25 6.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 120.948 1.098 . . . . 0.0 110.428 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.3 -6.48 12.93 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.673 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -108.65 158.7 17.35 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.823 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 6.3 m -94.35 148.47 22.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.734 0.302 . . . . 0.0 111.287 -172.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.3 mp -54.79 135.72 65.15 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.712 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HG2' HD11 ' A' ' 39' ' ' ILE . 72.7 Cg_endo -78.38 171.3 17.12 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.222 2.614 . . . . 0.0 112.051 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -72.31 156.94 38.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.414 ' HA ' HD13 ' A' ' 39' ' ' ILE . 27.3 m -54.98 -21.58 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 122.707 0.403 . . . . 0.0 112.066 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.15 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.8 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.38 -51.09 67.3 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 109.798 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.774 HG21 ' HB ' ' A' ' 50' ' ' VAL . 4.8 mp -56.96 -50.17 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.269 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.907 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . 63.0 ttt180 -44.71 -33.57 1.91 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.38 -33.89 13.68 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.926 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -75.14 -44.94 44.14 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.806 0.812 . . . . 0.0 109.052 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.907 ' CE1' ' HA ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -89.45 119.72 30.14 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 172.322 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.68 ' HA2' ' HB3' ' A' ' 4' ' ' LYS . . . -73.51 53.62 1.96 Allowed Glycine 0 C--N 1.302 -1.321 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.675 ' HA ' ' HB3' ' A' ' 6' ' ' PRO . 1.8 t -136.38 170.58 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -161.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' O ' ' CZ ' ' A' ' 43' ' ' PHE . . . -78.49 152.16 32.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.29 40.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.144 0.497 . . . . 0.0 110.9 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 5.4 tmmm? -92.61 -24.22 18.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.789 171.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 11' ' ' TYR . 4.1 m -69.34 -27.9 65.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.774 ' HB ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -61.59 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.624 ' HA ' HD12 ' A' ' 54' ' ' LEU . 32.3 t -63.5 -14.37 50.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.252 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 5.6 mmp_? -81.03 -58.17 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.683 0.278 . . . . 0.0 110.258 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.695 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -63.75 -25.41 68.18 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 41.4 mt -49.08 -38.91 25.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -18.93 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.988 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.06 -28.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.544 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.965 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -72.58 -1.93 17.94 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.988 -173.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 57.7 pttt -66.69 -42.35 86.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 78' ' ' ILE . 2.8 m -94.77 -36.17 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.003 0.906 . . . . 0.0 109.24 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 11.1 tp10 -83.95 -66.07 0.94 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.032 -169.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.965 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -83.29 1.18 89.12 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.635 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.865 HD21 HG13 ' A' ' 78' ' ' ILE . 20.7 mt 73.2 37.27 0.76 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 172.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 58' ' ' LYS . 8.4 p -113.15 150.16 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.739 -0.6 . . . . 0.0 111.332 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.834 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 31.8 t -148.32 145.28 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.385 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -67.9 106.8 2.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 7.0 ttm180 -114.3 97.38 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.996 -176.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.69 50.51 2.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.311 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.23 -63.89 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' HB2' HG21 ' A' ' 72' ' ' VAL . 71.0 mt -91.2 -14.36 31.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.543 176.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 114.11 -160.98 12.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.896 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.806 HG23 ' HB2' ' A' ' 33' ' ' LEU . 6.4 t -78.78 81.81 5.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.427 1.108 . . . . 0.0 109.611 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.823 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 38.5 t -92.94 141.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.671 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.615 HG11 HD12 ' A' ' 22' ' ' ILE . 4.5 t -88.22 75.67 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.815 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -146.56 80.31 1.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.737 158.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.834 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 88.2 tttt -98.85 -85.59 0.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.196 0.998 . . . . 0.0 111.745 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.421 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 5.9 t-20 -130.23 95.13 28.51 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.88 -165.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.437 ' HA ' HD22 ' A' ' 62' ' ' LEU . 84.1 Cg_exo -45.41 122.63 4.84 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.021 1.814 . . . . 0.0 111.059 175.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.865 HG13 HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -56.3 136.15 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -175.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 C--N 1.32 -0.687 0 O-C-N 124.395 1.059 . . . . 0.0 111.697 179.221 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.5 p90 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.657 ' HD3' ' H ' ' A' ' 44' ' ' GLY . 58.0 tttp -104.92 145.26 30.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.757 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 163.24 20.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.596 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 10.1 Cg_exo -76.08 96.24 1.06 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.121 1.88 . . . . 0.0 112.18 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.582 ' N ' ' HE3' ' A' ' 9' ' ' LYS . 1.8 mp0 -63.89 -65.38 0.69 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.18 54.1 0.31 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.039 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.792 ' HG3' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -123.42 164.98 17.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.918 0.389 . . . . 0.0 110.716 -176.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.39 -143.54 10.56 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.63 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 3.0 p90 -70.87 2.34 4.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.409 . . . . 0.0 111.524 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.26 54.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.569 . . . . 0.0 110.207 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.792 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 2.5 t70 -73.99 -47.99 33.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.778 HG13 HG11 ' A' ' 45' ' ' VAL . 33.0 m -70.22 -31.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.407 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.64 -45.15 89.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.253 0.549 . . . . 0.0 109.656 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -68.43 -34.43 75.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.704 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.692 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 45.0 t-80 -52.87 -54.38 35.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.954 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.429 ' CG ' HD13 ' A' ' 57' ' ' LEU . 5.7 m-85 -68.03 -40.17 82.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.811 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -60.88 -27.43 68.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.841 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.455 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 37.9 m -80.06 -36.01 36.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 0.0 109.95 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.892 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 68.8 mt -70.86 -44.81 65.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.223 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 61' ' ' GLY . 49.2 mm -68.69 -21.8 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.457 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 22.6 ttmm -56.78 -63.73 1.11 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.798 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -114.29 -33.16 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.8 -29.67 0.03 OUTLIER Glycine 0 CA--C 1.511 -0.177 0 C-N-CA 118.666 -1.731 . . . . 0.0 114.538 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.2 -57.57 12.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -164.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 tp -98.44 89.19 4.35 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.42 153.79 65.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.479 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 63.4 Cg_endo -77.31 137.63 17.04 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.102 1.868 . . . . 0.0 112.092 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.91 -24.99 9.14 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.007 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.41 161.85 14.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -79.03 161.23 26.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.731 0.3 . . . . 0.0 111.355 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.4 145.64 98.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.332 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.403 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 74.2 Cg_endo -78.11 171.49 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.826 2.351 . . . . 0.0 112.507 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.8 p -79.27 159.59 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.06 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.475 ' HA ' HD13 ' A' ' 39' ' ' ILE . 25.2 m -54.01 -26.25 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.9 82.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.131 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 16.6 m-20 -70.33 -29.66 66.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 110.297 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.692 ' HA ' ' CE1' ' A' ' 17' ' ' HIS . 3.7 mp -75.48 -49.94 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.244 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 22.0 ttm180 -66.93 -46.95 73.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.12 75.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 0.0 110.955 -170.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -84.39 -65.96 0.95 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.175 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.433 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 18.8 m-85 -93.48 102.12 14.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.269 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.657 ' H ' ' HD3' ' A' ' 4' ' ' LYS . . . -57.37 99.56 0.1 Allowed Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.624 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.778 HG11 HG13 ' A' ' 14' ' ' VAL . 19.4 m -140.73 179.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.115 0.483 . . . . 0.0 111.384 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -97.89 176.35 5.82 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.44 52.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.79 0.329 . . . . 0.0 110.748 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -79.16 -29.72 43.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 109.955 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.8 m -63.69 -43.58 96.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.539 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.674 ' HA ' HG11 ' A' ' 14' ' ' VAL . 96.4 t -55.81 -58.86 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.782 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.698 ' HA ' HD12 ' A' ' 54' ' ' LEU . 26.0 t -68.37 -6.41 24.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.871 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.462 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 4.6 tpm_? -77.74 -50.67 11.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.542 0.211 . . . . 0.0 110.678 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.756 ' HB3' HG23 ' A' ' 14' ' ' VAL . . . -90.74 -9.89 45.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 51' ' ' SER . 95.5 mt -51.6 -31.06 23.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.825 0.284 . . . . 0.0 111.486 174.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.845 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 44.2 t -80.73 -30.39 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.742 0.782 . . . . 0.0 109.514 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.64 HD21 ' HA ' ' A' ' 15' ' ' ALA . 86.9 mt -76.06 1.27 15.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.632 -173.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -66.04 -56.45 11.5 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.4 p -93.57 -34.43 13.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.481 0.657 . . . . 0.0 110.356 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.4 tp10 -77.07 -52.14 9.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.722 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.59 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -90.52 -7.4 67.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.977 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp 63.04 66.7 0.72 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.812 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 57' ' ' LEU . 31.1 m -136.14 162.49 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.681 175.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.8 m -144.59 128.5 17.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.139 0.495 . . . . 0.0 111.372 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -78.53 92.76 4.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.535 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 9.9 tpt180 -85.45 101.87 12.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.92 50.66 2.28 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.647 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.87 -60.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.05 -16.23 44.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.434 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 109.53 178.42 21.21 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.666 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.66 99.26 3.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 19.5 m -117.61 159.94 17.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 111.417 -170.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 22.3 t -85.68 93.82 3.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.789 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' A' ' 72' ' ' VAL . 31.2 mt-10 -102.64 151.3 22.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.679 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 57.6 mtpt -68.51 88.55 0.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -94.75 96.04 1.76 Allowed Pre-proline 0 CA--C 1.503 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 50.8 Cg_exo -56.39 151.34 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.216 1.944 . . . . 0.0 112.405 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -55.7 105.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.052 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 t . . . . . 0 C--N 1.32 -0.703 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.642 -179.589 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 121.026 0.441 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -85.05 134.88 34.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.958 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -96.35 150.05 36.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.451 0.167 . . . . 0.0 111.182 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 6.2 Cg_exo -78.59 118.45 4.21 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.067 2.512 . . . . 0.0 111.681 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -99.66 -74.41 0.6 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.707 -175.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.96 29.52 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.405 -176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -116.61 156.66 26.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.09 -107.7 2.66 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.898 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -95.85 -12.25 25.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 174.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.51 9.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.501 0.667 . . . . 0.0 111.141 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.488 ' OD1' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -91.14 -52.8 4.65 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.388 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.679 HG13 HH22 ' A' ' 52' ' ' ARG . 2.0 m -68.74 -34.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.642 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.63 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -55.73 -44.71 77.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.64 170.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -64.57 -39.11 93.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 22.9 t60 -57.62 -48.01 80.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.471 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.37 -40.31 85.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.192 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -56.66 -27.57 58.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.588 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 m -85.33 -54.02 4.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.802 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . 3.3 pp -75.64 -12.04 60.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.554 -172.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.02 -41.48 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 110.452 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -92.9 -13.34 29.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.218 0.533 . . . . 0.0 110.513 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.775 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 23.0 t -86.54 26.79 1.03 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.317 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.15 25.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.2 mt-10 -69.79 -34.98 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HG ' HD13 ' A' ' 21' ' ' LEU . 61.0 mt -122.9 92.1 3.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.526 166.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.05 54.63 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.751 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 5.8 Cg_exo -75.19 123.47 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.669 1.579 . . . . 0.0 110.691 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.35 27.89 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.43 163.5 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 1.007 ' HB ' HG23 ' A' ' 71' ' ' THR . 6.7 t -107.88 161.9 14.5 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -172.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.795 HD11 ' HB ' ' A' ' 63' ' ' VAL . 4.2 mp -57.52 109.69 1.95 Allowed Pre-proline 0 N--CA 1.432 -1.357 0 CA-C-N 111.196 -2.729 . . . . 0.0 108.435 167.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.95 175.41 10.87 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 123.359 2.706 . . . . 0.0 113.225 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -64.69 158.12 25.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.49 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.31 -19.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.02 -52.99 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.21 -53.42 58.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.375 0.607 . . . . 0.0 111.08 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.782 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -56.05 -53.66 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.652 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 43.8 ttp180 -65.6 -40.03 92.22 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.79 -46.23 25.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -75.84 -56.45 4.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.938 0.399 . . . . 0.0 110.673 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.471 ' O ' HG22 ' A' ' 45' ' ' VAL . 5.2 m-85 -91.81 103.99 16.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.795 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.79 86.31 0.01 OUTLIER Glycine 0 CA--C 1.516 0.111 0 O-C-N 124.642 1.214 . . . . 0.0 114.459 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 43' ' ' PHE . 33.6 m -137.77 177.38 5.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -97.17 178.89 5.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.57 -33.11 58.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.096 0.474 . . . . 0.0 109.973 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.966 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -68.49 -36.79 79.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 175.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.813 HG22 ' HE ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -65.18 -53.3 46.88 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 46' ' ' ALA . 92.0 t -41.25 -52.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.596 -0.69 . . . . 0.0 111.189 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.646 ' HA ' HD12 ' A' ' 54' ' ' LEU . 47.9 t -60.75 -34.07 73.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.063 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.898 ' CZ ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -72.25 -31.31 65.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.548 -169.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.664 ' N ' ' HD2' ' A' ' 52' ' ' ARG . . . -91.12 -5.37 55.18 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.671 -0.643 . . . . 0.0 111.807 173.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 51' ' ' SER . 44.5 mt -57.88 -35.05 70.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.708 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.16 -18.16 64.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.009 176.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 60' ' ' GLU . 34.3 t -90.46 -29.22 4.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.63 HD11 ' HA ' ' A' ' 15' ' ' ALA . 1.2 mp -73.85 2.89 7.48 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.251 -174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.97 -41.8 20.29 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' A' ' 78' ' ' ILE . 15.7 m -94.04 -41.68 9.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.773 0.797 . . . . 0.0 109.887 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.509 ' HB3' HG12 ' A' ' 56' ' ' VAL . 39.0 tp10 -89.6 -34.49 16.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.809 -175.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -90.72 -10.3 63.35 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.561 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 11.2 mp 79.36 12.78 1.19 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.795 ' HB ' HD11 ' A' ' 33' ' ' LEU . 9.3 m -100.91 154.62 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.647 -0.658 . . . . 0.0 109.5 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -128.28 179.01 5.86 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.611 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -52.47 122.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.829 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HA ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -64.94 163.93 13.57 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.374 -168.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.79 -67.45 1.43 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.683 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.448 ' H ' ' H ' ' A' ' 69' ' ' LEU . . . -160.71 -16.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.711 0.767 . . . . 0.0 109.504 168.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' H ' ' H ' ' A' ' 68' ' ' ALA . 2.5 mm? -93.64 -39.21 10.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.404 -170.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.696 ' N ' ' HG3' ' A' ' 66' ' ' ARG . . . 143.33 -5.04 1.83 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.706 -166.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 1.007 HG23 ' HB ' ' A' ' 32' ' ' THR . 89.0 m -97.52 92.86 6.13 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.806 HG23 ' HA ' ' A' ' 66' ' ' ARG . 90.8 t -151.52 96.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 123.852 0.72 . . . . 0.0 112.095 156.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 60.5 t -89.07 130.38 38.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 159.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 29' ' ' PRO . 40.1 mt-10 -133.39 165.14 25.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HA ' HD23 ' A' ' 62' ' ' LEU . 52.0 tttm -84.87 49.01 1.64 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 166.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -118.95 91.9 44.02 Favored Pre-proline 0 CA--C 1.515 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.477 -170.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.25 115.9 4.04 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.821 1.681 . . . . 0.0 109.473 171.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.461 ' H ' ' HA ' ' A' ' 59' ' ' SER . 19.1 mt -70.74 100.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.984 -176.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.47 0.553 0 O-C-N 124.728 1.268 . . . . 0.0 111.335 177.836 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.3 t80 . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.81 117.88 24.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.851 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.1 167.44 21.61 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.427 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.48 92.09 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.339 2.026 . . . . 0.0 110.804 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 9.3 pt-20 -71.39 73.31 0.71 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.905 -176.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.83 16.55 68.31 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.67 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.509 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 60.1 pttt -124.25 147.63 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.541 0.21 . . . . 0.0 110.456 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.1 -137.69 7.18 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.13 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.402 ' HA ' HG22 ' A' ' 49' ' ' THR . 11.1 p90 -68.48 -9.55 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.789 0.328 . . . . 0.0 111.81 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.47 -17.44 56.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.849 0.357 . . . . 0.0 110.516 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 15.5 t70 -74.36 -51.56 14.74 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.909 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.621 HG23 ' HB2' ' A' ' 53' ' ' ALA . 2.2 m -68.86 -33.7 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.72 63.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.966 0.413 . . . . 0.0 110.578 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -74.16 -37.04 64.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.21 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -68.13 -36.41 79.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CG ' HD21 ' A' ' 57' ' ' LEU . 5.2 m-85 -65.05 -44.28 89.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 0.0 110.14 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.624 ' HG2' ' HA2' ' A' ' 61' ' ' GLY . 73.8 mtp180 -53.11 -26.38 16.29 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.281 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.63 HG22 ' HB2' ' A' ' 24' ' ' SER . 13.1 m -88.53 -54.78 4.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.685 HD12 ' HA3' ' A' ' 25' ' ' GLY . 1.1 tp -52.55 -26.63 13.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.608 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 23' ' ' LYS . 1.3 mp -50.03 -58.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.688 0.28 . . . . 0.0 110.421 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.442 ' N ' HG22 ' A' ' 22' ' ' ILE . 16.5 ptpt -94.46 -29.54 14.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.63 ' HB2' HG22 ' A' ' 20' ' ' THR . 38.9 m -102.47 28.66 5.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.285 -171.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.685 ' HA3' HD12 ' A' ' 21' ' ' LEU . . . -165.1 20.57 0.12 Allowed Glycine 0 CA--C 1.505 -0.544 0 C-N-CA 119.37 -1.395 . . . . 0.0 112.239 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 64.92 10.35 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.56 -0.82 . . . . 0.0 112.852 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.62 HD12 HD21 ' A' ' 21' ' ' LEU . 23.2 mt -84.2 59.15 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 160.46 28.42 Favored Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 6.5 Cg_exo -75.09 136.77 20.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.944 1.763 . . . . 0.0 112.322 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.95 -17.75 11.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.717 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -95.55 159.89 14.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.606 HG22 HG12 ' A' ' 72' ' ' VAL . 36.8 p -78.66 165.06 24.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.636 0.255 . . . . 0.0 111.137 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.86 141.6 98.39 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 171.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.53 ' HG2' HD11 ' A' ' 39' ' ' ILE . 57.0 Cg_endo -77.71 163.86 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.379 2.052 . . . . 0.0 111.669 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 m -65.81 140.31 58.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.456 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.599 ' HA ' HD13 ' A' ' 39' ' ' ILE . 31.0 m -52.07 -27.19 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.81 86.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -66.67 -48.8 68.2 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.283 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -55.02 -50.76 60.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.257 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 19.9 ptt180 -81.17 -9.75 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -173.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.01 -38.66 17.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.721 0.296 . . . . 0.0 110.282 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.666 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.1 OUTLIER -87.99 -59.13 2.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.637 0.732 . . . . 0.0 110.09 177.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 45' ' ' VAL . 21.0 m-85 -90.23 81.85 6.07 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.416 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.412 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . -39.56 92.67 0.01 OUTLIER Glycine 0 CA--C 1.523 0.564 0 O-C-N 124.613 1.196 . . . . 0.0 115.274 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 14.7 m -139.01 178.71 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' OG1' ' A' ' 49' ' ' THR . . . -87.19 -175.02 5.15 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.8 51.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.372 . . . . 0.0 111.246 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -90.24 -22.32 21.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.521 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.675 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.5 m -64.16 -35.34 80.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.539 -174.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG13 HG21 ' A' ' 39' ' ' ILE . 65.1 t -56.17 -59.1 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.331 0.586 . . . . 0.0 110.571 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.606 ' HA ' HD12 ' A' ' 54' ' ' LEU . 42.1 t -66.14 -14.26 61.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.815 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -77.17 -40.53 45.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 109.847 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.621 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -74.17 -30.67 62.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.562 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 51' ' ' SER . 83.9 mt -51.92 -30.39 24.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.613 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . . . -68.59 -24.43 64.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.962 0.41 . . . . 0.0 111.096 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.93 -23.8 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.734 0.778 . . . . 0.0 109.448 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.694 ' HG ' ' HA3' ' A' ' 61' ' ' GLY . 4.5 mp -68.67 -19.49 64.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.019 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 55' ' ' ALA . 73.8 mttt -54.42 -59.23 4.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.166 0.508 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -93.02 -41.24 10.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.95 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.492 ' HG2' ' HD2' ' A' ' 19' ' ' ARG . 23.4 tt0 -93.2 -55.79 3.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.966 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.694 ' HA3' ' HG ' ' A' ' 57' ' ' LEU . . . -75.31 -10.23 84.38 Favored Glycine 0 N--CA 1.461 0.302 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.814 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.968 HD21 HG13 ' A' ' 78' ' ' ILE . 7.7 mt 69.74 80.33 0.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.686 0.755 . . . . 0.0 111.966 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.444 HG12 ' C ' ' A' ' 57' ' ' LEU . 9.0 p -140.32 161.29 25.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.2 m -141.77 102.23 4.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.215 0.531 . . . . 0.0 111.171 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 9.4 m -72.37 86.53 1.13 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 34.2 mmt180 -68.93 125.25 26.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.692 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.97 -9.0 87.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.925 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.54 -45.37 4.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.863 0.363 . . . . 0.0 110.999 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.34 -18.04 29.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.389 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 102.38 172.87 27.18 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 2.7 m -72.06 103.86 3.4 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.606 HG12 HG22 ' A' ' 32' ' ' THR . 23.1 m -121.96 169.5 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.238 -172.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 31.5 t -93.23 114.15 29.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.222 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.572 ' HG2' HG23 ' A' ' 72' ' ' VAL . 6.0 mm-40 -126.31 146.79 49.88 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -72.93 77.87 1.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 173.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.49 ' O ' HD22 ' A' ' 62' ' ' LEU . 59.9 t30 -64.65 132.69 95.49 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.05 113.97 1.71 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.076 1.184 . . . . 0.0 110.35 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.968 HG13 HD21 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -64.09 127.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 172.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.322 -0.606 0 O-C-N 124.056 0.847 . . . . 0.0 110.638 178.256 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.573 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 6.3 p90 . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -93.36 137.99 32.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -78.63 146.65 69.78 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.132 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 2.7 Cg_exo -77.68 117.42 4.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.746 2.297 . . . . 0.0 112.622 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -86.95 -157.61 0.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.04 175.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 7' ' ' GLU . . . -74.58 60.46 2.45 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 44' ' ' GLY . 19.5 ptpt -122.53 178.37 5.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 0.0 110.249 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.27 -148.47 5.44 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.271 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -71.15 -10.68 60.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.65 -17.98 57.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 110.397 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' CB ' ' HD3' ' A' ' 9' ' ' LYS . 26.9 t70 -71.08 -45.97 62.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.388 175.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.673 HG23 HG11 ' A' ' 45' ' ' VAL . 72.0 t -59.9 -40.25 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.065 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.594 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -57.2 -43.57 82.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -61.33 -34.77 75.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.711 ' CD2' ' HA ' ' A' ' 39' ' ' ILE . 5.2 t60 -67.53 -44.93 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.102 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.604 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-85 -69.21 -46.47 67.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.984 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -61.01 -19.43 61.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -85.66 -51.15 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.967 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD13 HD13 ' A' ' 27' ' ' LEU . 3.9 pp -71.84 -21.83 61.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 18' ' ' PHE . 26.5 mm -61.12 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 110.739 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -85.11 1.19 48.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.231 0.538 . . . . 0.0 110.525 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.424 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 27.5 t -96.88 24.93 5.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.603 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 22.34 26.12 0.0 OUTLIER Glycine 0 N--CA 1.475 1.268 0 N-CA-C 117.374 1.71 . . . . 0.0 117.374 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 24' ' ' SER . 7.9 pt-20 -85.78 -34.66 21.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.672 HD21 ' HG3' ' A' ' 34' ' ' PRO . 9.9 mp -109.16 72.77 0.82 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 166.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.55 153.31 83.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.483 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.45 123.21 7.47 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.113 1.875 . . . . 0.0 111.284 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.55 -10.03 10.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.033 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.2 161.31 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.661 HG22 HG12 ' A' ' 72' ' ' VAL . 17.1 p -81.53 167.77 18.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.883 0.373 . . . . 0.0 111.478 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.803 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.4 mm? -65.12 140.08 97.87 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.336 175.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.672 ' HG3' HD21 ' A' ' 27' ' ' LEU . 57.3 Cg_endo -76.95 165.56 28.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.598 2.199 . . . . 0.0 111.565 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -74.08 156.09 37.81 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.0 m -52.48 -22.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.76 -52.57 64.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -58.16 -30.24 66.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.043 0.449 . . . . 0.0 110.974 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.711 ' HA ' ' CD2' ' A' ' 17' ' ' HIS . 4.3 mp -80.02 -59.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.519 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 33.5 ptt180 -79.03 -19.88 50.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -166.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . . . -76.69 -39.76 51.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.396 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -78.71 -62.07 1.81 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.708 . . . . 0.0 109.206 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 9.7 m-85 -92.17 105.1 17.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.956 176.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' A' ' 9' ' ' LYS . . . -60.41 91.56 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.157 0 CA-C-N 115.225 -0.898 . . . . 0.0 114.0 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.673 HG11 HG23 ' A' ' 14' ' ' VAL . 17.6 m -134.82 178.31 5.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -94.98 -170.55 2.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.09 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -76.21 -22.71 54.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.647 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -65.68 -42.05 91.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 110.158 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HA ' HG21 ' A' ' 14' ' ' VAL . 99.1 t -59.48 -55.84 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.715 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 54' ' ' LEU . 29.7 t -66.9 -12.11 58.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.675 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -82.4 -36.13 27.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.038 0.446 . . . . 0.0 110.223 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' HD13 ' A' ' 57' ' ' LEU . . . -74.3 -29.85 61.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.277 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 83.7 mt -49.28 -32.26 10.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.62 -28.63 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.076 0.465 . . . . 0.0 111.355 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.27 -25.16 5.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.877 0.846 . . . . 0.0 109.76 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.706 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -76.48 -5.04 45.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.46 -175.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -66.02 -40.11 90.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 p -93.14 -53.8 3.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.573 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -81.35 -38.32 26.87 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -172.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.706 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -90.49 -3.56 71.65 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.489 -174.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.689 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 10.1 mp 57.85 57.08 4.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.084 0.469 . . . . 0.0 111.808 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 57' ' ' LEU . 33.7 m -124.57 161.39 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.1 t -130.56 143.56 50.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.064 0.459 . . . . 0.0 111.337 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 p -82.78 103.04 11.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 12.1 tpp180 -118.43 48.43 1.43 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.3 4.12 2.07 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.978 -169.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.0 -47.02 21.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.05 -62.1 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 175.1 171.31 39.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.146 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.803 HG23 ' HB2' ' A' ' 33' ' ' LEU . 4.9 t -70.0 134.71 48.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 -174.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.661 HG12 HG22 ' A' ' 32' ' ' THR . 34.3 m -131.47 162.51 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.311 -171.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -99.15 113.58 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -123.58 144.34 49.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -69.18 78.67 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.438 0.461 . . . . 0.0 110.858 -174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 18.2 m-80 -73.6 116.54 52.54 Favored Pre-proline 0 CA--C 1.517 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.365 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.56 116.92 4.34 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.785 2.323 . . . . 0.0 111.264 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.618 HD11 HD11 ' A' ' 62' ' ' LEU . 1.2 mp -79.89 103.35 6.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.241 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.64 0.733 . . . . 0.0 110.374 179.609 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.233 0.222 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.47 115.28 12.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.305 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.6 99.43 52.8 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -99.29 172.08 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.669 2.913 . . . . 0.0 111.731 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 157.52 46.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.23 -10.09 43.02 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -108.84 167.27 10.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -146.13 6.69 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.297 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.57 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 4.6 p90 -71.92 -4.53 28.85 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.038 0.446 . . . . 0.0 110.373 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.29 -12.83 60.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.864 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.71 -60.99 1.96 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG13 HG11 ' A' ' 45' ' ' VAL . 35.6 m -67.05 -29.32 45.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.486 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.72 -39.63 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.226 0.536 . . . . 0.0 110.455 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 m -83.41 -39.23 20.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.443 ' HB3' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-70 -70.43 -20.41 62.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.761 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.476 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.4 m-85 -77.02 -25.66 52.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 111.239 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 19' ' ' ARG . 24.0 mmm180 -70.96 -20.06 62.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.652 0.263 . . . . 0.0 111.377 -177.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -13.59 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.502 . . . . 0.0 110.453 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.714 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 82.7 mt -85.5 -47.16 10.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.918 175.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 18' ' ' PHE . 17.5 mm -75.65 2.23 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.743 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HD2' ' HB2' ' A' ' 24' ' ' SER . 4.8 tmmt? -61.09 -81.04 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.526 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.51 ' HB2' ' HD2' ' A' ' 23' ' ' LYS . 11.1 t -119.67 -31.7 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 118.732 -1.187 . . . . 0.0 113.809 -171.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.22 -20.9 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.065 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.714 ' HB2' ' HA ' ' A' ' 21' ' ' LEU . 33.2 mp0 -45.32 -45.44 12.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.729 0.812 . . . . 0.0 110.927 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.676 ' HG ' HG21 ' A' ' 73' ' ' VAL . 23.0 tp -133.87 91.03 2.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.4 152.29 89.92 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.185 -169.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 5.2 Cg_exo -76.81 129.39 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.005 2.47 . . . . 0.0 111.213 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.3 -15.43 17.99 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -95.7 162.08 13.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 72' ' ' VAL . 25.2 p -81.95 160.83 23.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.432 0.158 . . . . 0.0 110.705 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HB2' HG23 ' A' ' 71' ' ' THR . 10.9 mt -66.36 139.05 96.08 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.32 157.56 33.21 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.223 1.948 . . . . 0.0 111.834 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.8 t -69.31 155.36 40.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.6 m -54.85 -15.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.13 81.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.582 0.229 . . . . 0.0 111.404 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.96 -39.42 87.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 -176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.609 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.5 mp -66.3 -57.04 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.91 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 8.6 ttp180 -62.71 -31.27 72.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -170.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.65 -41.68 17.51 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.967 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -81.57 -50.47 9.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.401 0.62 . . . . 0.0 109.56 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 45' ' ' VAL . 5.4 m-85 -92.07 101.9 14.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.355 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.433 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . -52.67 92.42 0.01 OUTLIER Glycine 0 CA--C 1.518 0.27 0 O-C-N 123.587 0.554 . . . . 0.0 113.865 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.777 HG11 HG13 ' A' ' 14' ' ' VAL . 17.6 m -146.85 178.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 123.042 0.537 . . . . 0.0 109.725 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.53 -174.99 3.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 -36.31 57.05 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.689 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -84.06 -15.11 48.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.94 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.697 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.9 m -68.5 -39.46 81.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 39' ' ' ILE . 52.3 t -57.5 -58.29 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.314 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 54' ' ' LEU . 24.8 t -59.38 -17.45 30.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.237 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 74.7 ttt180 -79.8 -44.6 20.3 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.377 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 14' ' ' VAL . . . -79.68 -15.64 57.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.577 HD23 HD12 ' A' ' 57' ' ' LEU . 69.6 mt -48.64 -33.79 10.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.728 0.299 . . . . 0.0 111.407 174.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.493 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.17 -38.2 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.965 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.07 -28.56 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.45 0.643 . . . . 0.0 109.994 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.577 HD12 HD23 ' A' ' 54' ' ' LEU . 69.6 mt -73.28 -15.64 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.283 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 55' ' ' ALA . 49.2 mtmt -66.51 -48.13 70.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.338 0.59 . . . . 0.0 110.007 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -90.61 -54.88 3.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.649 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.34 -31.64 15.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.0 -169.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 57' ' ' LEU . . . -78.43 -29.48 52.77 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.128 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 77' ' ' PRO . 22.6 mt 75.16 80.05 0.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.159 0.984 . . . . 0.0 111.39 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 57' ' ' LEU . 36.0 m -145.92 172.85 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.174 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.0 m -146.6 116.21 7.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.39 0.614 . . . . 0.0 110.943 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.753 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 38.0 t -84.33 105.41 15.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.875 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.548 ' HD3' ' OE2' ' A' ' 74' ' ' GLU . 15.1 mmm-85 -83.79 119.14 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.39 34.7 1.34 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.127 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.25 -68.3 0.21 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -69.92 -31.53 69.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.347 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.81 172.1 13.22 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 9.0 t -78.55 120.58 23.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.315 0.579 . . . . 0.0 109.441 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.613 HG12 HG22 ' A' ' 32' ' ' THR . 33.6 m -126.05 170.72 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.277 0.56 . . . . 0.0 111.387 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.676 HG21 ' HG ' ' A' ' 27' ' ' LEU . 29.4 t -93.87 120.42 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.131 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 66' ' ' ARG . 48.6 mt-10 -131.57 158.87 39.84 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.061 0.457 . . . . 0.0 110.95 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -79.22 38.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 74' ' ' GLU . 66.8 m-20 -123.95 84.23 54.83 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.561 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.508 ' HB3' HD22 ' A' ' 62' ' ' LEU . 10.0 Cg_endo -52.2 116.07 2.58 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.003 2.468 . . . . 0.0 110.472 166.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.0 mm -64.61 127.79 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-O 121.561 0.696 . . . . 0.0 109.807 177.018 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 96.0 m-85 . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -88.23 142.2 27.94 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.58 134.4 34.2 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 64.7 Cg_endo -78.14 111.48 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.339 2.026 . . . . 0.0 111.656 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -69.33 -77.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.039 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.11 -6.41 4.88 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.91 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.54 154.25 42.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.821 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.88 -135.27 3.68 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.81 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.597 ' HA ' HG12 ' A' ' 14' ' ' VAL . 3.0 p90 -74.24 -1.6 21.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.127 0.489 . . . . 0.0 111.011 -175.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.34 22.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.256 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.05 -36.65 13.91 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.64 0.733 . . . . 0.0 109.105 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.722 ' HB ' HG11 ' A' ' 45' ' ' VAL . 7.3 p -75.1 -32.6 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.856 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.67 -46.22 84.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.934 0.397 . . . . 0.0 110.681 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -71.46 -27.89 63.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.875 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -74.34 -20.84 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.834 0.35 . . . . 0.0 110.883 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.0 -24.07 65.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.886 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.1 m -75.27 -28.11 59.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.316 0.579 . . . . 0.0 110.038 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.038 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 67.5 mt -78.96 -28.84 43.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.87 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 tp -90.29 -7.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.364 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.06 -79.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 26' ' ' GLU . 8.5 t -119.71 -34.62 3.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 159.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.038 ' HA3' ' HA ' ' A' ' 21' ' ' LEU . . . 18.12 22.46 0.0 OUTLIER Glycine 0 C--N 1.354 1.561 0 C-N-CA 127.949 2.69 . . . . 0.0 118.652 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' SER . 33.0 mt-10 59.53 9.79 1.66 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 117.413 0.606 . . . . 0.0 111.225 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 21' ' ' LEU . 8.3 mp -129.64 34.2 4.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.07 166.28 2.15 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.137 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 10.7 Cg_exo -73.53 123.81 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.744 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.03 5.5 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.929 -172.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -104.37 164.07 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.689 HG22 HG12 ' A' ' 72' ' ' VAL . 2.7 p -97.38 153.23 18.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.65 0.262 . . . . 0.0 110.953 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 10.5 mp -72.42 120.0 78.08 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 111.881 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.51 6.69 5.48 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 123.284 2.656 . . . . 0.0 111.871 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 1.127 ' HA ' HD13 ' A' ' 39' ' ' ILE . 5.7 p -79.04 59.15 2.61 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -160.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 37' ' ' ALA . 2.4 m -100.87 -58.05 4.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.614 1.197 . . . . 0.0 110.008 142.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' H ' HG23 ' A' ' 36' ' ' VAL . . . -89.32 -58.98 2.34 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.924 -166.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.65 -30.49 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.401 -174.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.127 HD13 ' HA ' ' A' ' 35' ' ' SER . 1.8 mp -86.1 -56.07 5.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.03 -173.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 4.2 ptm180 -66.01 -18.62 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.826 -172.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . . . -67.99 -57.53 6.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.513 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -81.16 -51.86 7.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.846 0.831 . . . . 0.0 110.065 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.702 ' HD2' HG23 ' A' ' 39' ' ' ILE . 4.8 m-85 -89.8 83.11 6.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.867 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.46 88.17 0.01 OUTLIER Glycine 0 N--CA 1.462 0.419 0 O-C-N 125.002 1.439 . . . . 0.0 115.182 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.722 HG11 ' HB ' ' A' ' 14' ' ' VAL . 17.4 m -142.02 178.11 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB3' ' OG1' ' A' ' 49' ' ' THR . . . -89.08 -175.12 4.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.83 -35.17 51.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.277 0.56 . . . . 0.0 110.645 -174.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.924 ' HE2' ' HA ' ' A' ' 48' ' ' LYS . 10.5 mmpt? -85.12 -13.05 51.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.678 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.689 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 m -71.95 -40.07 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.678 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG13 HG21 ' A' ' 39' ' ' ILE . 48.7 t -55.16 -57.01 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.396 0.617 . . . . 0.0 110.375 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.708 ' HA ' HD12 ' A' ' 54' ' ' LEU . 36.0 t -64.16 -14.06 52.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.639 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 16.2 tpp180 -78.28 -44.14 26.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -66.58 -33.4 75.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.881 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 51' ' ' SER . 69.1 mt -53.56 -31.33 46.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.628 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.534 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.6 -26.34 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.078 0.466 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.55 -29.98 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.647 0.737 . . . . 0.0 109.669 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -74.03 -13.8 60.91 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.624 -173.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.534 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 62.2 pttt -64.53 -36.69 85.04 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.602 173.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.701 ' HA ' HG13 ' A' ' 78' ' ' ILE . 6.1 m -93.09 -53.48 4.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.284 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -88.37 -31.02 19.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.005 -170.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.548 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.43 -12.52 59.64 Favored Glycine 0 C--O 1.229 -0.216 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.922 -176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp 63.49 52.43 2.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.874 0.368 . . . . 0.0 111.707 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.82 164.2 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.68 ' HB3' HG23 ' A' ' 72' ' ' VAL . 22.6 t -117.17 105.2 11.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.184 0.516 . . . . 0.0 110.608 -174.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.2 m -81.39 71.38 8.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 20.9 tpp180 -75.77 96.46 3.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.313 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.15 49.47 3.54 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.001 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.23 -47.26 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.96 -44.66 10.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.093 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 138.06 -177.6 19.87 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.692 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 33' ' ' LEU . 17.7 p -75.01 106.66 6.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.968 0.413 . . . . 0.0 110.466 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.689 HG12 HG22 ' A' ' 32' ' ' THR . 18.2 m -123.05 150.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.101 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 27' ' ' LEU . 17.5 t -92.57 105.18 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -126.45 135.54 51.5 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 20.8 pttm -66.63 92.73 0.22 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.503 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 19.8 m-80 -90.35 110.86 43.78 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.056 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 76' ' ' ASN . 28.0 Cg_endo -62.64 115.38 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.021 1.814 . . . . 0.0 109.703 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.701 HG13 ' HA ' ' A' ' 59' ' ' SER . 13.1 mm -95.68 117.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.078 0.466 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 113.682 -1.599 . . . . 0.0 111.658 -177.151 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.612 0.244 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -88.67 93.14 9.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.184 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.8 117.33 66.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 68.2 Cg_endo -91.77 178.79 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.414 2.742 . . . . 0.0 112.544 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.41 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 3.1 mp0 -93.23 -89.45 0.21 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 7' ' ' GLU . . . -125.76 101.27 0.61 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -123.48 150.97 43.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.969 0.414 . . . . 0.0 110.875 -174.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.34 -145.29 14.94 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 170.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.673 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 2.0 p90 -80.17 23.47 0.47 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.769 0.318 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.57 -46.46 8.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.857 0.361 . . . . 0.0 111.567 -172.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -77.45 -26.58 51.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.45 0.643 . . . . 0.0 110.157 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.991 ' HB ' HG11 ' A' ' 45' ' ' VAL . 12.8 p -75.1 -26.09 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.257 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 19' ' ' ARG . . . -63.16 -34.79 78.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.498 ' HB ' ' CE2' ' A' ' 43' ' ' PHE . 10.3 m -60.02 -26.59 66.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.11 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 53.9 t-80 -56.12 -48.47 76.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.65 ' HE2' HD22 ' A' ' 33' ' ' LEU . 74.7 m-85 -83.21 -35.71 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.523 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 72.4 mtp180 -57.08 -32.63 66.47 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 110.635 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.6 m -79.13 -55.55 5.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.827 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 HD13 HD22 ' A' ' 27' ' ' LEU . 31.1 mt -48.88 -46.91 43.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 61' ' ' GLY . 1.8 mp -68.97 -43.25 82.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -86.26 -7.07 58.79 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.454 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.2 p -105.23 17.53 23.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.54 27.49 0.0 OUTLIER Glycine 0 N--CA 1.469 0.88 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -169.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.07 -32.3 71.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 21' ' ' LEU . 22.7 tp -102.95 95.58 6.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.52 153.92 95.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.518 -170.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.24 126.68 8.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.654 2.236 . . . . 0.0 110.914 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.45 -6.24 33.76 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -95.99 149.97 20.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.816 HG22 HG12 ' A' ' 72' ' ' VAL . 19.2 p -78.37 156.8 29.33 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.717 HD21 HG21 ' A' ' 63' ' ' VAL . 14.0 mt -60.63 139.39 92.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.814 172.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.06 168.13 25.53 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.336 2.024 . . . . 0.0 111.913 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.7 p -66.09 148.94 51.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.668 ' HA ' HD13 ' A' ' 39' ' ' ILE . 20.0 m -49.72 -28.11 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.306 0.378 . . . . 0.0 111.681 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.96 91.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.561 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.51 -23.67 63.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.668 HD13 ' HA ' ' A' ' 36' ' ' VAL . 3.8 mp -79.35 -55.67 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 7.1 ptm180 -77.64 -20.64 53.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.46 68.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.673 . . . . 0.0 110.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -83.16 -60.61 2.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.018 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 48.6 m-85 -92.54 99.06 11.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.777 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 6' ' ' PRO . . . -56.33 100.13 0.1 OUTLIER Glycine 0 CA--C 1.515 0.078 0 CA-C-N 115.299 -0.864 . . . . 0.0 114.044 -172.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.991 HG11 ' HB ' ' A' ' 14' ' ' VAL . 6.1 m -146.38 178.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 122.575 0.35 . . . . 0.0 110.141 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -90.92 175.15 7.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.8 -19.3 55.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.467 0.651 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 71.8 mmtt -74.36 -46.48 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.963 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.745 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.5 m -56.38 -43.06 78.84 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.833 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.755 ' HA ' HG21 ' A' ' 14' ' ' VAL . 93.5 t -52.83 -53.66 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.327 0.584 . . . . 0.0 110.95 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.566 ' HA ' HD12 ' A' ' 54' ' ' LEU . 23.2 t -70.48 -6.68 37.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.624 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 5.2 mmp_? -83.61 -47.05 11.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.122 -0.362 . . . . 0.0 110.293 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.518 ' CB ' HG13 ' A' ' 14' ' ' VAL . . . -70.77 -20.11 62.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.791 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 51' ' ' SER . 65.5 mt -53.22 -29.81 34.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.234 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.535 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -63.03 -30.87 71.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.146 0.498 . . . . 0.0 110.643 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.68 -31.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.369 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.705 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -75.36 -17.71 60.16 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -171.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -66.41 -34.76 78.67 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.347 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 m -93.57 -51.74 4.81 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.31 0.576 . . . . 0.0 110.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -84.32 -53.5 5.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.008 -172.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.705 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -77.06 -7.02 86.62 Favored Glycine 0 C--O 1.225 -0.423 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.801 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 16.7 mt 63.29 78.28 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.375 0.67 . . . . 0.0 111.972 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.717 HG21 HD21 ' A' ' 33' ' ' LEU . 1.4 p -160.57 135.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.7 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 8.4 t 147.9 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.843 1.339 . . . . 0.0 111.687 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.6 ' CB ' HG22 ' A' ' 72' ' ' VAL . 3.8 t -94.82 -59.87 1.82 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.283 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.596 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -118.72 135.28 54.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.214 0.53 . . . . 0.0 112.217 -169.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.74 -30.79 9.25 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 168.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.22 -61.35 2.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.88 -62.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 169.28 160.63 17.91 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.904 176.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 121.1 24.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.678 0.752 . . . . 0.0 109.829 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.816 HG12 HG22 ' A' ' 32' ' ' THR . 2.6 m -121.92 163.96 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.229 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.481 HG21 ' HG ' ' A' ' 27' ' ' LEU . 16.7 t -84.97 123.41 39.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.185 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -132.28 159.49 38.95 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -76.09 66.09 2.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.834 0.826 . . . . 0.0 110.128 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 7.5 m-20 -55.17 142.24 58.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.491 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 76' ' ' ASN . 9.8 Cg_exo -71.11 117.92 5.41 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.141 1.894 . . . . 0.0 111.51 175.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.435 HG23 HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -79.73 111.64 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.418 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 78' ' ' ILE . 34.3 m . . . . . 0 N--CA 1.468 0.433 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.255 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 47.9 p90 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.965 0.412 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -93.67 128.63 39.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.705 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.45 118.27 60.75 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.604 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -88.31 160.55 6.88 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.938 2.425 . . . . 0.0 112.65 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.6 95.44 3.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.03 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.99 38.64 55.64 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.484 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.568 ' HD2' ' HB2' ' A' ' 13' ' ' ASP . 3.3 tppp? -104.44 108.66 20.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -157.86 33.39 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.868 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.555 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -71.92 0.51 9.07 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.622 0.369 . . . . 0.0 111.308 -177.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.5 50.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.687 0.28 . . . . 0.0 111.338 -169.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.568 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 40.3 t0 -76.1 -38.65 56.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.375 0.607 . . . . 0.0 109.511 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.651 HG23 ' HB2' ' A' ' 53' ' ' ALA . 3.8 m -85.19 -23.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.56 61.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.264 0.554 . . . . 0.0 109.873 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.643 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 5.1 m -104.13 -27.31 12.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.993 174.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.521 ' HD2' HG23 ' A' ' 39' ' ' ILE . 4.0 t60 -60.54 -21.22 62.28 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.709 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 24.8 p90 -58.21 -33.43 69.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.365 0.602 . . . . 0.0 110.453 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 16' ' ' THR . 2.6 ptm180 -68.25 -25.88 65.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.767 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.458 ' HB ' HD22 ' A' ' 21' ' ' LEU . 2.4 m -65.13 -35.63 81.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.219 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.137 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.1 mm? -91.93 -48.12 6.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.298 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' A' ' 27' ' ' LEU . 36.4 mm -67.52 -12.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.861 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 2.7 tmmt? -48.0 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.325 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 p -118.31 -32.08 4.77 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.73 -20.7 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.198 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.701 ' HG2' ' HA ' ' A' ' 21' ' ' LEU . 2.1 pm0 -63.37 -21.39 66.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -168.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.137 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.7 tp -121.59 83.4 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.24 141.34 80.66 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.508 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 3.0 Cg_exo -77.09 123.7 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 110.903 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.14 46.43 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -174.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -118.26 156.63 28.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 24.1 p -82.69 138.77 34.0 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.256 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 151.09 86.2 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.63 168.32 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.696 2.264 . . . . 0.0 112.694 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -76.73 -179.23 5.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.192 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.17 -19.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.924 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.63 75.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.53 -55.06 19.86 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.861 0.362 . . . . 0.0 111.058 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.725 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.4 mp -58.11 -39.83 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.047 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 5.2 tmm_? -79.76 -28.25 40.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.347 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . . . -82.6 -31.73 28.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.48 -65.36 0.9 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 45' ' ' VAL . 3.1 m-85 -91.92 111.27 22.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.19 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.95 92.33 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 O-C-N 124.016 0.822 . . . . 0.0 113.363 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 18.8 m -138.81 -179.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.51 174.61 7.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.913 0.387 . . . . 0.0 110.535 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -76.45 -14.62 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 176.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 44.0 m -73.15 -42.11 63.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 81.5 t -54.52 -61.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.484 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.621 ' HA ' HD12 ' A' ' 54' ' ' LEU . 13.0 t -57.48 -25.43 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.522 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 77.1 ttt180 -72.93 -48.29 38.19 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.099 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -63.58 -31.04 72.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.037 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.647 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 86.8 mt -58.18 -29.52 65.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.161 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -67.77 -28.84 67.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.354 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 26.3 t -84.84 -32.15 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 175.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.721 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.8 mp -77.51 4.46 11.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.828 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 41.4 mtmt -65.62 -56.63 11.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -93.85 -40.5 10.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.893 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 9.7 tp10 -73.62 -51.07 18.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.772 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.721 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -88.64 -13.23 63.3 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.877 -176.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 76' ' ' ASN . 63.9 mt 66.2 66.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.979 0.458 . . . . 0.0 111.826 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 57' ' ' LEU . 32.8 m -136.87 156.45 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.46 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -116.61 95.63 5.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.359 0.6 . . . . 0.0 109.842 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -84.86 109.17 17.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.92 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.41 108.6 20.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.141 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.15 47.24 2.58 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.164 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.76 -55.87 0.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.293 0.568 . . . . 0.0 109.613 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -85.81 -36.53 20.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.253 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.0 175.41 13.88 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.56 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.4 p -87.83 104.9 17.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 15.5 t -114.54 139.84 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.388 . . . . 0.0 110.267 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 21.4 t -90.84 91.0 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -94.51 138.81 31.97 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.475 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -71.31 84.73 0.78 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.547 ' O ' HD22 ' A' ' 62' ' ' LEU . 83.1 m-20 -67.97 140.13 93.5 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.615 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 76' ' ' ASN . 6.3 Cg_exo -77.67 118.2 4.46 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.705 2.27 . . . . 0.0 110.055 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.517 HG12 HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -58.88 115.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.743 -174.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.471 0.611 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.245 179.048 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 66.5 t80 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.176 0.512 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.93 114.12 26.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.401 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -81.89 122.28 79.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.731 0.301 . . . . 0.0 110.531 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.504 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 84.6 Cg_endo -95.53 134.08 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.199 2.6 . . . . 0.0 113.182 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -99.87 -73.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.11 92.08 1.71 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.66 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -75.92 178.55 6.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.196 0.998 . . . . 0.0 112.919 -172.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 168.57 151.13 6.98 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.122 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 9.3 p90 -70.66 8.03 0.96 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.419 0.609 . . . . 0.0 110.584 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . -79.78 -28.1 40.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.17 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 12.4 t70 -67.56 -50.08 60.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.026 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.551 HG23 ' CB ' ' A' ' 53' ' ' ALA . 2.3 m -71.02 -36.89 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.415 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -55.37 -48.76 73.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.036 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -80.05 -22.41 42.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.486 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 1.7 m170 -85.97 -30.3 22.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -73.27 -18.44 61.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.983 0.421 . . . . 0.0 110.625 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -63.18 -17.53 62.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.504 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.83 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 6.8 m -81.94 -26.48 33.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.137 0.494 . . . . 0.0 110.769 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.955 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.6 mm? -81.88 -51.81 7.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.496 HG21 ' HA2' ' A' ' 61' ' ' GLY . 11.2 tp -79.69 14.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.072 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.83 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 24.4 ttmm -67.64 -77.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 m -117.36 -29.79 5.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.6 -25.84 0.02 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 118.84 -1.648 . . . . 0.0 114.957 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -53.95 -42.74 69.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.025 0.412 . . . . 0.0 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.955 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -113.31 78.31 1.13 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.92 95.27 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.447 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.894 ' HA ' HG13 ' A' ' 73' ' ' VAL . 37.5 Cg_endo -70.93 136.84 30.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.032 2.488 . . . . 0.0 111.767 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.4 56.59 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.481 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 73' ' ' VAL . 4.8 t0 -122.77 164.19 18.81 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 22.1 p -78.87 152.81 31.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.969 0.414 . . . . 0.0 111.11 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.66 HD21 ' HB ' ' A' ' 73' ' ' VAL . 8.7 mt -85.94 152.12 55.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.287 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.49 168.09 24.41 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.594 2.196 . . . . 0.0 111.017 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 t -73.21 155.82 39.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.8 m -53.86 -21.21 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 O-C-N 123.28 0.363 . . . . 0.0 111.914 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.83 92.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.59 -51.88 63.38 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.393 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.4 mp -57.88 -54.51 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.218 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -73.26 -17.89 61.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -171.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 3' ' ' TYR . . . -82.57 -44.81 15.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.595 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.921 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -75.99 -52.24 10.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.579 ' HD2' HG23 ' A' ' 39' ' ' ILE . 2.9 m-85 -93.11 105.78 17.83 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.631 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 85.43 0.01 OUTLIER Glycine 0 CA--C 1.516 0.115 0 O-C-N 123.638 0.586 . . . . 0.0 113.926 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.787 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 27.8 m -142.03 179.12 2.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.61 -169.93 2.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.22 -40.36 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.987 0.422 . . . . 0.0 110.349 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -75.05 -31.07 61.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.604 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.787 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 5.4 m -58.06 -34.49 70.18 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.141 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.641 HG13 HG21 ' A' ' 39' ' ' ILE . 60.8 t -57.32 -59.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.376 0.608 . . . . 0.0 109.974 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.561 ' HA ' HD12 ' A' ' 54' ' ' LEU . 23.1 t -65.25 -11.9 46.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.612 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 49' ' ' THR . 32.2 tpt180 -76.74 -42.68 40.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.551 ' CB ' HG23 ' A' ' 14' ' ' VAL . . . -80.56 -19.66 45.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.437 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.686 HD22 HG21 ' A' ' 63' ' ' VAL . 44.8 mt -57.31 -25.52 59.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.512 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -72.65 -20.71 61.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.078 0.466 . . . . 0.0 110.71 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.06 -39.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.715 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 4.8 mp -71.27 6.68 1.59 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.922 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.877 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 22.0 pttp -76.37 -42.37 44.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -92.7 -45.05 8.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.161 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -75.97 -46.42 29.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.088 0.47 . . . . 0.0 111.243 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.715 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.21 -13.52 58.65 Favored Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.605 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.797 HD21 HG12 ' A' ' 78' ' ' ILE . 22.2 mt 67.69 28.33 7.33 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.785 0.434 . . . . 0.0 111.742 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.805 HG12 HG23 ' A' ' 73' ' ' VAL . 8.6 m -108.81 143.38 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.903 0.383 . . . . 0.0 111.342 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 41.0 t -144.95 149.24 34.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 p -90.32 90.1 7.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.526 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 4.3 tpp180 -71.48 105.19 3.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.054 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.97 59.07 3.53 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.239 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.95 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.48 -28.1 37.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.753 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 128.51 -159.21 21.95 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.591 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.91 112.57 16.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 60.9 t -132.24 135.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -169.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 29' ' ' PRO . 11.6 p -82.56 75.7 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 122.335 1.064 . . . . 0.0 110.856 -173.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -144.96 83.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.11 162.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.877 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 55.6 tptt -95.82 -81.1 0.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.764 0.792 . . . . 0.0 111.374 175.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.462 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 3.1 t-20 -130.7 91.96 35.89 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.839 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 76' ' ' ASN . 3.6 Cg_exo -40.06 122.41 1.14 Allowed 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.983 2.455 . . . . 0.0 111.23 175.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.797 HG12 HD21 ' A' ' 62' ' ' LEU . 4.0 mm -55.41 118.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t . . . . . 0 C--O 1.235 0.331 0 O-C-N 124.567 1.167 . . . . 0.0 111.384 -177.184 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 120.804 0.335 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -91.98 116.24 0.4 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.095 2.53 . . . . 0.0 111.246 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -69.56 102.57 1.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.757 0.789 . . . . 0.0 110.155 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.68 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 23.3 ttpt -94.67 118.71 32.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.489 -170.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.44 142.67 50.47 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.005 -173.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.675 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 72.1 Cg_endo -79.33 112.18 2.97 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.757 2.305 . . . . 0.0 111.713 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -70.34 -56.21 7.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.414 -176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.88 34.98 0.62 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.92 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HD2' ' CB ' ' A' ' 13' ' ' ASP . 51.2 pttt -123.34 148.88 45.56 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.813 -0.227 . . . . 0.0 110.906 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.9 -140.52 10.08 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.657 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.615 ' HA ' HG12 ' A' ' 14' ' ' VAL . 4.2 p90 -80.29 10.83 4.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.849 0.459 . . . . 0.0 112.209 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.87 -38.82 19.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.485 ' CB ' ' HD2' ' A' ' 9' ' ' LYS . 24.4 t70 -70.57 -35.46 73.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.338 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.695 HG13 ' HB2' ' A' ' 53' ' ' ALA . 2.5 p -71.58 -42.81 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.499 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.82 -37.53 76.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.237 0.541 . . . . 0.0 109.859 175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.3 m -67.83 -46.08 72.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.122 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -78.22 -20.8 51.05 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.513 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.578 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -69.74 -29.2 66.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.841 0.353 . . . . 0.0 110.397 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -61.68 -23.4 66.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.492 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.8 m -80.49 -44.29 19.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.432 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -53.53 -40.76 65.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.29 0.567 . . . . 0.0 111.295 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.615 HD12 HG11 ' A' ' 73' ' ' VAL . 19.3 mm -72.82 -14.3 16.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.477 -176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -75.88 -75.93 0.17 Allowed 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 26' ' ' GLU . 5.5 t -119.39 -31.87 4.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.951 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 26' ' ' GLU . . . 10.31 -41.01 0.0 OUTLIER Glycine 0 C--N 1.354 1.576 0 C-N-CA 129.745 3.545 . . . . 0.0 119.558 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 24' ' ' SER . 2.0 pt-20 111.79 -15.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 126.834 2.054 . . . . 0.0 107.949 -162.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 32.4 tp -112.79 58.5 0.65 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.467 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.54 166.34 14.89 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.758 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 7.6 Cg_exo -74.01 121.25 6.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 120.948 1.098 . . . . 0.0 110.428 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.3 -6.48 12.93 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.673 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -108.65 158.7 17.35 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.823 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 6.3 m -94.35 148.47 22.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.734 0.302 . . . . 0.0 111.287 -172.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.3 mp -54.79 135.72 65.15 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.712 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HG2' HD11 ' A' ' 39' ' ' ILE . 72.7 Cg_endo -78.38 171.3 17.12 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.222 2.614 . . . . 0.0 112.051 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.8 t -72.31 156.94 38.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.414 ' HA ' HD13 ' A' ' 39' ' ' ILE . 27.3 m -54.98 -21.58 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 122.707 0.403 . . . . 0.0 112.066 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.15 99.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.8 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -63.38 -51.09 67.3 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.213 0.53 . . . . 0.0 109.798 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.774 HG21 ' HB ' ' A' ' 50' ' ' VAL . 4.8 mp -56.96 -50.17 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.269 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.907 ' HA ' ' CE1' ' A' ' 43' ' ' PHE . 63.0 ttt180 -44.71 -33.57 1.91 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.38 -33.89 13.68 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.926 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -75.14 -44.94 44.14 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.806 0.812 . . . . 0.0 109.052 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.907 ' CE1' ' HA ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -89.45 119.72 30.14 Favored 'General case' 0 N--CA 1.413 -2.325 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 172.322 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.68 ' HA2' ' HB3' ' A' ' 4' ' ' LYS . . . -73.51 53.62 1.96 Allowed Glycine 0 C--N 1.302 -1.321 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.675 ' HA ' ' HB3' ' A' ' 6' ' ' PRO . 1.8 t -136.38 170.58 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -161.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' O ' ' CZ ' ' A' ' 43' ' ' PHE . . . -78.49 152.16 32.19 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -5.29 40.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.144 0.497 . . . . 0.0 110.9 -168.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 5.4 tmmm? -92.61 -24.22 18.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.789 171.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 11' ' ' TYR . 4.1 m -69.34 -27.9 65.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.774 ' HB ' HG21 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -61.59 -48.72 87.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.624 ' HA ' HD12 ' A' ' 54' ' ' LEU . 32.3 t -63.5 -14.37 50.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.252 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HG2' ' HD2' ' A' ' 48' ' ' LYS . 5.6 mmp_? -81.03 -58.17 3.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.683 0.278 . . . . 0.0 110.258 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.695 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -63.75 -25.41 68.18 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 50' ' ' VAL . 41.4 mt -49.08 -38.91 25.85 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.75 -18.93 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.988 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.06 -28.85 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.544 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.965 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -72.58 -1.93 17.94 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.988 -173.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 57.7 pttt -66.69 -42.35 86.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 173.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 78' ' ' ILE . 2.8 m -94.77 -36.17 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.003 0.906 . . . . 0.0 109.24 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 11.1 tp10 -83.95 -66.07 0.94 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.032 -169.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.965 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -83.29 1.18 89.12 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.635 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.865 HD21 HG13 ' A' ' 78' ' ' ILE . 20.7 mt 73.2 37.27 0.76 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 172.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 58' ' ' LYS . 8.4 p -113.15 150.16 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.739 -0.6 . . . . 0.0 111.332 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.834 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 31.8 t -148.32 145.28 28.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.385 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -67.9 106.8 2.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 7.0 ttm180 -114.3 97.38 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.996 -176.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.69 50.51 2.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.114 -0.565 . . . . 0.0 113.311 -173.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.23 -63.89 0.43 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' HB2' HG21 ' A' ' 72' ' ' VAL . 71.0 mt -91.2 -14.36 31.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.543 176.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 114.11 -160.98 12.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.896 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.806 HG23 ' HB2' ' A' ' 33' ' ' LEU . 6.4 t -78.78 81.81 5.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.427 1.108 . . . . 0.0 109.611 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.823 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 38.5 t -92.94 141.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.671 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.615 HG11 HD12 ' A' ' 22' ' ' ILE . 4.5 t -88.22 75.67 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.815 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -146.56 80.31 1.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.737 158.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.834 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 88.2 tttt -98.85 -85.59 0.38 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.196 0.998 . . . . 0.0 111.745 173.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.421 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 5.9 t-20 -130.23 95.13 28.51 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 113.453 -1.703 . . . . 0.0 109.88 -165.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.437 ' HA ' HD22 ' A' ' 62' ' ' LEU . 84.1 Cg_exo -45.41 122.63 4.84 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.021 1.814 . . . . 0.0 111.059 175.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.865 HG13 HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -56.3 136.15 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -175.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.7 t -55.3 79.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 124.395 1.059 . . . . 0.0 111.697 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 85' ' ' ARG . 41.1 mm -113.43 106.77 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.948 175.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.1 t -120.04 -0.76 10.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.725 0.774 . . . . 0.0 109.034 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.17 171.28 36.41 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.073 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.06 -0.54 36.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.176 0.512 . . . . 0.0 111.205 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -76.98 -35.12 57.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.768 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.58 ' HB2' HD13 ' A' ' 80' ' ' ILE . 22.4 mmm180 -73.52 -32.53 64.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.976 -174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.4 tp -100.36 -40.71 7.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.029 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -94.11 -30.41 14.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.044 -174.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.443 ' HG2' ' H ' ' A' ' 90' ' ' GLU . 22.7 ttm-85 66.53 111.23 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.907 0.754 . . . . 0.0 111.08 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -0.8 13.48 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.443 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 27.9 mt-10 -75.99 -39.58 55.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.39 176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -100.88 167.1 10.49 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.879 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.11 138.58 55.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.719 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.96 67.82 2.61 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.955 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 73.4 mtm -86.4 171.31 11.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.324 -0.251 . . . . 0.0 110.324 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 46.0 mtm105 -59.03 129.96 44.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.242 0.544 . . . . 0.0 112.444 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -112.99 166.41 11.43 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 169.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.86 106.46 0.88 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.742 0.306 . . . . 0.0 110.68 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.5 -4.07 4.23 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.028 2.485 . . . . 0.0 113.095 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.81 43.12 0.51 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.194 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 C--O 1.25 1.12 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.126 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.495 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 23.6 ptm . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 5.1 Cg_exo -78.73 98.19 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.786 2.324 . . . . 0.0 111.161 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -72.31 141.8 48.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.657 ' HD3' ' H ' ' A' ' 44' ' ' GLY . 58.0 tttp -104.92 145.26 30.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.757 -175.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.98 163.24 20.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.596 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 10.1 Cg_exo -76.08 96.24 1.06 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.121 1.88 . . . . 0.0 112.18 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.582 ' N ' ' HE3' ' A' ' 9' ' ' LYS . 1.8 mp0 -63.89 -65.38 0.69 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.078 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.18 54.1 0.31 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.039 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.792 ' HG3' ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -123.42 164.98 17.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.918 0.389 . . . . 0.0 110.716 -176.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.39 -143.54 10.56 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.63 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 3.0 p90 -70.87 2.34 4.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.958 0.409 . . . . 0.0 111.524 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.54 -18.26 54.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.569 . . . . 0.0 110.207 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.792 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 2.5 t70 -73.99 -47.99 33.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.737 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.778 HG13 HG11 ' A' ' 45' ' ' VAL . 33.0 m -70.22 -31.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.407 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.64 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.64 -45.15 89.91 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.253 0.549 . . . . 0.0 109.656 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -68.43 -34.43 75.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.704 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.692 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 45.0 t-80 -52.87 -54.38 35.29 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.954 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.429 ' CG ' HD13 ' A' ' 57' ' ' LEU . 5.7 m-85 -68.03 -40.17 82.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.811 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -60.88 -27.43 68.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.841 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.455 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 37.9 m -80.06 -36.01 36.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 0.0 109.95 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.892 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 68.8 mt -70.86 -44.81 65.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.223 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 61' ' ' GLY . 49.2 mm -68.69 -21.8 26.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.457 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 22.6 ttmm -56.78 -63.73 1.11 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.798 -173.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -114.29 -33.16 5.73 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -174.8 -29.67 0.03 OUTLIER Glycine 0 CA--C 1.511 -0.177 0 C-N-CA 118.666 -1.731 . . . . 0.0 114.538 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.2 -57.57 12.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -164.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 13.6 tp -98.44 89.19 4.35 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.42 153.79 65.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.479 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 63.4 Cg_endo -77.31 137.63 17.04 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.102 1.868 . . . . 0.0 112.092 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.91 -24.99 9.14 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.007 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -93.41 161.85 14.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -79.03 161.23 26.74 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.731 0.3 . . . . 0.0 111.355 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.4 145.64 98.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.332 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.403 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 74.2 Cg_endo -78.11 171.49 17.03 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.826 2.351 . . . . 0.0 112.507 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.8 p -79.27 159.59 27.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.06 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.475 ' HA ' HD13 ' A' ' 39' ' ' ILE . 25.2 m -54.01 -26.25 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.9 82.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.131 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 34' ' ' PRO . 16.6 m-20 -70.33 -29.66 66.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 110.297 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.692 ' HA ' ' CE1' ' A' ' 17' ' ' HIS . 3.7 mp -75.48 -49.94 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.244 176.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.579 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 22.0 ttm180 -66.93 -46.95 73.2 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.12 75.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 0.0 110.955 -170.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -84.39 -65.96 0.95 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.175 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.433 ' HB3' ' OD1' ' A' ' 13' ' ' ASP . 18.8 m-85 -93.48 102.12 14.33 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.269 176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.657 ' H ' ' HD3' ' A' ' 4' ' ' LYS . . . -57.37 99.56 0.1 Allowed Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.624 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.778 HG11 HG13 ' A' ' 14' ' ' VAL . 19.4 m -140.73 179.26 2.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.115 0.483 . . . . 0.0 111.384 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -97.89 176.35 5.82 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.31 -26.44 52.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.79 0.329 . . . . 0.0 110.748 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -79.16 -29.72 43.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.991 0.424 . . . . 0.0 109.955 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.553 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.8 m -63.69 -43.58 96.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.539 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.674 ' HA ' HG11 ' A' ' 14' ' ' VAL . 96.4 t -55.81 -58.86 3.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.782 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.698 ' HA ' HD12 ' A' ' 54' ' ' LEU . 26.0 t -68.37 -6.41 24.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.871 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' HA ' ' NE ' ' A' ' 52' ' ' ARG . 4.6 tpm_? -77.74 -50.67 11.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.542 0.211 . . . . 0.0 110.678 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.756 ' HB3' HG23 ' A' ' 14' ' ' VAL . . . -90.74 -9.89 45.0 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 51' ' ' SER . 95.5 mt -51.6 -31.06 23.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 117.825 0.284 . . . . 0.0 111.486 174.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.845 177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 44.2 t -80.73 -30.39 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.742 0.782 . . . . 0.0 109.514 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.64 HD21 ' HA ' ' A' ' 15' ' ' ALA . 86.9 mt -76.06 1.27 15.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.632 -173.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -66.04 -56.45 11.5 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.4 p -93.57 -34.43 13.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.481 0.657 . . . . 0.0 110.356 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.4 tp10 -77.07 -52.14 9.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.722 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.59 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -90.52 -7.4 67.06 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.977 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mp 63.04 66.7 0.72 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.956 0.407 . . . . 0.0 111.812 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 57' ' ' LEU . 31.1 m -136.14 162.49 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.681 175.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.8 m -144.59 128.5 17.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.139 0.495 . . . . 0.0 111.372 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -78.53 92.76 4.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.535 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 9.9 tpt180 -85.45 101.87 12.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.202 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.92 50.66 2.28 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.647 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.87 -60.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -84.05 -16.23 44.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.434 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 109.53 178.42 21.21 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.666 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -74.66 99.26 3.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 19.5 m -117.61 159.94 17.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 111.417 -170.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 22.3 t -85.68 93.82 3.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.789 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' A' ' 72' ' ' VAL . 31.2 mt-10 -102.64 151.3 22.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 172.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.679 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 57.6 mtpt -68.51 88.55 0.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -94.75 96.04 1.76 Allowed Pre-proline 0 CA--C 1.503 -0.849 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 75' ' ' LYS . 50.8 Cg_exo -56.39 151.34 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.216 1.944 . . . . 0.0 112.405 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -55.7 105.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.052 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.9 t 65.85 72.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.642 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.676 ' CG1' ' HB2' ' A' ' 77' ' ' PRO . 2.9 mm -115.61 128.68 72.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.752 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.2 t -91.79 152.57 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -79.15 120.96 5.41 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.866 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.42 -55.14 3.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -101.75 -14.32 17.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.244 174.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -82.51 -6.54 59.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.522 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.1 tp -101.58 116.39 32.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.905 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -84.93 130.16 34.69 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.712 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -82.15 -173.48 4.55 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 62.0 mtm -97.0 -51.99 4.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.192 0.52 . . . . 0.0 110.314 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 90' ' ' GLU . 1.1 pm0 -72.66 -35.72 67.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.386 -175.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -108.89 102.6 11.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.964 0.411 . . . . 0.0 111.138 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -105.15 98.66 8.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.995 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.0 -26.19 22.56 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.516 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.8 ttm -105.24 171.78 7.14 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -69.79 160.05 32.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.265 0.555 . . . . 0.0 111.609 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -131.77 166.74 20.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.379 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' A' ' 100' ' ' GLU . . . -82.06 110.87 22.87 Favored Pre-proline 0 C--N 1.321 -0.659 0 O-C-N 123.325 0.391 . . . . 0.0 110.327 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -87.74 27.08 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.091 2.528 . . . . 0.0 112.072 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.76 -47.23 0.43 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HB2' ' HB1' ' A' ' 97' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.834 -0.603 . . . . 0.0 110.615 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 27.2 ttt . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.491 0.186 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 23.4 Cg_exo -64.93 142.66 76.32 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.776 2.317 . . . . 0.0 111.991 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -73.12 155.89 39.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.492 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -85.05 134.88 34.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.958 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -96.35 150.05 36.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.451 0.167 . . . . 0.0 111.182 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 6.2 Cg_exo -78.59 118.45 4.21 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.067 2.512 . . . . 0.0 111.681 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -99.66 -74.41 0.6 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.707 -175.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.96 29.52 4.14 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.405 -176.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -116.61 156.66 26.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.09 -107.7 2.66 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.898 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -95.85 -12.25 25.52 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 174.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 5.51 9.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.501 0.667 . . . . 0.0 111.141 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.488 ' OD1' HG13 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -91.14 -52.8 4.65 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.388 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.679 HG13 HH22 ' A' ' 52' ' ' ARG . 2.0 m -68.74 -34.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.642 -172.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.63 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -55.73 -44.71 77.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.64 170.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -64.57 -39.11 93.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.526 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 22.9 t60 -57.62 -48.01 80.61 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.471 176.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.37 -40.31 85.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.192 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -56.66 -27.57 58.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.588 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.5 m -85.33 -54.02 4.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.982 0.42 . . . . 0.0 110.802 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . 3.3 pp -75.64 -12.04 60.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.554 -172.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.5 tp -67.02 -41.48 87.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 110.452 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -92.9 -13.34 29.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.218 0.533 . . . . 0.0 110.513 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.775 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 23.0 t -86.54 26.79 1.03 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.317 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.15 25.87 0.0 OUTLIER Glycine 0 N--CA 1.471 1.013 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 37.2 mt-10 -69.79 -34.98 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 171.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HG ' HD13 ' A' ' 21' ' ' LEU . 61.0 mt -122.9 92.1 3.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.526 166.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.06 164.05 54.63 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.751 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 5.8 Cg_exo -75.19 123.47 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.669 1.579 . . . . 0.0 110.691 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.35 27.89 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -169.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -91.43 163.5 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 1.007 ' HB ' HG23 ' A' ' 71' ' ' THR . 6.7 t -107.88 161.9 14.5 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -172.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.795 HD11 ' HB ' ' A' ' 63' ' ' VAL . 4.2 mp -57.52 109.69 1.95 Allowed Pre-proline 0 N--CA 1.432 -1.357 0 CA-C-N 111.196 -2.729 . . . . 0.0 108.435 167.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.95 175.41 10.87 Favored 'Trans proline' 0 C--N 1.328 -0.548 0 C-N-CA 123.359 2.706 . . . . 0.0 113.225 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 t -64.69 158.12 25.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.49 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.8 m -55.31 -19.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.02 -52.99 59.05 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.21 -53.42 58.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.375 0.607 . . . . 0.0 111.08 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.782 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -56.05 -53.66 36.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.652 177.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 43.8 ttp180 -65.6 -40.03 92.22 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.79 -46.23 25.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -172.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -75.84 -56.45 4.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.938 0.399 . . . . 0.0 110.673 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.471 ' O ' HG22 ' A' ' 45' ' ' VAL . 5.2 m-85 -91.81 103.99 16.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.795 175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -49.79 86.31 0.01 OUTLIER Glycine 0 CA--C 1.516 0.111 0 O-C-N 124.642 1.214 . . . . 0.0 114.459 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 43' ' ' PHE . 33.6 m -137.77 177.38 5.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -97.17 178.89 5.1 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.57 -33.11 58.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.096 0.474 . . . . 0.0 109.973 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.966 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -68.49 -36.79 79.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 175.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.813 HG22 ' HE ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -65.18 -53.3 46.88 Favored 'General case' 0 C--O 1.215 -0.753 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 177.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 46' ' ' ALA . 92.0 t -41.25 -52.58 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.596 -0.69 . . . . 0.0 111.189 176.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.646 ' HA ' HD12 ' A' ' 54' ' ' LEU . 47.9 t -60.75 -34.07 73.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.924 -1.034 . . . . 0.0 113.063 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.898 ' CZ ' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -72.25 -31.31 65.68 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.548 -169.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.664 ' N ' ' HD2' ' A' ' 52' ' ' ARG . . . -91.12 -5.37 55.18 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.671 -0.643 . . . . 0.0 111.807 173.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 51' ' ' SER . 44.5 mt -57.88 -35.05 70.45 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.708 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.16 -18.16 64.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 111.009 176.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 60' ' ' GLU . 34.3 t -90.46 -29.22 4.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.63 HD11 ' HA ' ' A' ' 15' ' ' ALA . 1.2 mp -73.85 2.89 7.48 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.251 -174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.97 -41.8 20.29 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' A' ' 78' ' ' ILE . 15.7 m -94.04 -41.68 9.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.773 0.797 . . . . 0.0 109.887 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' HB3' HG12 ' A' ' 56' ' ' VAL . 39.0 tp10 -89.6 -34.49 16.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.809 -175.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 62' ' ' LEU . . . -90.72 -10.3 63.35 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.561 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 61' ' ' GLY . 11.2 mp 79.36 12.78 1.19 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.795 ' HB ' HD11 ' A' ' 33' ' ' LEU . 9.3 m -100.91 154.62 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 121.647 -0.658 . . . . 0.0 109.5 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -128.28 179.01 5.86 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.575 -0.85 . . . . 0.0 112.611 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.3 t -52.47 122.45 8.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.829 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HA ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -64.94 163.93 13.57 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.374 -168.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.79 -67.45 1.43 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.683 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.448 ' H ' ' H ' ' A' ' 69' ' ' LEU . . . -160.71 -16.69 0.05 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.711 0.767 . . . . 0.0 109.504 168.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' H ' ' H ' ' A' ' 68' ' ' ALA . 2.5 mm? -93.64 -39.21 10.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.404 -170.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.696 ' N ' ' HG3' ' A' ' 66' ' ' ARG . . . 143.33 -5.04 1.83 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.706 -166.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 1.007 HG23 ' HB ' ' A' ' 32' ' ' THR . 89.0 m -97.52 92.86 6.13 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -172.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.806 HG23 ' HA ' ' A' ' 66' ' ' ARG . 90.8 t -151.52 96.61 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 123.852 0.72 . . . . 0.0 112.095 156.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 60.5 t -89.07 130.38 38.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 159.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 29' ' ' PRO . 40.1 mt-10 -133.39 165.14 25.54 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HA ' HD23 ' A' ' 62' ' ' LEU . 52.0 tttm -84.87 49.01 1.64 Allowed 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 166.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -118.95 91.9 44.02 Favored Pre-proline 0 CA--C 1.515 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.477 -170.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HB2' HG22 ' A' ' 80' ' ' ILE . 6.0 Cg_exo -77.25 115.9 4.04 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.821 1.681 . . . . 0.0 109.473 171.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.461 ' H ' ' HA ' ' A' ' 59' ' ' SER . 19.1 mt -70.74 100.24 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.984 -176.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 t 33.9 43.5 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 124.728 1.268 . . . . 0.0 111.335 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -71.99 105.97 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 122.094 0.95 . . . . 0.0 109.291 -170.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 m -85.49 -59.49 2.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.841 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.71 123.14 1.29 Allowed Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.302 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.14 -13.76 23.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.417 0.627 . . . . 0.0 109.581 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -84.87 -3.92 58.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.513 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -60.66 -33.21 72.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.107 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.6 tp -85.21 152.22 23.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.583 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 113.92 4.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.929 0.395 . . . . 0.0 111.056 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 88' ' ' ARG . 21.3 mtm180 -76.98 -164.71 0.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 57.0 ttp -67.49 -17.52 64.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.149 0.499 . . . . 0.0 110.227 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.53 -58.23 6.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.801 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -80.43 104.51 11.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.327 0.584 . . . . 0.0 110.851 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -79.74 100.05 7.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.836 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.71 141.04 15.61 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.745 -0.74 . . . . 0.0 111.719 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.606 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 5.5 mmt -90.62 69.66 6.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.232 0.539 . . . . 0.0 110.588 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -167.77 131.83 1.75 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.314 176.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -114.41 156.8 23.83 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.168 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -99.09 103.06 17.68 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -85.0 12.23 3.14 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.85 2.367 . . . . 0.0 112.648 -174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.2 77.47 0.25 Allowed Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.056 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.102 177.693 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 mmt . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.832 0.349 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -81.82 118.54 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.601 2.201 . . . . 0.0 111.449 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -72.83 127.56 32.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.643 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.81 117.88 24.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.851 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.1 167.44 21.61 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.427 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.48 92.09 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.339 2.026 . . . . 0.0 110.804 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' HG2' ' HE2' ' A' ' 9' ' ' LYS . 9.3 pt-20 -71.39 73.31 0.71 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.905 -176.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.83 16.55 68.31 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.67 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.509 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 60.1 pttt -124.25 147.63 47.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.541 0.21 . . . . 0.0 110.456 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.1 -137.69 7.18 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.13 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.402 ' HA ' HG22 ' A' ' 49' ' ' THR . 11.1 p90 -68.48 -9.55 49.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.789 0.328 . . . . 0.0 111.81 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.47 -17.44 56.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.849 0.357 . . . . 0.0 110.516 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.478 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 15.5 t70 -74.36 -51.56 14.74 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.909 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.621 HG23 ' HB2' ' A' ' 53' ' ' ALA . 2.2 m -68.86 -33.7 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.02 -51.72 63.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.966 0.413 . . . . 0.0 110.578 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -74.16 -37.04 64.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.21 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -68.13 -36.41 79.67 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CG ' HD21 ' A' ' 57' ' ' LEU . 5.2 m-85 -65.05 -44.28 89.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.834 0.35 . . . . 0.0 110.14 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.624 ' HG2' ' HA2' ' A' ' 61' ' ' GLY . 73.8 mtp180 -53.11 -26.38 16.29 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.281 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.63 HG22 ' HB2' ' A' ' 24' ' ' SER . 13.1 m -88.53 -54.78 4.0 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.685 HD12 ' HA3' ' A' ' 25' ' ' GLY . 1.1 tp -52.55 -26.63 13.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.608 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 23' ' ' LYS . 1.3 mp -50.03 -58.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.688 0.28 . . . . 0.0 110.421 173.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.442 ' N ' HG22 ' A' ' 22' ' ' ILE . 16.5 ptpt -94.46 -29.54 14.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.227 0.537 . . . . 0.0 111.494 177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.63 ' HB2' HG22 ' A' ' 20' ' ' THR . 38.9 m -102.47 28.66 5.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.285 -171.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.685 ' HA3' HD12 ' A' ' 21' ' ' LEU . . . -165.1 20.57 0.12 Allowed Glycine 0 CA--C 1.505 -0.544 0 C-N-CA 119.37 -1.395 . . . . 0.0 112.239 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 64.92 10.35 6.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.56 -0.82 . . . . 0.0 112.852 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.62 HD12 HD21 ' A' ' 21' ' ' LEU . 23.2 mt -84.2 59.15 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 168.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.87 160.46 28.42 Favored Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.739 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 6.5 Cg_exo -75.09 136.77 20.65 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.944 1.763 . . . . 0.0 112.322 -172.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.95 -17.75 11.72 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.717 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -95.55 159.89 14.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.606 HG22 HG12 ' A' ' 72' ' ' VAL . 36.8 p -78.66 165.06 24.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.636 0.255 . . . . 0.0 111.137 -178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.86 141.6 98.39 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 171.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.53 ' HG2' HD11 ' A' ' 39' ' ' ILE . 57.0 Cg_endo -77.71 163.86 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.379 2.052 . . . . 0.0 111.669 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 m -65.81 140.31 58.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.456 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.599 ' HA ' HD13 ' A' ' 39' ' ' ILE . 31.0 m -52.07 -27.19 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -174.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.63 -38.81 86.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -66.67 -48.8 68.2 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.283 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.2 mp -55.02 -50.76 60.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.257 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 19.9 ptt180 -81.17 -9.75 59.74 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -173.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.01 -38.66 17.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.721 0.296 . . . . 0.0 110.282 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.666 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.1 OUTLIER -87.99 -59.13 2.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.637 0.732 . . . . 0.0 110.09 177.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 45' ' ' VAL . 21.0 m-85 -90.23 81.85 6.07 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.416 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.412 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . -39.56 92.67 0.01 OUTLIER Glycine 0 CA--C 1.523 0.564 0 O-C-N 124.613 1.196 . . . . 0.0 115.274 -175.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 14.7 m -139.01 178.71 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' OG1' ' A' ' 49' ' ' THR . . . -87.19 -175.02 5.15 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.69 -28.8 51.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.372 . . . . 0.0 111.246 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -90.24 -22.32 21.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 0.0 110.521 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.675 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.5 m -64.16 -35.34 80.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.539 -174.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG13 HG21 ' A' ' 39' ' ' ILE . 65.1 t -56.17 -59.1 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.331 0.586 . . . . 0.0 110.571 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.606 ' HA ' HD12 ' A' ' 54' ' ' LEU . 42.1 t -66.14 -14.26 61.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.815 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -77.17 -40.53 45.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.061 0.458 . . . . 0.0 109.847 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.621 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -74.17 -30.67 62.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.562 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 51' ' ' SER . 83.9 mt -51.92 -30.39 24.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.613 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . . . -68.59 -24.43 64.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.962 0.41 . . . . 0.0 111.096 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.93 -23.8 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.734 0.778 . . . . 0.0 109.448 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.694 ' HG ' ' HA3' ' A' ' 61' ' ' GLY . 4.5 mp -68.67 -19.49 64.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.019 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 55' ' ' ALA . 73.8 mttt -54.42 -59.23 4.96 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.166 0.508 . . . . 0.0 110.394 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -93.02 -41.24 10.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.95 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' HG2' ' HD2' ' A' ' 19' ' ' ARG . 23.4 tt0 -93.2 -55.79 3.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.966 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.694 ' HA3' ' HG ' ' A' ' 57' ' ' LEU . . . -75.31 -10.23 84.38 Favored Glycine 0 N--CA 1.461 0.302 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.814 -170.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.968 HD21 HG13 ' A' ' 78' ' ' ILE . 7.7 mt 69.74 80.33 0.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.686 0.755 . . . . 0.0 111.966 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.444 HG12 ' C ' ' A' ' 57' ' ' LEU . 9.0 p -140.32 161.29 25.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 173.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.2 m -141.77 102.23 4.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.215 0.531 . . . . 0.0 111.171 177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 9.4 m -72.37 86.53 1.13 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.053 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 70' ' ' GLY . 34.2 mmt180 -68.93 125.25 26.05 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.692 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.97 -9.0 87.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.797 -1.192 . . . . 0.0 111.925 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.54 -45.37 4.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.863 0.363 . . . . 0.0 110.999 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -88.34 -18.04 29.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.389 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 102.38 172.87 27.18 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 2.7 m -72.06 103.86 3.4 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.606 HG12 HG22 ' A' ' 32' ' ' THR . 23.1 m -121.96 169.5 13.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 0.0 111.238 -172.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 31.5 t -93.23 114.15 29.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.222 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.572 ' HG2' HG23 ' A' ' 72' ' ' VAL . 6.0 mm-40 -126.31 146.79 49.88 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -72.93 77.87 1.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 173.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.49 ' O ' HD22 ' A' ' 62' ' ' LEU . 59.9 t30 -64.65 132.69 95.49 Favored Pre-proline 0 N--CA 1.447 -0.578 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.05 113.97 1.71 Allowed 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.076 1.184 . . . . 0.0 110.35 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.968 HG13 HD21 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -64.09 127.26 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 172.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t -52.49 91.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 O-C-N 124.056 0.847 . . . . 0.0 110.638 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.612 HG13 HG22 ' A' ' 78' ' ' ILE . 69.7 mt -104.61 122.31 57.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.838 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.8 m -78.48 -43.49 26.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.818 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.85 55.91 3.73 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.991 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.86 -173.84 2.62 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.2 -12.53 59.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.816 0.341 . . . . 0.0 111.373 -176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -71.46 -52.53 17.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 172.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB3' ' H ' ' A' ' 87' ' ' LYS . 0.9 OUTLIER 57.18 -89.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.05 0.844 . . . . 0.0 111.347 177.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.441 ' H ' ' HB3' ' A' ' 86' ' ' LEU . 4.9 ttpm? -155.77 122.49 5.28 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.58 32.86 5.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.711 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 64.7 mtt 70.23 -55.51 0.61 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.384 0.674 . . . . 0.0 110.734 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -62.31 -69.14 0.27 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.533 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 91' ' ' LYS . 25.2 mtpp -82.36 114.86 21.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.308 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -113.14 142.48 45.72 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.863 175.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.42 -165.55 13.2 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.462 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.16 58.57 2.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.646 0.736 . . . . 0.0 110.496 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -147.27 162.61 38.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.951 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.512 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 17.9 t80 -121.5 134.71 55.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.94 106.39 4.87 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.868 0.366 . . . . 0.0 110.353 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 74.0 Cg_endo -83.22 -1.23 10.24 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.594 2.196 . . . . 0.0 112.016 -175.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.9 21.46 7.9 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.042 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.044 178.433 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.902 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 47.4 ttm . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 119.697 -0.192 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.902 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 12.5 Cg_exo -73.29 159.92 46.03 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.207 1.938 . . . . 0.0 111.631 176.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.573 ' HB2' ' HA ' ' A' ' 41' ' ' ALA . 6.3 p90 -90.91 153.47 20.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.211 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -93.36 137.99 32.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.865 0.364 . . . . 0.0 110.393 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -78.63 146.65 69.78 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.132 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 2.7 Cg_exo -77.68 117.42 4.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.746 2.297 . . . . 0.0 112.622 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -86.95 -157.61 0.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.04 175.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 7' ' ' GLU . . . -74.58 60.46 2.45 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' A' ' 44' ' ' GLY . 19.5 ptpt -122.53 178.37 5.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.738 0.304 . . . . 0.0 110.249 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.27 -148.47 5.44 Favored Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.271 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -71.15 -10.68 60.17 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -176.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.65 -17.98 57.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 110.397 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' CB ' ' HD3' ' A' ' 9' ' ' LYS . 26.9 t70 -71.08 -45.97 62.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.388 175.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.673 HG23 HG11 ' A' ' 45' ' ' VAL . 72.0 t -59.9 -40.25 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.065 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.594 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -57.2 -43.57 82.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 177.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -61.33 -34.77 75.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.711 ' CD2' ' HA ' ' A' ' 39' ' ' ILE . 5.2 t60 -67.53 -44.93 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.102 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.604 ' O ' HG12 ' A' ' 22' ' ' ILE . 8.2 m-85 -69.21 -46.47 67.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.984 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -61.01 -19.43 61.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 m -85.66 -51.15 6.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.877 0.37 . . . . 0.0 110.967 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD13 HD13 ' A' ' 27' ' ' LEU . 3.9 pp -71.84 -21.83 61.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 18' ' ' PHE . 26.5 mm -61.12 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.821 0.343 . . . . 0.0 110.739 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -85.11 1.19 48.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.231 0.538 . . . . 0.0 110.525 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.424 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 27.5 t -96.88 24.93 5.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.603 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 22.34 26.12 0.0 OUTLIER Glycine 0 N--CA 1.475 1.268 0 N-CA-C 117.374 1.71 . . . . 0.0 117.374 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 24' ' ' SER . 7.9 pt-20 -85.78 -34.66 21.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.672 HD21 ' HG3' ' A' ' 34' ' ' PRO . 9.9 mp -109.16 72.77 0.82 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 166.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.55 153.31 83.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.483 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.45 123.21 7.47 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.113 1.875 . . . . 0.0 111.284 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.55 -10.03 10.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.033 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -98.2 161.31 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.661 HG22 HG12 ' A' ' 72' ' ' VAL . 17.1 p -81.53 167.77 18.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.883 0.373 . . . . 0.0 111.478 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.803 ' HB2' HG23 ' A' ' 71' ' ' THR . 1.4 mm? -65.12 140.08 97.87 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.336 175.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.672 ' HG3' HD21 ' A' ' 27' ' ' LEU . 57.3 Cg_endo -76.95 165.56 28.21 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.598 2.199 . . . . 0.0 111.565 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -74.08 156.09 37.81 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.0 m -52.48 -22.8 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.76 -52.57 64.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -58.16 -30.24 66.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.043 0.449 . . . . 0.0 110.974 -176.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.711 ' HA ' ' CD2' ' A' ' 17' ' ' HIS . 4.3 mp -80.02 -59.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.519 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 33.5 ptt180 -79.03 -19.88 50.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -166.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 3' ' ' TYR . . . -76.69 -39.76 51.03 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.396 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -78.71 -62.07 1.81 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.586 0.708 . . . . 0.0 109.206 175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 9.7 m-85 -92.17 105.1 17.4 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.956 176.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' A' ' 9' ' ' LYS . . . -60.41 91.56 0.05 OUTLIER Glycine 0 N--CA 1.454 -0.157 0 CA-C-N 115.225 -0.898 . . . . 0.0 114.0 -172.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.673 HG11 HG23 ' A' ' 14' ' ' VAL . 17.6 m -134.82 178.31 5.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -94.98 -170.55 2.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.09 34.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 110.473 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -76.21 -22.71 54.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.698 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.647 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 1.9 m -65.68 -42.05 91.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.064 0.459 . . . . 0.0 110.158 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HA ' HG21 ' A' ' 14' ' ' VAL . 99.1 t -59.48 -55.84 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.715 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 54' ' ' LEU . 29.7 t -66.9 -12.11 58.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.675 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -82.4 -36.13 27.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.038 0.446 . . . . 0.0 110.223 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' HD13 ' A' ' 57' ' ' LEU . . . -74.3 -29.85 61.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.277 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 83.7 mt -49.28 -32.26 10.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.62 -28.63 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.076 0.465 . . . . 0.0 111.355 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.27 -25.16 5.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.877 0.846 . . . . 0.0 109.76 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.706 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -76.48 -5.04 45.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.46 -175.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -66.02 -40.11 90.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.6 p -93.14 -53.8 3.97 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.573 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -81.35 -38.32 26.87 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -172.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.706 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -90.49 -3.56 71.65 Favored Glycine 0 C--N 1.318 -0.422 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.489 -174.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.689 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 10.1 mp 57.85 57.08 4.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.084 0.469 . . . . 0.0 111.808 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 57' ' ' LEU . 33.7 m -124.57 161.39 27.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.1 t -130.56 143.56 50.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.064 0.459 . . . . 0.0 111.337 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 p -82.78 103.04 11.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.611 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.555 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 12.1 tpp180 -118.43 48.43 1.43 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.3 4.12 2.07 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.253 -0.885 . . . . 0.0 114.978 -169.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.0 -47.02 21.86 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.05 -62.1 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 175.1 171.31 39.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.146 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.803 HG23 ' HB2' ' A' ' 33' ' ' LEU . 4.9 t -70.0 134.71 48.6 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.062 0.458 . . . . 0.0 110.202 -174.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.661 HG12 HG22 ' A' ' 32' ' ' THR . 34.3 m -131.47 162.51 39.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.311 -171.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -99.15 113.58 34.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -123.58 144.34 49.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -69.18 78.67 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.438 0.461 . . . . 0.0 110.858 -174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 18.2 m-80 -73.6 116.54 52.54 Favored Pre-proline 0 CA--C 1.517 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.365 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.56 116.92 4.34 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.785 2.323 . . . . 0.0 111.264 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.618 HD11 HD11 ' A' ' 62' ' ' LEU . 1.2 mp -79.89 103.35 6.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.241 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.4 t 49.51 36.29 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.64 0.733 . . . . 0.0 110.374 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.7 mm -88.95 107.35 17.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.73 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 82' ' ' GLY . 3.2 t -158.87 -54.88 0.06 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.999 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 81' ' ' THR . . . -160.26 128.08 1.9 Allowed Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.889 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.91 171.37 8.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -90.62 8.76 32.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.118 0.485 . . . . 0.0 110.622 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 85' ' ' ARG . 6.2 tpm_? -69.86 -42.54 73.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.453 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.7 tp 59.45 -81.65 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.001 0.813 . . . . 0.0 110.478 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -87.61 106.13 17.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.753 ' HB2' ' HB2' ' A' ' 91' ' ' LYS . 68.3 mtp180 -65.3 148.39 51.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 54.3 tpp -58.13 108.65 0.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.895 0.378 . . . . 0.0 111.027 -172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 64.52 18.26 11.28 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.392 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 37.7 mttp -118.31 79.38 1.37 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.543 0.687 . . . . 0.0 111.669 -178.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -128.94 99.25 5.22 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.242 171.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.63 -61.18 1.31 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.012 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.2 mtt -106.19 52.83 0.72 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.266 0.555 . . . . 0.0 109.562 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HD2' ' HA ' ' A' ' 95' ' ' ARG . 16.2 tpt180 -155.42 157.63 37.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.457 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -148.27 166.37 28.19 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.81 108.62 5.15 Favored Pre-proline 0 C--N 1.318 -0.779 0 O-C-N 123.541 0.526 . . . . 0.0 109.969 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.04 18.03 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.853 2.369 . . . . 0.0 112.287 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.33 44.21 0.78 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.785 -177.799 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.87 151.78 68.54 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.509 2.139 . . . . 0.0 112.143 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.61 109.18 17.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.928 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -73.47 115.28 12.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.305 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.6 99.43 52.8 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.046 0.45 . . . . 0.0 111.497 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -99.29 172.08 0.46 Allowed 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.669 2.913 . . . . 0.0 111.731 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 157.52 46.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.23 -10.09 43.02 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -108.84 167.27 10.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -146.13 6.69 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.297 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.57 ' HB3' ' HD3' ' A' ' 52' ' ' ARG . 4.6 p90 -71.92 -4.53 28.85 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.038 0.446 . . . . 0.0 110.373 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.29 -12.83 60.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.864 -173.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.71 -60.99 1.96 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG13 HG11 ' A' ' 45' ' ' VAL . 35.6 m -67.05 -29.32 45.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.486 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 57' ' ' LEU . . . -58.72 -39.63 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.226 0.536 . . . . 0.0 110.455 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.6 m -83.41 -39.23 20.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.443 ' HB3' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-70 -70.43 -20.41 62.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.761 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.476 ' HA ' HD12 ' A' ' 21' ' ' LEU . 1.4 m-85 -77.02 -25.66 52.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 111.239 176.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 19' ' ' ARG . 24.0 mmm180 -70.96 -20.06 62.49 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.652 0.263 . . . . 0.0 111.377 -177.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -13.59 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.155 0.502 . . . . 0.0 110.453 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.714 ' HA ' ' HB2' ' A' ' 26' ' ' GLU . 82.7 mt -85.5 -47.16 10.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.918 175.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 18' ' ' PHE . 17.5 mm -75.65 2.23 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.743 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HD2' ' HB2' ' A' ' 24' ' ' SER . 4.8 tmmt? -61.09 -81.04 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.781 -1.1 . . . . 0.0 111.526 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.51 ' HB2' ' HD2' ' A' ' 23' ' ' LYS . 11.1 t -119.67 -31.7 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 118.732 -1.187 . . . . 0.0 113.809 -171.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.22 -20.9 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.065 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.714 ' HB2' ' HA ' ' A' ' 21' ' ' LEU . 33.2 mp0 -45.32 -45.44 12.31 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.729 0.812 . . . . 0.0 110.927 -175.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.676 ' HG ' HG21 ' A' ' 73' ' ' VAL . 23.0 tp -133.87 91.03 2.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.4 152.29 89.92 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.185 -169.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 28' ' ' ALA . 5.2 Cg_exo -76.81 129.39 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.005 2.47 . . . . 0.0 111.213 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.3 -15.43 17.99 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -95.7 162.08 13.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 72' ' ' VAL . 25.2 p -81.95 160.83 23.26 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.432 0.158 . . . . 0.0 110.705 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HB2' HG23 ' A' ' 71' ' ' THR . 10.9 mt -66.36 139.05 96.08 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 172.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.32 157.56 33.21 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.223 1.948 . . . . 0.0 111.834 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.8 t -69.31 155.36 40.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.6 m -54.85 -15.11 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.13 81.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.582 0.229 . . . . 0.0 111.404 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.96 -39.42 87.23 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 -176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.609 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.5 mp -66.3 -57.04 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.91 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 45' ' ' VAL . 8.6 ttp180 -62.71 -31.27 72.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -170.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.65 -41.68 17.51 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.967 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -81.57 -50.47 9.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.401 0.62 . . . . 0.0 109.56 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.587 ' O ' HG22 ' A' ' 45' ' ' VAL . 5.4 m-85 -92.07 101.9 14.44 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.355 175.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.433 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . -52.67 92.42 0.01 OUTLIER Glycine 0 CA--C 1.518 0.27 0 O-C-N 123.587 0.554 . . . . 0.0 113.865 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.777 HG11 HG13 ' A' ' 14' ' ' VAL . 17.6 m -146.85 178.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 123.042 0.537 . . . . 0.0 109.725 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.53 -174.99 3.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 -36.31 57.05 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.689 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -84.06 -15.11 48.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.94 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.697 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 6.9 m -68.5 -39.46 81.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 39' ' ' ILE . 52.3 t -57.5 -58.29 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.314 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 54' ' ' LEU . 24.8 t -59.38 -17.45 30.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.237 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 74.7 ttt180 -79.8 -44.6 20.3 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.377 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.655 ' HB3' HG23 ' A' ' 14' ' ' VAL . . . -79.68 -15.64 57.19 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.577 HD23 HD12 ' A' ' 57' ' ' LEU . 69.6 mt -48.64 -33.79 10.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.728 0.299 . . . . 0.0 111.407 174.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.493 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.17 -38.2 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.965 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.07 -28.56 26.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.45 0.643 . . . . 0.0 109.994 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.577 HD12 HD23 ' A' ' 54' ' ' LEU . 69.6 mt -73.28 -15.64 61.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.283 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 55' ' ' ALA . 49.2 mtmt -66.51 -48.13 70.77 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.338 0.59 . . . . 0.0 110.007 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.585 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . 3.0 p -90.61 -54.88 3.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.649 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.34 -31.64 15.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.0 -169.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 57' ' ' LEU . . . -78.43 -29.48 52.77 Favored Glycine 0 C--O 1.231 -0.093 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.128 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 77' ' ' PRO . 22.6 mt 75.16 80.05 0.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.159 0.984 . . . . 0.0 111.39 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 57' ' ' LEU . 36.0 m -145.92 172.85 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.174 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.0 m -146.6 116.21 7.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.39 0.614 . . . . 0.0 110.943 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.753 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 38.0 t -84.33 105.41 15.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.875 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.548 ' HD3' ' OE2' ' A' ' 74' ' ' GLU . 15.1 mmm-85 -83.79 119.14 24.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.39 34.7 1.34 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.127 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -149.25 -68.3 0.21 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -69.92 -31.53 69.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.347 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.81 172.1 13.22 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.753 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 9.0 t -78.55 120.58 23.45 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.315 0.579 . . . . 0.0 109.441 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.613 HG12 HG22 ' A' ' 32' ' ' THR . 33.6 m -126.05 170.72 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.277 0.56 . . . . 0.0 111.387 -172.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.676 HG21 ' HG ' ' A' ' 27' ' ' LEU . 29.4 t -93.87 120.42 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.131 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 66' ' ' ARG . 48.6 mt-10 -131.57 158.87 39.84 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.061 0.457 . . . . 0.0 110.95 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -79.22 38.53 0.36 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 74' ' ' GLU . 66.8 m-20 -123.95 84.23 54.83 Favored Pre-proline 0 CA--C 1.515 -0.395 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.561 -175.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.508 ' HB3' HD22 ' A' ' 62' ' ' LEU . 10.0 Cg_endo -52.2 116.07 2.58 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.003 2.468 . . . . 0.0 110.472 166.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.0 mm -64.61 127.79 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 174.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.24 74.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.561 0.696 . . . . 0.0 109.807 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.585 ' HB ' ' HB3' ' A' ' 59' ' ' SER . 38.5 mm -79.95 107.27 12.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.892 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.7 p -110.18 -69.26 0.87 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.31 149.13 20.36 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.755 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . . . -109.55 163.89 13.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.97 0.385 . . . . 0.0 110.78 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -77.81 -34.0 52.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.253 0.549 . . . . 0.0 110.154 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -75.54 -21.24 58.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.357 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.755 ' HG ' ' HB3' ' A' ' 83' ' ' ALA . 48.5 mt -68.98 93.96 0.6 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.367 0.603 . . . . 0.0 110.375 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.59 ' HD2' ' HG3' ' A' ' 98' ' ' PRO . 0.2 OUTLIER -161.99 -44.39 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.641 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -142.76 138.97 30.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.774 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.3 tpt -71.04 -46.77 61.47 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -91.47 76.92 5.81 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.49 113.23 2.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.861 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -81.38 142.01 33.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.753 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -61.14 -36.44 92.37 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.476 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 2.3 tpt -79.46 99.64 7.31 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -98.44 151.0 21.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.275 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.88 163.12 29.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.413 175.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -92.65 110.14 43.34 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.906 0.384 . . . . 0.0 110.279 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.59 ' HG3' ' HD2' ' A' ' 87' ' ' LYS . 95.3 Cg_endo -83.07 12.74 2.85 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.96 2.44 . . . . 0.0 112.544 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.12 35.46 1.9 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.862 -177.586 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 18.6 mmt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.636 0.255 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 7.6 Cg_exo -73.68 7.81 2.18 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.083 2.522 . . . . 0.0 112.621 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 96.0 m-85 -90.68 119.41 30.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.037 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -88.23 142.2 27.94 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.58 134.4 34.2 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 64.7 Cg_endo -78.14 111.48 3.07 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.339 2.026 . . . . 0.0 111.656 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -69.33 -77.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.039 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.11 -6.41 4.88 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.91 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -69.54 154.25 42.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 110.821 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.88 -135.27 3.68 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.81 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.597 ' HA ' HG12 ' A' ' 14' ' ' VAL . 3.0 p90 -74.24 -1.6 21.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.127 0.489 . . . . 0.0 111.011 -175.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.15 -21.34 22.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.256 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -91.05 -36.65 13.91 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.64 0.733 . . . . 0.0 109.105 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.722 ' HB ' HG11 ' A' ' 45' ' ' VAL . 7.3 p -75.1 -32.6 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.856 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.67 -46.22 84.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.934 0.397 . . . . 0.0 110.681 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 m -66.13 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.633 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -71.46 -27.89 63.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.875 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -74.34 -20.84 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.834 0.35 . . . . 0.0 110.883 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.0 -24.07 65.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.886 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.1 m -75.27 -28.11 59.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.316 0.579 . . . . 0.0 110.038 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.038 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . 67.5 mt -78.96 -28.84 43.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.87 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.8 tp -90.29 -7.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.364 -175.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -66.06 -79.64 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 26' ' ' GLU . 8.5 t -119.71 -34.62 3.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 159.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.038 ' HA3' ' HA ' ' A' ' 21' ' ' LEU . . . 18.12 22.46 0.0 OUTLIER Glycine 0 C--N 1.354 1.561 0 C-N-CA 127.949 2.69 . . . . 0.0 118.652 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 24' ' ' SER . 33.0 mt-10 59.53 9.79 1.66 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 117.413 0.606 . . . . 0.0 111.225 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.698 HD13 HD22 ' A' ' 21' ' ' LEU . 8.3 mp -129.64 34.2 4.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.07 166.28 2.15 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.137 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 10.7 Cg_exo -73.53 123.81 8.9 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.232 1.955 . . . . 0.0 111.744 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 131.36 -12.03 5.5 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.929 -172.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -104.37 164.07 11.99 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.689 HG22 HG12 ' A' ' 72' ' ' VAL . 2.7 p -97.38 153.23 18.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.65 0.262 . . . . 0.0 110.953 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 71' ' ' THR . 10.5 mp -72.42 120.0 78.08 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 111.881 -176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.51 6.69 5.48 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 C-N-CA 123.284 2.656 . . . . 0.0 111.871 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 1.127 ' HA ' HD13 ' A' ' 39' ' ' ILE . 5.7 p -79.04 59.15 2.61 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -160.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 37' ' ' ALA . 2.4 m -100.87 -58.05 4.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 122.614 1.197 . . . . 0.0 110.008 142.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' H ' HG23 ' A' ' 36' ' ' VAL . . . -89.32 -58.98 2.34 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 112.895 -1.957 . . . . 0.0 112.924 -166.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.65 -30.49 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.401 -174.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.127 HD13 ' HA ' ' A' ' 35' ' ' SER . 1.8 mp -86.1 -56.07 5.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.03 -173.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 45' ' ' VAL . 4.2 ptm180 -66.01 -18.62 65.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.826 -172.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . . . -67.99 -57.53 6.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.513 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -81.16 -51.86 7.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.846 0.831 . . . . 0.0 110.065 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.702 ' HD2' HG23 ' A' ' 39' ' ' ILE . 4.8 m-85 -89.8 83.11 6.18 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.42 -1.264 . . . . 0.0 107.867 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.46 88.17 0.01 OUTLIER Glycine 0 N--CA 1.462 0.419 0 O-C-N 125.002 1.439 . . . . 0.0 115.182 -176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.722 HG11 ' HB ' ' A' ' 14' ' ' VAL . 17.4 m -142.02 178.11 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB3' ' OG1' ' A' ' 49' ' ' THR . . . -89.08 -175.12 4.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.83 -35.17 51.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.277 0.56 . . . . 0.0 110.645 -174.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.924 ' HE2' ' HA ' ' A' ' 48' ' ' LYS . 10.5 mmpt? -85.12 -13.05 51.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.678 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.689 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 10.9 m -71.95 -40.07 68.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.678 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG13 HG21 ' A' ' 39' ' ' ILE . 48.7 t -55.16 -57.01 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.396 0.617 . . . . 0.0 110.375 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.708 ' HA ' HD12 ' A' ' 54' ' ' LEU . 36.0 t -64.16 -14.06 52.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.639 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 16.2 tpp180 -78.28 -44.14 26.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.675 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -66.58 -33.4 75.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.881 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 51' ' ' SER . 69.1 mt -53.56 -31.33 46.08 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.628 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.534 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -64.6 -26.34 68.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.078 0.466 . . . . 0.0 110.974 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.55 -29.98 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.647 0.737 . . . . 0.0 109.669 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -74.03 -13.8 60.91 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.624 -173.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.534 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 62.2 pttt -64.53 -36.69 85.04 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.602 173.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.701 ' HA ' HG13 ' A' ' 78' ' ' ILE . 6.1 m -93.09 -53.48 4.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.284 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -88.37 -31.02 19.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.005 -170.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.548 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.43 -12.52 59.64 Favored Glycine 0 C--O 1.229 -0.216 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.922 -176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp 63.49 52.43 2.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.874 0.368 . . . . 0.0 111.707 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.8 m -118.82 164.2 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.68 ' HB3' HG23 ' A' ' 72' ' ' VAL . 22.6 t -117.17 105.2 11.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.184 0.516 . . . . 0.0 110.608 -174.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.2 m -81.39 71.38 8.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 20.9 tpp180 -75.77 96.46 3.65 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.313 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.15 49.47 3.54 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.001 -175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.23 -47.26 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.96 -44.66 10.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.093 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 138.06 -177.6 19.87 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.692 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 33' ' ' LEU . 17.7 p -75.01 106.66 6.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.968 0.413 . . . . 0.0 110.466 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.689 HG12 HG22 ' A' ' 32' ' ' THR . 18.2 m -123.05 150.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.101 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 27' ' ' LEU . 17.5 t -92.57 105.18 16.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -126.45 135.54 51.5 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 20.8 pttm -66.63 92.73 0.22 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.503 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 19.8 m-80 -90.35 110.86 43.78 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.056 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 76' ' ' ASN . 28.0 Cg_endo -62.64 115.38 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.021 1.814 . . . . 0.0 109.703 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.701 HG13 ' HA ' ' A' ' 59' ' ' SER . 13.1 mm -95.68 117.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.078 0.466 . . . . 0.0 111.881 -173.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.3 m 44.77 31.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 113.682 -1.599 . . . . 0.0 111.658 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mm -76.12 118.62 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.062 -174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 81.7 m -117.17 -25.8 7.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.471 0.653 . . . . 0.0 109.812 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.52 112.48 3.55 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.589 176.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.05 -19.34 64.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.903 0.382 . . . . 0.0 111.091 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -79.54 -19.29 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.087 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -88.6 -1.64 58.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.782 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.0 tp -79.13 -22.72 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -115.81 -178.13 3.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.403 170.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -84.52 178.56 7.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.695 0.283 . . . . 0.0 110.944 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.5 tpt -68.97 -37.91 79.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -71.3 73.3 0.69 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 91' ' ' LYS . 4.8 ttmp? -90.92 132.06 36.17 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.652 -167.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.456 HD22 ' N ' ' A' ' 92' ' ' ASN . 0.9 OUTLIER -99.91 136.22 40.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.446 175.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.18 -27.38 66.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.797 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.89 -174.77 3.52 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -64.46 143.32 57.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.198 0.523 . . . . 0.0 111.195 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 81.0 t80 -96.5 132.43 42.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 100' ' ' GLU . . . -73.37 108.72 5.07 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 123.361 0.413 . . . . 0.0 110.728 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 64.1 Cg_endo -89.72 -2.06 5.77 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.883 2.389 . . . . 0.0 112.502 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -147.99 45.4 0.74 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.056 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.425 ' HB2' ' HB1' ' A' ' 97' ' ' ALA . 30.6 tt0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.393 -0.813 . . . . 0.0 109.659 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.473 ' HB3' ' HD2' ' A' ' 3' ' ' TYR . 90.3 mtp . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.021 0.439 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.22 36.39 0.5 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.219 2.613 . . . . 0.0 112.858 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.473 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 93.7 m-85 -79.91 135.93 36.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.791 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -88.67 93.14 9.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.184 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.8 117.33 66.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.138 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 68.2 Cg_endo -91.77 178.79 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.414 2.742 . . . . 0.0 112.544 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.41 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 3.1 mp0 -93.23 -89.45 0.21 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 7' ' ' GLU . . . -125.76 101.27 0.61 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -123.48 150.97 43.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.969 0.414 . . . . 0.0 110.875 -174.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.34 -145.29 14.94 Favored Glycine 0 N--CA 1.434 -1.434 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 170.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.673 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 2.0 p90 -80.17 23.47 0.47 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.769 0.318 . . . . 0.0 110.93 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.57 -46.46 8.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.857 0.361 . . . . 0.0 111.567 -172.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -77.45 -26.58 51.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.45 0.643 . . . . 0.0 110.157 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.991 ' HB ' HG11 ' A' ' 45' ' ' VAL . 12.8 p -75.1 -26.09 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.257 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 19' ' ' ARG . . . -63.16 -34.79 78.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.498 ' HB ' ' CE2' ' A' ' 43' ' ' PHE . 10.3 m -60.02 -26.59 66.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.11 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' A' ' 39' ' ' ILE . 53.9 t-80 -56.12 -48.47 76.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.65 ' HE2' HD22 ' A' ' 33' ' ' LEU . 74.7 m-85 -83.21 -35.71 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.523 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 15' ' ' ALA . 72.4 mtp180 -57.08 -32.63 66.47 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 110.635 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.6 m -79.13 -55.55 5.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.827 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 HD13 HD22 ' A' ' 27' ' ' LEU . 31.1 mt -48.88 -46.91 43.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -177.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 61' ' ' GLY . 1.8 mp -68.97 -43.25 82.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -86.26 -7.07 58.79 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.454 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.2 p -105.23 17.53 23.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 23.54 27.49 0.0 OUTLIER Glycine 0 N--CA 1.469 0.88 0 N-CA-C 116.779 1.472 . . . . 0.0 116.779 -169.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.07 -32.3 71.65 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 21' ' ' LEU . 22.7 tp -102.95 95.58 6.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.52 153.92 95.3 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.518 -170.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.24 126.68 8.66 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.654 2.236 . . . . 0.0 110.914 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.45 -6.24 33.76 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -95.99 149.97 20.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.816 HG22 HG12 ' A' ' 72' ' ' VAL . 19.2 p -78.37 156.8 29.33 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.717 HD21 HG21 ' A' ' 63' ' ' VAL . 14.0 mt -60.63 139.39 92.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.814 172.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -74.06 168.13 25.53 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.336 2.024 . . . . 0.0 111.913 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.7 p -66.09 148.94 51.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.668 ' HA ' HD13 ' A' ' 39' ' ' ILE . 20.0 m -49.72 -28.11 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 O-C-N 123.306 0.378 . . . . 0.0 111.681 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.96 91.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.561 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -69.51 -23.67 63.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.058 0.456 . . . . 0.0 110.51 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.668 HD13 ' HA ' ' A' ' 36' ' ' VAL . 3.8 mp -79.35 -55.67 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 7.1 ptm180 -77.64 -20.64 53.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.46 68.13 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.673 . . . . 0.0 110.084 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -83.16 -60.61 2.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.018 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.624 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 48.6 m-85 -92.54 99.06 11.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.777 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' A' ' 6' ' ' PRO . . . -56.33 100.13 0.1 OUTLIER Glycine 0 CA--C 1.515 0.078 0 CA-C-N 115.299 -0.864 . . . . 0.0 114.044 -172.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.991 HG11 ' HB ' ' A' ' 14' ' ' VAL . 6.1 m -146.38 178.98 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 122.575 0.35 . . . . 0.0 110.141 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 50' ' ' VAL . . . -90.92 175.15 7.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 172.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.8 -19.3 55.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.467 0.651 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 52' ' ' ARG . 71.8 mmtt -74.36 -46.48 40.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.963 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.745 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.5 m -56.38 -43.06 78.84 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.833 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.755 ' HA ' HG21 ' A' ' 14' ' ' VAL . 93.5 t -52.83 -53.66 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.327 0.584 . . . . 0.0 110.95 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.566 ' HA ' HD12 ' A' ' 54' ' ' LEU . 23.2 t -70.48 -6.68 37.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.624 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 48' ' ' LYS . 5.2 mmp_? -83.61 -47.05 11.68 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.122 -0.362 . . . . 0.0 110.293 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.518 ' CB ' HG13 ' A' ' 14' ' ' VAL . . . -70.77 -20.11 62.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.791 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 51' ' ' SER . 65.5 mt -53.22 -29.81 34.36 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.234 175.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.535 ' HA ' ' HE2' ' A' ' 58' ' ' LYS . . . -63.03 -30.87 71.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.146 0.498 . . . . 0.0 110.643 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.68 -31.1 6.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.369 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.705 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -75.36 -17.71 60.16 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.185 -171.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -66.41 -34.76 78.67 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.347 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 m -93.57 -51.74 4.81 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.31 0.576 . . . . 0.0 110.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -84.32 -53.5 5.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.008 -172.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.705 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -77.06 -7.02 86.62 Favored Glycine 0 C--O 1.225 -0.423 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.801 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 76' ' ' ASN . 16.7 mt 63.29 78.28 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.375 0.67 . . . . 0.0 111.972 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.717 HG21 HD21 ' A' ' 33' ' ' LEU . 1.4 p -160.57 135.42 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.665 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.7 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 8.4 t 147.9 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 124.843 1.339 . . . . 0.0 111.687 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.6 ' CB ' HG22 ' A' ' 72' ' ' VAL . 3.8 t -94.82 -59.87 1.82 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.283 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.596 ' HA ' ' HE ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -118.72 135.28 54.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.214 0.53 . . . . 0.0 112.217 -169.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -92.74 -30.79 9.25 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 168.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.22 -61.35 2.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.88 -62.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 66' ' ' ARG . . . 169.28 160.63 17.91 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.904 176.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 t -79.8 121.1 24.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.678 0.752 . . . . 0.0 109.829 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.816 HG12 HG22 ' A' ' 32' ' ' THR . 2.6 m -121.92 163.96 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.229 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.481 HG21 ' HG ' ' A' ' 27' ' ' LEU . 16.7 t -84.97 123.41 39.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.185 -176.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -132.28 159.49 38.95 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -76.09 66.09 2.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.834 0.826 . . . . 0.0 110.128 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 7.5 m-20 -55.17 142.24 58.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.491 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 76' ' ' ASN . 9.8 Cg_exo -71.11 117.92 5.41 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.141 1.894 . . . . 0.0 111.51 175.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.435 HG23 HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -79.73 111.64 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.418 -179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 78' ' ' ILE . 34.3 m 40.74 36.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 114.165 -1.38 . . . . 0.0 112.255 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.0 mm -81.41 139.69 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.496 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.9 m -142.53 -28.0 0.6 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.029 0.442 . . . . 0.0 111.158 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.54 56.59 0.74 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.823 -178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.01 -33.91 24.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.073 0.464 . . . . 0.0 110.297 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -80.01 -8.5 59.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.16 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -78.86 -44.72 22.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.903 0.382 . . . . 0.0 110.641 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.47 107.34 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.036 -172.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' A' ' 88' ' ' ARG . 7.4 ptpp? -157.91 -10.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.472 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.409 ' H ' ' H ' ' A' ' 87' ' ' LYS . 21.2 ttt180 -175.07 -55.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.207 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 47.5 ttm -149.92 -70.08 0.19 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.514 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -142.42 -74.33 0.29 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -155.48 96.7 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.308 0.575 . . . . 0.0 110.872 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -81.45 139.22 35.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.428 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.09 44.9 2.69 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.59 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.6 mmt -121.86 130.31 53.28 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -70.86 106.41 3.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.529 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 79.9 t80 -81.85 130.61 35.12 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.16 105.68 3.11 Favored Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 123.366 0.416 . . . . 0.0 110.025 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 32.9 Cg_endo -92.79 17.25 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.04 2.494 . . . . 0.0 111.495 -175.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.34 78.67 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -175.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.185 -175.868 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.15 115.08 3.64 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.681 2.254 . . . . 0.0 111.085 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 47.9 p90 -75.13 143.75 43.16 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.965 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -93.67 128.63 39.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.705 -172.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.45 118.27 60.75 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.604 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -88.31 160.55 6.88 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.938 2.425 . . . . 0.0 112.65 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.6 95.44 3.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.03 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.99 38.64 55.64 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.484 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.568 ' HD2' ' HB2' ' A' ' 13' ' ' ASP . 3.3 tppp? -104.44 108.66 20.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.98 -157.86 33.39 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.868 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.555 ' HD1' ' H ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -71.92 0.51 9.07 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.622 0.369 . . . . 0.0 111.308 -177.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.5 50.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.687 0.28 . . . . 0.0 111.338 -169.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.568 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 40.3 t0 -76.1 -38.65 56.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.375 0.607 . . . . 0.0 109.511 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.651 HG23 ' HB2' ' A' ' 53' ' ' ALA . 3.8 m -85.19 -23.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -13.56 61.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.264 0.554 . . . . 0.0 109.873 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.643 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 5.1 m -104.13 -27.31 12.15 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.993 174.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.521 ' HD2' HG23 ' A' ' 39' ' ' ILE . 4.0 t60 -60.54 -21.22 62.28 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -174.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.709 ' CD2' ' HA2' ' A' ' 61' ' ' GLY . 24.8 p90 -58.21 -33.43 69.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.365 0.602 . . . . 0.0 110.453 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 16' ' ' THR . 2.6 ptm180 -68.25 -25.88 65.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.767 -174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.458 ' HB ' HD22 ' A' ' 21' ' ' LEU . 2.4 m -65.13 -35.63 81.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.219 176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.137 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.1 mm? -91.93 -48.12 6.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.298 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' A' ' 27' ' ' LEU . 36.4 mm -67.52 -12.61 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.861 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 2.7 tmmt? -48.0 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.325 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.9 p -118.31 -32.08 4.77 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -172.73 -20.7 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.198 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.701 ' HG2' ' HA ' ' A' ' 21' ' ' LEU . 2.1 pm0 -63.37 -21.39 66.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -168.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.137 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 4.7 tp -121.59 83.4 2.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . . . -73.24 141.34 80.66 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.508 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 3.0 Cg_exo -77.09 123.7 6.87 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 110.903 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.14 46.43 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -174.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -118.26 156.63 28.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 24.1 p -82.69 138.77 34.0 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.256 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 151.09 86.2 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.63 168.32 24.62 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.696 2.264 . . . . 0.0 112.694 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -76.73 -179.23 5.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.192 -177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -62.17 -19.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.924 -171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.63 75.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.53 -55.06 19.86 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.861 0.362 . . . . 0.0 111.058 -176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.725 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.4 mp -58.11 -39.83 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.047 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 5.2 tmm_? -79.76 -28.25 40.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.347 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . . . -82.6 -31.73 28.74 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -75.48 -65.36 0.9 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 45' ' ' VAL . 3.1 m-85 -91.92 111.27 22.74 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.19 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.95 92.33 0.01 OUTLIER Glycine 0 CA--C 1.519 0.311 0 O-C-N 124.016 0.822 . . . . 0.0 113.363 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 18.8 m -138.81 -179.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.51 174.61 7.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.913 0.387 . . . . 0.0 110.535 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -76.45 -14.62 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.741 176.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.449 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 44.0 m -73.15 -42.11 63.18 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.948 0.404 . . . . 0.0 109.947 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 81.5 t -54.52 -61.33 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.484 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.621 ' HA ' HD12 ' A' ' 54' ' ' LEU . 13.0 t -57.48 -25.43 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.522 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 11' ' ' TYR . 77.1 ttt180 -72.93 -48.29 38.19 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.099 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -63.58 -31.04 72.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.037 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.647 ' HA ' ' HB2' ' A' ' 57' ' ' LEU . 86.8 mt -58.18 -29.52 65.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.161 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' O ' ' HE2' ' A' ' 58' ' ' LYS . . . -67.77 -28.84 67.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.354 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 60' ' ' GLU . 26.3 t -84.84 -32.15 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.859 0.838 . . . . 0.0 109.059 175.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.721 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 1.8 mp -77.51 4.46 11.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.828 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 55' ' ' ALA . 41.4 mtmt -65.62 -56.63 11.14 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -93.85 -40.5 10.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.893 -177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 9.7 tp10 -73.62 -51.07 18.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.772 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.721 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -88.64 -13.23 63.3 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.877 -176.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 76' ' ' ASN . 63.9 mt 66.2 66.95 0.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.979 0.458 . . . . 0.0 111.826 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 57' ' ' LEU . 32.8 m -136.87 156.45 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.46 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.9 t -116.61 95.63 5.13 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.359 0.6 . . . . 0.0 109.842 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -84.86 109.17 17.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.92 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.41 108.6 20.2 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.141 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -77.15 47.24 2.58 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.164 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.76 -55.87 0.05 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.293 0.568 . . . . 0.0 109.613 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -85.81 -36.53 20.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.253 176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.0 175.41 13.88 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.56 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.4 p -87.83 104.9 17.02 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 15.5 t -114.54 139.84 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.388 . . . . 0.0 110.267 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 29' ' ' PRO . 21.4 t -90.84 91.0 3.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -94.51 138.81 31.97 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.475 ' NZ ' ' HB3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -71.31 84.73 0.78 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.547 ' O ' HD22 ' A' ' 62' ' ' LEU . 83.1 m-20 -67.97 140.13 93.5 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.615 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HB2' HG13 ' A' ' 80' ' ' ILE . 6.3 Cg_exo -77.67 118.2 4.46 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.705 2.27 . . . . 0.0 110.055 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.517 HG12 HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -58.88 115.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.743 -174.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 m 23.62 70.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.245 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.522 HG13 ' HB2' ' A' ' 77' ' ' PRO . 29.5 mm -88.08 107.58 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.347 0.594 . . . . 0.0 111.329 -173.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.533 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 6.6 p -104.43 -27.03 12.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.518 172.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.652 ' HA2' ' HB2' ' A' ' 86' ' ' LEU . . . -96.58 -148.58 24.38 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.834 177.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 61.52 -72.14 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.716 0.806 . . . . 0.0 112.624 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.552 ' HA ' ' HE3' ' A' ' 87' ' ' LYS . 31.1 t70 -103.83 -33.53 8.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.361 . . . . 0.0 111.16 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -90.81 -14.33 32.11 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.329 -0.549 . . . . 0.0 111.518 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.652 ' HB2' ' HA2' ' A' ' 82' ' ' GLY . 52.3 mt -115.62 94.52 4.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 173.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.552 ' HE3' ' HA ' ' A' ' 84' ' ' ASP . 87.8 mttt -121.17 -66.64 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.989 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 67.46 -74.89 0.07 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.733 0.646 . . . . 0.0 110.803 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.403 ' O ' ' HB3' ' A' ' 90' ' ' GLU . 12.7 tpt -167.99 156.38 8.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -174.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 89' ' ' MET . 23.0 tt0 75.2 -65.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.714 0.634 . . . . 0.0 111.523 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -90.35 119.98 31.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.344 0.592 . . . . 0.0 111.262 -174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -128.35 121.97 30.4 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.488 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.11 -89.2 1.39 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.921 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.479 ' HG2' ' H ' ' A' ' 95' ' ' ARG . 44.2 ttp -95.02 174.67 6.97 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 94' ' ' MET . 66.4 mtt85 -108.19 157.27 18.46 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -83.76 153.61 24.04 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.54 112.68 28.36 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.029 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.39 24.65 0.73 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.966 2.444 . . . . 0.0 112.23 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.67 27.37 2.07 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.719 -179.144 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.88 127.76 19.34 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.599 2.199 . . . . 0.0 111.16 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 66.5 t80 -85.62 128.66 34.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.176 0.512 . . . . 0.0 111.26 -175.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -92.93 114.12 26.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.401 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -81.89 122.28 79.91 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.731 0.301 . . . . 0.0 110.531 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.504 ' HB2' ' HG3' ' A' ' 9' ' ' LYS . 84.6 Cg_endo -95.53 134.08 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.199 2.6 . . . . 0.0 113.182 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -99.87 -73.81 0.62 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.11 92.08 1.71 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.66 ' HD3' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -75.92 178.55 6.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.196 0.998 . . . . 0.0 112.919 -172.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' ALA . . . 168.57 151.13 6.98 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.122 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 9.3 p90 -70.66 8.03 0.96 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.419 0.609 . . . . 0.0 110.584 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . -79.78 -28.1 40.34 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.17 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 12.4 t70 -67.56 -50.08 60.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.026 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.551 HG23 ' CB ' ' A' ' 53' ' ' ALA . 2.3 m -71.02 -36.89 65.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.415 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 57' ' ' LEU . . . -55.37 -48.76 73.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.036 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -80.05 -22.41 42.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.486 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 1.7 m170 -85.97 -30.3 22.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -73.27 -18.44 61.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.983 0.421 . . . . 0.0 110.625 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -63.18 -17.53 62.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.504 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.83 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 6.8 m -81.94 -26.48 33.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.137 0.494 . . . . 0.0 110.769 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.955 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 3.6 mm? -81.88 -51.81 7.72 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.496 HG21 ' HA2' ' A' ' 61' ' ' GLY . 11.2 tp -79.69 14.03 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.072 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.83 ' HE2' ' HA ' ' A' ' 20' ' ' THR . 24.4 ttmm -67.64 -77.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 m -117.36 -29.79 5.75 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.6 -25.84 0.02 OUTLIER Glycine 0 C--N 1.332 0.316 0 C-N-CA 118.84 -1.648 . . . . 0.0 114.957 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -53.95 -42.74 69.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.025 0.412 . . . . 0.0 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.955 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -113.31 78.31 1.13 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.92 95.27 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.447 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.894 ' HA ' HG13 ' A' ' 73' ' ' VAL . 37.5 Cg_endo -70.93 136.84 30.81 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.032 2.488 . . . . 0.0 111.767 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.89 13.4 56.59 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.481 -170.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 73' ' ' VAL . 4.8 t0 -122.77 164.19 18.81 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 72' ' ' VAL . 22.1 p -78.87 152.81 31.01 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.969 0.414 . . . . 0.0 111.11 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.66 HD21 ' HB ' ' A' ' 73' ' ' VAL . 8.7 mt -85.94 152.12 55.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.287 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.49 168.09 24.41 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.594 2.196 . . . . 0.0 111.017 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 t -73.21 155.82 39.19 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HA ' HD13 ' A' ' 39' ' ' ILE . 28.8 m -53.86 -21.21 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 O-C-N 123.28 0.363 . . . . 0.0 111.914 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.83 92.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.962 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.59 -51.88 63.38 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.393 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 39' ' ' ILE . 4.4 mp -57.88 -54.51 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.218 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER -73.26 -17.89 61.28 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -171.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 3' ' ' TYR . . . -82.57 -44.81 15.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.359 -0.537 . . . . 0.0 110.595 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.921 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -75.99 -52.24 10.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.579 ' HD2' HG23 ' A' ' 39' ' ' ILE . 2.9 m-85 -93.11 105.78 17.83 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.261 -1.336 . . . . 0.0 108.631 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 85.43 0.01 OUTLIER Glycine 0 CA--C 1.516 0.115 0 O-C-N 123.638 0.586 . . . . 0.0 113.926 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.787 ' HB ' ' HB ' ' A' ' 49' ' ' THR . 27.8 m -142.03 179.12 2.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.61 -169.93 2.23 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.22 -40.36 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.987 0.422 . . . . 0.0 110.349 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -75.05 -31.07 61.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.604 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.787 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 5.4 m -58.06 -34.49 70.18 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.141 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.641 HG13 HG21 ' A' ' 39' ' ' ILE . 60.8 t -57.32 -59.05 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.376 0.608 . . . . 0.0 109.974 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.561 ' HA ' HD12 ' A' ' 54' ' ' LEU . 23.1 t -65.25 -11.9 46.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.612 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 49' ' ' THR . 32.2 tpt180 -76.74 -42.68 40.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.551 ' CB ' HG23 ' A' ' 14' ' ' VAL . . . -80.56 -19.66 45.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.437 176.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.686 HD22 HG21 ' A' ' 63' ' ' VAL . 44.8 mt -57.31 -25.52 59.44 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.512 ' O ' ' HG2' ' A' ' 58' ' ' LYS . . . -72.65 -20.71 61.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.078 0.466 . . . . 0.0 110.71 176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.06 -39.02 11.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.715 ' HA ' ' H ' ' A' ' 61' ' ' GLY . 4.8 mp -71.27 6.68 1.59 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.922 178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.877 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 22.0 pttp -76.37 -42.37 44.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -92.7 -45.05 8.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.161 173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -75.97 -46.42 29.76 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.088 0.47 . . . . 0.0 111.243 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.715 ' H ' ' HA ' ' A' ' 57' ' ' LEU . . . -91.21 -13.52 58.65 Favored Glycine 0 N--CA 1.454 -0.163 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.605 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.797 HD21 HG12 ' A' ' 78' ' ' ILE . 22.2 mt 67.69 28.33 7.33 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.785 0.434 . . . . 0.0 111.742 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.805 HG12 HG23 ' A' ' 73' ' ' VAL . 8.6 m -108.81 143.38 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.903 0.383 . . . . 0.0 111.342 -171.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 41.0 t -144.95 149.24 34.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.572 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.9 p -90.32 90.1 7.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.341 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.526 ' HB3' ' O ' ' A' ' 70' ' ' GLY . 4.3 tpp180 -71.48 105.19 3.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.054 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -76.97 59.07 3.53 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.239 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -158.95 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.48 -28.1 37.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.753 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 66' ' ' ARG . . . 128.51 -159.21 21.95 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.591 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.91 112.57 16.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 60.9 t -132.24 135.83 57.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -169.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 29' ' ' PRO . 11.6 p -82.56 75.7 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 122.335 1.064 . . . . 0.0 110.856 -173.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -144.96 83.3 1.69 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.11 162.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.877 ' HG2' ' HB2' ' A' ' 58' ' ' LYS . 55.6 tptt -95.82 -81.1 0.41 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.764 0.792 . . . . 0.0 111.374 175.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.462 ' HB2' ' HG3' ' A' ' 75' ' ' LYS . 3.1 t-20 -130.7 91.96 35.89 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.839 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 76' ' ' ASN . 3.6 Cg_exo -40.06 122.41 1.14 Allowed 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.983 2.455 . . . . 0.0 111.23 175.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.797 HG12 HD21 ' A' ' 62' ' ' LEU . 4.0 mm -55.41 118.27 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.4 t -56.68 79.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 124.567 1.167 . . . . 0.0 111.384 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 78' ' ' ILE . 69.1 mt -78.92 112.84 17.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.072 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -83.38 38.88 0.63 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.654 0.74 . . . . 0.0 110.674 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.55 -127.04 0.87 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.266 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' O ' HD22 ' A' ' 86' ' ' LEU . . . -162.69 172.93 14.55 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.81 5.67 15.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.078 0.942 . . . . 0.0 109.852 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -76.44 -3.93 39.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.822 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' A' ' 89' ' ' MET . 1.9 pt? -72.42 89.47 1.25 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.963 0.887 . . . . 0.0 110.887 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -69.48 -30.75 68.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.5 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 88' ' ' ARG . 6.5 tpp180 -127.75 21.16 6.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.487 0.661 . . . . 0.0 109.596 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.63 ' HA ' HD12 ' A' ' 86' ' ' LEU . 47.5 ttm 63.36 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.56 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.83 46.48 1.36 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.251 0.548 . . . . 0.0 111.169 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -78.97 109.8 13.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.495 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 0.9 OUTLIER -63.23 143.58 57.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.082 -177.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -42.92 -70.17 0.54 Allowed Glycine 0 C--N 1.333 0.396 0 O-C-N 123.854 0.721 . . . . 0.0 113.413 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 39.7 tpp -91.15 53.87 2.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.722 0.773 . . . . 0.0 110.325 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.495 ' HG3' ' HB2' ' A' ' 92' ' ' ASN . 43.1 mmt180 -142.44 108.01 5.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.03 175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -118.71 104.92 11.05 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.95 108.24 1.75 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.105 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -93.93 5.2 2.81 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.259 2.639 . . . . 0.0 112.736 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.78 43.0 1.29 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.41 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.234 177.061 . . . . . . . . 0 0 . 1 stop_ save_